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1.1 Aquaculture – the current status  
Aquaculture plays an important role for generating lasting benefits for global food security, 
rural development and poverty alleviation in many countries. In addition, about 58.3 million 
people were engaged in 2012 in the primary sector of capture fisheries and aquaculture, and 
about 10 – 12% of the world’s population depends on fisheries and aquaculture for their 
livelihoods. 
Today, aquaculture is one of the fastest growing food-production sectors in the world. 
According to FAO statistics, the world total production of aquaculture rapidly increased from 
13.1 million tons in 1990 to 66.6 million tons in 2012 (Table 1). From those, two-thirds (44.2 
million tons) were finfish species from inland aquaculture
1
 (38.6 million tons) and 
mariculture
2
 (5.6 million tons) (Figure 1.1). In the last five decades (1960 – 2012) food fish 
supply has increased at an average annual rate of 3.2 percent outpacing world population 
growth which amounts to 1.6 percent. The average fish consumption per capita increased 
from 9.9 kg in 1960s to 19.2 kg in 2012.  
On the other hand, the global capture fishery production remained stable in the last five 
decades (1970 – 2012), at an average of 91.3 million tons in 2012. The major fish capture 
countries such as China, Indonesia, United States of America and Peru have seen their 
fisheries reaching their maximum potential. Therefore, total fish capture from nature is 
anticipated not to reach the global demand of aquatic food. FAO estimated that the global 
aquaculture production would need to reach 80 million tons by 2050 to guarantee fish supply. 
In addition, overfishing not only causes negative ecological consequences but also reduces 
fish production, further leading to negative social and economic consequences. Therefore 
aquaculture will play a critical role to meet the increasing global demand contributing to safe 
and quality food fish.  
                                                        
1 inland aquaculture: freshwater aquaculture 
 
2 mariculture: coastal and brackishwater aquaculture 
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Figure 1.1 World production (million tonnes) of farmed species groups from inland 
aquaculture and mariculture in 2012 (Source: [1]). 
Inland aquaculture growth has outpaced marine culture growth, with average annual growth 
rates of 9.2 and 7.6 percent, respectively. Consequently, inland aquaculture steadily increased 
its contribution to total farmed food fish production from 50% in 1980 to 63% in 2012.  
Aquaculture development is imbalanced among the world regions. Asia holds the top position 
in world aquaculture production, accounting for 88% of global aquaculture production by 
volume in 2012, in which China alone supplied 61.7% of world aquaculture production by 
volume (Table 1.1). Generally, the world aquaculture production in different regions remains 
stable since 2010. 
In 2012, the farmed crustaceans accounted for 9.7% (6.4 million tons) of food fish 
aquaculture production by volume but 22.4% (US$30.9 billion) by value. Mollusc production 
(15.2 million tons) was more than double that of crustaceans, but its value was only half that 
of crustaceans (Table 1.2). 
Table 1.1 Production by region: quantity (tons) and percentage of world total production 
2012 (Source: [1]). 
Regions Quantity 
(tonnes) 
Percentage 
(%) 
Africa   1485367  2.23 
Americas   3187319  4.78 
Asia 58895736                    88.39 
Europe   2880641   4.32 
Oceania     184191   0.28 
World 66633253  
 Data exclude aquatic plants 
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Aquaculture remains a critical food producing sector that can create a significant contribution 
to the increasing demand for safe and high quality products. However, currently the 
aquaculture sector is facing issues such as biological threats and infectious diseases mainly 
due to the intensive aquaculture conditions. It is also anticipated that aquaculture will face a 
shortage of fish protein and fish oil. Moreover, depending on use of chemicals, such as 
antibiotics, still remains a problem. Although more than 88% of the world’s aquaculture 
production was from Asian countries such as Indonesia, Philippines and Vietnam [1], 
aquaculture production is mostly relying on the conventional and empirical approaches (with 
a strong evolution ongoing) in theses countries. In addition, management and regulations (and 
their enforcement) from the local authority and government is often insufficient. Despite 
aquaculture production in Asia being successful so far, in order to develop a more predictable, 
reliable, cost-effective and ultimately more sustainable industry, development of more 
knowledge-based procedures based on the understanding of the underlying mechanism of all 
biological processes are becoming increasingly indispensable [2]. 
Table 1.2 World production of aquaculture species from inland aquaculture and mariculture 
(Source [1]). 
 Inland 
aquaculture 
Mariculture Quantity 
subtotal 
Value subtotal 
(Million 
tons) 
(Million tons) (Million 
tons) 
(% by 
volume) 
(US$million) (% by 
value) 
Finfish 38.599   5.56 44.151 60.30   87.499 63.5 
Crustacean   2.530   3.917   6.447   9.70   30.864 22.4 
Molluscs   0.287 14.89 15.171 22.80   15.857 11.5 
Other 
species 
  0.530   0.335   0.865   1.30     3.512   2.5 
Total 41.95 24.69 66.63 100 137.732 100 
1.2 Vibriosis in aquaculture  
Disease outbreaks are major threats to the aquaculture sector, affecting the economic 
development of the sector in many countries [3]. Economic losses in the aquaculture industry 
resulting from disease outbreaks have been estimated by the FAO to be in excess of US$9 
billion per year, which is roughly 15% of the value of world farmed fish and shellfish 
production. Bacteria and viruses are the major etiological agents in aquaculture. Bacterial 
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pathogens have been reported to cause more disease problems than all other causes combined 
[4].  
Vibrio spp. such as V. anguillarum, V. alginolyticus, V. campbellii, V. splendidus, V. 
coralliilyticus and V. harveyi, are the common and serious pathogens in fish and selfish 
marine aquaculture worldwide. Vibrios are Gram-negative, ubiquitous in marine and estuarine 
ecosystems as well as aquaculture farms. Many vibrios are serious pathogens for animals 
reared in aquaculture. Vibriosis, caused by infection by Vibrio spp, is one of the most 
prevalent diseases in fishes and other aquaculture-raised organisms, and is widely responsible 
for mortality in culture aquaculture systems worldwide. Vibriosis is a disease which occurs 
rapidly, induces weak muscular movement, red discoloration, partial tail cramping, tissue and 
appendage necrosis, slow metamorphosis and growth, body malformation, bioluminescence. 
Resulting in high mortality for many aquatic species such as shrimp, fin fish and mollusks [5].  
Recently, V. parahaemolyticus has been received more attention as one of the agents that 
causes early mortality in shrimp cultivation ponds. Early mortality syndrome (EMS) refers to 
unusual, acute mortality in shrimp approximately within the first 35 days after stocking 
cultivation ponds. Such outbreaks in farmed pacific white shrimp or whiteleg shrimp 
(Panaeus vannamei) were first reported in Thailand from farms in 2012. The Thai 
Department of Fisheries reported that outbreaks of EMS in cultivated shrimp were responsible 
for a 33% drop in shrimp production during the first quarter of 2013. Currently, it has been 
reported that unlike other fish-pathogenic Vibrio species, in which the plasmids contribute to 
virulence via a plasmid-encoded iron acquisition system or confer resistance against the 
serum killing effect to overcome host defenses. In V. parahaemolyticus, the virulence 
plasmids produce toxins that immediately destroy the host cells [6]. 
V. harveyi is associated with luminescent vibriosis in shrimps for instance, Litopenaeus 
vannamei and Penaeus monodon, and it has been considered as a major constraint to shrimp 
production by causing mass mortality in South America and Asia [7]. Moreover, V. harveyi is 
one of the most significant pathogens in larviculture. It has been regarded as both a primary 
and opportunistic pathogen for a wide range of marine species, including corals, finfish, 
oysters, shrimp, prawns and lobsters. Accumulating evidence have suggested that V. harveyi 
causes diseases in the host through several steps, which include penetration of the host tissues 
by chemotactic motility, sequestration of iron from the host in order to replicate and cause 
disease [8], and infliction of damage by producing a extracellular virulence factors, such as 
hemolysins, phospholipases, proteases, and biofilm formation [7, 9].  
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As virulence factors are often costly metabolic products, their expression usually is controlled 
by regulatory mechanism such as quorum sensing, bacterial cell-to-cell communication with 
small signal molecules [10]. In V. harveyi, virulence factors have been found to be quorum 
sensing-regulated include biofilm formation, the production of siderophores, chitinase, 
caseinase, gelatinase, metalloprotease, phospholipase, extracellular toxins, type III secretion 
and motility [11-13]. In addition, quorum sensing has also been reported to control the 
virulence of luminescent V. harveyi towards different hosts in vivo [14, 15].  
V. harveyi is also one of the model organisms in studies on quorum sensing in bacteria. This 
bacterium contains a three-channel quorum sensing system, with three different types of 
signal molecules feeding a shared signal transduction cascade. Central in the signal 
transduction cascade is the LuxO protein. Phosphorylated LuxO indirectly inhibits production 
of the transcriptional regulator protein LuxR, whereas unphosphorylated LuxO is incapable of 
exerting this activity because of a conformational change. LuxR directly activates the lux 
operon and directly or indirectly controls many other quorum sensing target genes [16, 17]. 
Despite extensive studies on this species, the pathogenicity mechanisms of V. harveyi are not 
completely understood. A good understandings of the behavior of bacterial pathogens or how 
do they perform to adapt under alterations of the natural ecosystems and within the host is 
urgently needed for vaccine development and for sustainable development of aquaculture.  
 
Research objectives and thesis outline 
This PhD study consists of two main parts: the first part of this study focuses on producing 
the non-luminescent variants from the luminescent of the wild type V. harveyi and its quorum 
sensing mutant strains. Subsequently, differences in virulence factors such as caseinase, 
haemolysin, elastase, biofilm formation between the luminescent and its non-luminescent 
variant of the V. harveyi are investigated. In the second part, the GART system is used in 
order to verify how the host responds to luminescent and non-luminescent variants of V. 
harveyi at both transcriptional level for instance, the expression profile of some immune 
related genes, and translational level of heat shock protein 70 and high-mobility group box-1 
proteins. Finally, the molecular characterization and expression of hmgb1 in Escherichia coli 
is solved for further applications.  
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The general objective of this study was to evaluate phenotypic alterations in Vibrio (e.g. in 
term of virulence factors production) and their effect on host immune responses using brine 
shrimp Artemia as a model.  
The specific objectives and the thesis outline were as follows: 
Chapter 2 (Review of literature) aimed at giving an overview of the literature on 
phenotypic variation in bacteria, their role in natural ecosystems, and consequence of 
these variations for host microbial interactions for instance in relation to the immune 
response. 
Chapter 3 (Characterization of phenotype variation of luminescent and non-
luminescent variants of V. harveyi wild type and quorum sensing mutants) aimed at 
studying phenotype variation with respect to haemolysis, elastase, caseinase and biofilm 
formation of luminescent and non-luminescent variants of Vibrio harveyi wild type and 
its quorum sensing mutants. 
Chapter 4 (Expression profile of immune-related genes in Artemia franciscana 
challenged with luminescent and non-luminescent variants of V. harveyi wild type 
and quorum sensing mutants) aimed at investigating the expression profile of immune-
related genes in Artemia franciscana challenged with luminescent and non-luminescent 
variants of Vibrio harveyi wild type and its quorum sensing mutants. 
Chapter 5 (Transcriptional and translational analysis of expression profiles of heat 
shock protein 70 and high-mobility group box-1 protein in gnotobiotic brine shrimp 
challenged with isogenic V. harveyi with different levels of virulence) aimed at 
investigating the transcriptional and translational analysis of expression profiles of heat 
shock protein 70 and high-mobility group box-1 protein in gnotobiotic brine shrimp 
challenged with Vibrio harveyi. 
Chapter 6 (Molecular characterization and expression of the Artemia franciscana 
hmgb1 gene) aimed at cloning and sequencing the full-length cDNA of the high-mobility 
group box-1 gene and its recombinant production in E. coli. 
Chapter 7 (General discussion and conclusion) highlights and discusses the most 
important findings of this work and provides some direction for future research. 
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2.1. Phenotypic variation in bacteria: an opportunity for thriving, persisting and 
evading the host immune system 
The potential of bacteria to thrive in a variety of ecological niches strongly depends on their 
genetic content. However, bacteria are influenced within these niches by fluctuating 
environmental factors, such as pH, salinity, temperature and the availability of nutrients [18]. 
In addition, pathogenic bacteria may encounter interspecies competition, such as the immune 
defense system from the host during infection. Bacteria adapt to survive these stressors by 
sensing the changes and responding appropriately, changing phenotype to meet fluctuating 
environmental conditions [19]. For example, E. coli can switch spontaneously and reversibly 
to a phenotype that can slow down its growth, reducing its sensitivity to antibiotics [20].  
Phenotypic (phase) variation (Figure 2.1) is defined as a process of reversible, high frequency 
phenotypic variation that is mediated by DNA mutations, reorganization or modification [21]. 
Phenotypic variation was first described in Candida albicans over 20 years ago and later this 
phenomenon was observed in fungal and bacterial species, such as Cryptococcus neoformans, 
Pseudomonas aeruginosa, Staphylococcus aureus, Escherichia coli, Salmonella spp and 
Neisseria spp [22-24]. Phenotypic variation has been observed in both pathogenic and non-
pathogenic bacteria. The switch involves changes in the polysaccharide capsule and cell wall 
that affect the pathogen’s ability to resist phagocytosis. In addition, the phenotypic switch 
variants elicit qualitatively different inflammatory responses in the host [22]. Moreover, 
phenotypic variation can alter the host-pathogen relationship. For example, pathogenic 
Neisseria spp. possess 12 different phase-variable Opa proteins that mediate various 
pathogen-host cell interaction, including bacterial engulfment by epithelial cells and opsonin-
independent phagocytosis by phagocytes [25]. 
Phenotypic variation is used by several bacterial species to generate population diversity that 
enhances bacterial fitness under certain conditions and is important in niche adaptation and 
host immune evasion. However, a fraction of the population preserves its phenotypic 
unaltered status ensuring the ability of the population to overcome future and new adverse 
conditions that may occur [26]. Phenotypic variation can be modulated by a variety of 
external factors (responsive switching) [23, 27]. For example, studies on the capsular 
polysaccharide (CPS) phase variation in Vibrio vulnificus revealed that under the alteration of 
environmental conditions, such as variation in aeration, temperature, and incubation time, the 
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amount of CPS expressed on the cell surface was significantly changed, and the colony 
phenotype converted from an opaque to a translucent colony [28]. 
 
Figure 2. 1 Phenotypic variation refers to a reversible switch between two phenotypic states, 
analogue to a mechanism ON/OFF (Source [29]).  
 
(A) When the expression state of one of the cells of an “off” cell has switched, and both grow to a 
colony. “ON” cells are depicted blue and “OFF” cells white. (B) Colonies from a streak of a single 
white colony. Combination of phenotypes: colonies with predominantly “ON” cells are blue and 
colonies with predominantly “OFF” cells are white. (C) Typical result of streaking an “ON” (blue) 
colony and an “OFF” (white) colony for single colonies. The plates clearly illustrate the bias in 
progeny phenotypes as a result of parental phenotype. The number of generations during which this 
bias exists depends on the frequency of switching.  
Phase variation has been intensively studied in Pseudomonas [23, 24, 30] and Vibrio bacteria 
[31, 32]. The studies on Pseudomonas showed that phenotypic variation is involved in 
influencing the production of exo-enzymes, secondary metabolites, colonization behavior, and 
biocontrol activity of rhizosphere bacteria [33, 34]. In addition, phenotypic variation may 
contribute both to pathogenicity of V. vulnificus and to its survival under adverse 
environmental conditions [35] or enhance predation-driven persistence of V. cholera from the 
predation of protozoa in the environment [31]. Recently, Srivastava et al. [32] showed that the 
virulence of V. vulnificus was related to phenotypic variation in colony morphology, for 
example, opaque (encapsulated, virulent), translucent (reduced encapsulation, avirulent) and 
rugose (wrinkled, biofilm-enhanced) colony morphology. Results from this study also 
suggested that variable colony types reflect differences in the capsular polysaccharide 
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composition or level of expression and provide adaptive strategies for survival in different 
environments. 
2.1.1. Role of phenotypic variation in bacteria 
In general, the role of phenotypic variation is to provide the bacterium with a strategy for 
adapting to more than one particular environment [36]. The existence of single cells in the 
clonal population may ensure the survival of the population as a whole. Reversible phase 
variation (ON-OFF) continuously generates cells with varied phenotypes, leading to a mixed 
population. This phenotypic diversity ensures that, a percentage of the bacterial cells will 
express the phenotypic variation necessary for survival, regardless of the environmental 
changes[37]. These environments may be inside or outside the host, or may comprise more 
than one site within that host or even different steps in a pathogenic progress. Paenibacillus 
dendritiformis, a gram-positive, spore-forming bacterium can overcome competition and 
nutrient limitation by switching between two distinct vegetative phenotypes: motile rods and 
immotile cocci. Growing colonies of the rod-shaped bacteria can produce a toxic protein, or 
“sibling lethal factor” (Slf), which reduce the population density by killing cells of 
encroaching sibling colonies. However, sublethal concentrations of Slf induce the switch from 
motile, rod-shaped cells to non-motile, Slf-resistance, cocci in a small proportion of the cells. 
These cocci replicate, unlike dormant spores of P. dendritiformis. When over population is 
reduced and nutrients are no longer limiting, bacteria produce a signal that induces cocci to 
switch back to motile rods, allowing the population to disseminate [38]. 
Phenotypic variation has been intensively studied in Pseudomonas, highlighting the important 
roles of phenotypic variation in Pseudomonas. Different morphology variants were achieved 
as a result of phenotypic variation.  For instance, thick, small and opaque versus thin 
translucent colonies [39-41]. However, the determinants of these differences in colony 
morphology in Pseudomonas are not known. These variants showed differences in swimming 
and swarming.  Switching motility in P. aeruginosa via regulation of type IV pili gene 
expression [41] can regulate root colonization by P. fluorescens WCS365 and P. fluorescens 
F113 in tomato rhizosphere [42]. Phenotypic variation is also suggested to be an effective 
strategy for increasing the colonization ability in P. brassicacearum [43]. In addition, 
pathogenicity was affected by phenotypic variation in Pseudomonas species.  Weiser et al. 
[44] suggested that pathogenicity of in P. aeruginosa  may be associated with the expression 
of the phosphorylcholine epitope of a 43 kDa protein through phase variation [44].  
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Previous studies have proposed that phase variation is a mechanism by which pathogenic 
bacteria evade the host immune responses [45]. Surface components of the bacteria are highly 
immunogenic and therefore prime targets for protective antibodies. Recent studies showed 
that fimbrial phase variation in Salmonella is a mechanism by which the microorganism 
evade cross-immunity between different serotypes, thereby allowing their co-existence within 
a host [36].  In addition, phase variation of adhesion may assist bacteria to detach from 
colonized surfaces, to disseminate within the host, to shed back into the environment and/or to 
transfer to another host [46]. 
Recent work has shown that phenotypic variation is a phenomenon that is not only relevant in 
host-pathogen interactions but also influences colonization, biocontrol activity and the 
expression of co-enzymes and secondary metabolites (6).  
2.1.2. Implication of phenotypic variation 
Colony morphology variants 
The generation of heterogeneous and dynamic populations as a result of phenotypic variation 
can overcome stressful factors. The most visible feature of phenotypic variation is colony 
morphology variation, first described in 1964 by Zierdt et al. [47]. Colony macroscopic 
visualization, allows for predicting bacterial traits probably altered and their relationship with 
external factors. Moreover, the relationship between colony morphology changes, virulence, 
antimicrobial resistance and persistence can be established as well, which will be extremely 
useful in the design of biotechnological and therapeutic approaches. 
Several different colony morphologies have been identified and described for several bacteria, 
such as the small colonies variants (SCVs), rugose colony, and the mucoid morphotypes. 
Some of these morphotypes were associated with antimicrobial resistance, altered metabolism 
and reduced immunogenicity, contributing to increased bacterial pathogenicity and 
persistence. SCVs have been involved in persistent and device-related infections [48]. Deziel 
et al. [41] have revealed that SCVs are hyperpiliated with increased ability to form biofilm in 
comparison with the fast growing wild type morphotypes. Besides SCVs, the mucoid 
phenotype has also been addressed and was associated with the overproduction of 
exopolysaccharides (EPS). The overproduction of EPS protects bacteria from host defense 
and antibiotic therapy, extending the length of the infection [26]. 
Chapter 2 Review of literature  
15 
 
In addition, phenotypic variation can be visualized in some cases by color variation in 
colonies grown on specific media including a dye. For example, Phuoc et al. [49] reported 
that phase variation in V. campbellii leads to variable colony color when grown on Congo red 
agar, for example, non-luminescent colonies were black while its luminescent variant was red 
(Figure 2.2). The same phenomenon was also observed in Staphylococcus epidermidis under 
phase variation process of a polysaccharide adhesion [50]. 
 A            B 
 
Figure 2. 2 Non-luminescent (A) and luminescent (B) colonies of V. campbellii in Marine 
Agar with Congo red [49]. 
In addition, the capsule can influence interaction with the host cells and host environment, 
including invasion, adhesion, and serum sensitivity, and is well known as virulence factor. 
Phase variation of capsule synthesis can involve a classic ON/OFF but also has been used to 
describe modulation in the level of capsule production; thereby it can change colony 
morphology [51]. For example, a study using encapsulating bacterium, Neisseria 
meningitidis, showed that phenotypic phase variation controls the expression of the capsule 
gene in this bacterium. This finding indicated that bacteria could escape vaccine-induced or 
natural protective immunity by switching of capsule phenotype. Capsule switching may be an 
important virulence mechanism in other encapsulated bacterial pathogens. As vaccine 
development progresses and broader immunization with capsular polysaccharide conjugate 
vaccines becomes a reality, the ability to switch capsular types may have importance for the 
impact of these vaccines [52].  
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Phenotypic persisters 
In medicine and technology, the existence of subpopulation of cells highly tolerant to 
conventional treatments has a huge impact on the control and elimination of the infected 
bacteria and contaminations.  
Persistence is one of the most remarkable features of bacteria; it is the ability of bacteria to 
thrive after exposure to severe stressful conditions. Consequently, a rapid killing of the vast 
majority of cells is observed, followed by a more complex and slow killing of the remaining 
cells, called persister cells. Persisters are not resistant cells and do not have genetically-
acquired antimicrobial resistance. They are dormant cells, i.e., they remain metabolically 
inactive in stressful conditions, in a “non-dividing state”. After removal of the lethal 
conditions, persister cells can switch back to normal cells and generate a new population that 
is equally susceptible. The ability of persister cells to revert the to original population is 
supposed to be a sign of phenotypic variation [53]. 
Kussell et al. [54] suggested persistence as a bet-hedging strategy because under optimal 
conditions, the normal cells grow quickly and a small subpopulation suppresses growth. 
During time of stress, such as the presence of antibiotics, these persistent cells can prevent 
extinction of the entire population by their slow proliferation rate under growth condition 
leading to lower population fitness against antibiotic encounters [54]. Persisters show ability 
to reduce translation and topoisomerase activity, and/or reduce cell wall biosynthesis. As a 
result the target of many bactericidal antibiotics are blocked, and therefore these cells cannot 
be easily killed [53]. The molecular mechanism underlying persistence remained unclear until 
recently.  
Biofilm phenotypic switching 
The ability of biofilm formation in bacteria is an important virulence factor. Biofilm are 
assemblages of microorganisms, encased in a matrix [55]. Biofilm formation is an efficient 
microbial strategy to persist adverse conditions. Biofilm is developed through several stages. 
It is initiated when planktonic cells are released, migrate to a new surface and subsequently 
attach irreversibly. Later, bacteria grow and divide forming a mature biofilm. In the mature 
biofilm, cells are encased in an extracellular matrix composed of protein, exopolysaccharides 
and extracellular DNA. In addition, to immobilizing the bacteria, the matrix is a scaffold that 
traps nutrients and various biologically active molecules. The matrix works as an external 
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digestion system, as it can accumulate enzymes that can degrade various matrix components 
as well as any nutrients or other substrates. Subsequently, the degraded products are in close 
proximity to the cell and therefore facilitate uptake (Figure 2.3) [55]. Moreover, the matrix 
acts as a shield therefore bacteria in a biofilm exhibit various advantages over their planktonic 
counterparts, such as enhanced antimicrobial resistance, protection against predation, 
dehydration and phagocytosis [56]. During biofilm growth, bacteria receive a biofilm-specific 
phenotype that is distinct from their corresponding planktonic cells. 
 
Figure 2. 3 The complex structure of bacterial biofilm (Source [55]) 
a. Microcolonies in the mature biofilm are characterized by an extracellular polymerix 
substances (EPS) matrix, composed of extracellular DNA, polysaccharides, proteins, amyloid 
fibres and bacteriophages. The matrix functions as a shield to protect the bacterial community 
or population from predator, such as protozoa or lytic phages, as well as from chemical toxins. 
The EPS matrix may help to sequester nutrients, and along with the underlying bacteria, is 
also responsible for the establishment of gradients (for example, oxygen and nutrients 
diffusing inwards, and waste products as well as signals, such as nitric oxide diffusing 
outwards). 
b. At the time of dispersal, microcolonies undergo cell death and lysis along with appearance of 
superinfective bacteriophases as well as morphotypic and genetic variants in the biofilm 
effluent. 
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Bacteria in a mature biofilm undergo specific changes in physiological and protein regulation, 
especially those related with proteins involved in resistance to oxidative damage, 
exopolysaccharide production, phospholipids synthesis and membrane transport [24]. In fact, 
gene expression, morphology, phenotype, stage of differentiation and development are 
different between the cells in a mature biofilm [55]. For example, genes encoding for pili and 
flagella synthesis are down regulated because these elements are no longer required in a 
mature biofilm. Switching to biofilm-specific phenotypes can trigger mechanisms that are 
responsible for antimicrobial resistance, enhanced virulence and persistence [24]. The 
heterogeneous nature of the mature biofilm may be a consequence of differential gene 
expression by cells across different regions in the biofilm structure, as a result of nutrient  
gradients, electron acceptors and waste products or mutations that lead to a diversity of 
genotypic and phenotypic variants [55]. In addition, biofilms have been documented to reduce 
activation of complement systems, and as biofilm-growing bacteria are encased within 
exopolysaccharide matrix, they are less susceptible to phagocytosis. In some cases, biofilms 
are resistant even to humoral response [57]. For example, it has been shown that there is a 
link between antibiotic resistant and ability to form biofilms in P. aeruginosa [58]. In 
addition, another study also suggested that the increased resistance of Staphylococcus aureus 
biofilms to amikacin is largely dependent on the presence of persister cells. Biofilms harbor a 
greater number of persisters than the planktonic culture. In addition, planktonic persisters, 
even if they exist, are liable to be eliminated by the immune system in vivo, whereas biofilm 
persisters are protected by the exopolysaccharide matrix [59]. The persistence and survival of 
V. harveyi in shrimp hatcheries has been attributed to the bacterium’s biofilm formation 
ability, which is governing resistance to antibiotics and disinfectants [60]. 
Virulence phenotypic variants 
As stated above, phenotypic variation assists bacteria to escape the host’s immune recognition 
during their colonization and infection, affecting host-pathogen interaction [27]. Deitsch et al. 
[61] revealed that the subpopulation generated by present different sets of antigens and the 
immune system only reacts against those antigens that they can recognize. Therefore the 
phenotypic variants become a problem when the host immune system does not respond 
effectively.  
The relationship between phenotypic variation and virulence has been documented in many 
pathogenic bacteria. For example, in a study carried out on Streptococcus pneumoniae, it was 
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shown that opaque colony variants exhibited higher virulence than translucent variants [62]. 
Similar trends were observed for Helicobacter pylori [63], Salmonella enterica and 
Pseudomonas fluorescens. Phuoc et al. [64] have reported that non-luminescent variants of V. 
harveyi obtained by culturing luminescent variants under static conditions, showed colonies 
with different morphology compared with those of their parental luminescent strain. The 
difference in colony appearance was determined by differential staining on Marine Agar 
Congo red and it was found that the non-luminescent colonies were less round shaped on 
Marine Agar compared to the luminescent ones. It was also shown that non-luminescent 
strains exhibited less pathogenicity as verified in a challenge test carried out using the 
gnotobiotic Artemia franciscana model organism (GART) system. Following this study, 
Hong et al.[65] showed that there was a significant difference in virulence factors production 
such as swimming motility, biofilm formation, hemolysis and caseinase activities in non-
luminescent variants compared to its luminescent counterparts. 
Extracellular proteases play vital role in the virulence of many vibrios [66]. Serine protease 
and metalloprotease seem to be the major proteases in V. harveyi [67, 68]. Ruwandeepika et 
al. [69] reported that metalloprotease levels were found to be lower in the non-luminescent 
variants of V. harveyi when compared with the corresponding luminescent strains. The lower 
level of metalloprotease in the non-luminescent form was accompanied with the lower level 
of luxR mRNA – a virulence gene regulator. Moreover, differences in the metalloprotease 
expression might explain the lower pathogenicity of the non-luminescent variants towards the 
host Artemia in the challenge test. Recently, Zhou et al. [70] have reported that the non-
luminescent V. harveyi HBL0905 is highly pathogenic and generally causes epizootics with 
high mortalities in pond-cultivated penaeid shrimp population, especially following stressful 
events. The parental luminescent strain could be extremely virulent in comparison with its 
non-luminescent one, although, the luminescent strain was not investigated in this study. 
These results indicate that there may be a link between the phenotypic variation and 
pathogenicity in V. harveyi. 
Viable but non-culturable state 
The viable but non-culturable state (VBNC) state is a unique survival strategy that bacteria 
employ in response to adverse environmental conditions. The VBNC state of bacteria was 
previously referred as dormancy state but VBNC has been currently accepted as a distinct 
survival state of bacteria [71]. Cells in the VBNC state exhibit very low, but detectable, 
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metabolic activity compared to actively growing cells. Such dormant cells maintain the 
integrity of their cell membranes and continue to express genes at low levels. However, when 
they are transferred to solid nutrient media, they fail to form colonies, as opposed to active 
cells (Figure 2.4) 
 
Figure 2. 4 Classic VBNC induction experiment (Source [72]).  
VBNC cells (dark red) are induced by incubating a cell suspension (green) in a stressful environment 
(for example at low temperature). Over time, cells become undetectable on nutrient media (solid line); 
however, a large portion of the population remains viable (dashed curve). When the inducing stress is 
removed, the population becomes active after a resuscitation period (broken arrow). When cells are 
provided with nutrients they give rise to a population that is similarly tolerant to the inducing stress as 
was the original population (unbroken arrow).  
VBNC cells can be induced by variety of stressful conditions such as starvation, growth-
inhibiting temperature, and pH. For example, V. vulnificus can withstand a variety of stresses 
while dormant, including high dose of antibiotics, toxic heavy metals, high temperature, high 
salinity, ethanol, and acids [73]. In addition, in V. parahaemolyticus, a halophilic Gram-
negative bacterium is frequently isolated from fish, clams and crustaceans. V. 
parahaemolyticus may be present in a VBNC state during the winter, and could not be 
cultured on agar medium. It has been shown that V. parahaemolyticus can reach the VBNC 
state in 50 to 80 days during starvation at 3.5C. Moreover, the VBNC cells of V. 
parahaemolyticus were highly resistant to thermal (42, 47C), low salinity (0% NaCl), or acid 
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(pH 4.0) inactivation. These results suggested that the VBNC state is part of a survival 
strategy in an adverse environment of V. parahaemolyticus [74]. 
The physiological consequence of the VBNC state could be an adaptive effect that supports 
long-term survival under unfavorable conditions or an effect of cellular deterioration, which 
conserves specific features of viable cells but results in a loss of cultivability with available 
techniques. This state can be thought of as an inactive form of life waiting for revival under 
suitable conditions [75].  
The luminous vibrio species such as V. harveyi, V. fisheri, V. cholera are capable of 
transforming into a VBNC state and undergo alteration in cell morphology. In this state, V. 
cholera cells become smaller in size and change from rod to ovoid or coccoid morphology, 
with the central region of the cells becoming compressed and surrounded by denser cytoplasm 
by using transmission and scanning electron microscopy [76]. 
V. harveyi and V. fisheri entered into the VBNC state upon salinity and nutrient limitation of 
the artificial sea water. Adaptation of these bacteria to low nutrient conditions or to other 
environmental parameters was demonstrated by the rapid switching off of bioluminescence in 
nutrient-free microcosms. The ability of these luminous bacteria to recover from VBNC state 
was observed after addition of a low concentration of several nutrients [77].  
2.1.3 Mechanism of phenotypic variation 
Phenotypic variation can be mediated by specific genetic alterations or by epigenetic 
mechanisms. Hence, it has been difficult to demonstrate whether the mechanism attributed to 
phenotypic variation in vitro are the same at play in vivo. The following are the (proposed) 
molecular mechanisms that may be involved in phenotypic variation in bacteria.  
Slipped-strand mispairing 
Slipped-strand mispairing uses short sequence repeats to regulate gene expression at the 
transcriptional or translational level.  Repeats associated with a single locus, present in the 
promoter region or within the coding region, can alter gene expression as a result of changes 
in the number of repeats. The number of repeats is varied via a RecA-independent mechanism 
through the formation of heteroduplex DNA (H-DNA), which is induced by superhelical 
coiling [78]. This H-DNA consists of a triple-stranded region, based on the formation of triple 
residue bonds within the repeat region, with as a result a single-stranded region, which will 
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stimulate slipped-strand mispairing [36]. Change in number of repeats will result in an 
incomplete gene product due to a shift in reading frames (Figure 2.5). Examples of traits 
regulated via slipped-strand mispairing are presented in Table 2.1. 
 
 
Figure 2. 5 Model for phase variation via slipped-strand mispairing (Source [21]) 
A. Model of ON and OFF switching of traits via slipped-strand mispairing. Variation in the 
number of repeats within the coding region of the gene results in a shift of reading frame in or out of 
the frame. A shift out of frame will introduce the premature stop codon (*). 
B. Model for volume control via slipped-strand mispairing. Variations in the number of repeats 
within the promoter region of the gene will vary promoter -10 and -35 spacing, thereby increasing 
(ON
++
) or decreasing (ON or OFF) promoter efficiency [21]. 
The alteration of slipped-strand mispairing mechanism regulates gene expression at the level of 
transcription [79]. This regulation is mediated by the presence of the repeats upstream of the encoding 
gene, which upon variation of the number of repeats, results in an increase or decrease in expression 
by varying the promoter spacing. Slipped-strand mispairing as a regulator mechanism is present in a 
wide range of bacteria and regulates various traits. 
 
Genomic rearrangement  
Genomic rearrangements combine a wide range of processes involved in phase variation, 
including inversions, deletions, gene duplication and gene transfer using silent copies 
(recombinational deletion) [80]. For example, control of expression of type 1 fimbriae in 
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Escherichia coli is based on the presence of inverted repeats and the action of site-specific 
recombinases. The presence of inverted repeats within the promoter region facilitates the 
inversion of the promoter switching expression ON or OFF. Alternatively, when the promoter 
itself is flanked by inverted repeats, different sets of genes can be expressed. 
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Table 2.1 Examples of phase variation traits (Source [21]) 
Mechanism Locus Species Property affected Reference 
Slipped-strand 
mispairing ONOFF 
fucT2 (AF076779) Helicobacter pylori LPS antigenicity, Lewis Y antigen [81] 
 lic1A, 2A, 3A (M37912-14) Haemophilus influenza LPS antigenicity [82] 
 pilC (Z49120) Neisseria gonorhoeae Fimlbrial expression [83] 
 siaD (M95053) N. meningitides Capsular polysaccharides [84] 
 flhB (AF031418) Pseudomonas putida Flagellum export [43] 
 opa (P11296) N. gonorhoeae/N. meninggitides Adhension/invation/neutrophil interaction [85] 
 bvgS (M25401) Bordetella spp. Two component sensing [86] 
 lob1 (U94833) Haemophilus somnus Antigenicity of LOS [87] 
 p78 (AF100324) Mycoplasma fermantans ABC transporter [88] 
 ctpH (X74730) Vibrio cholera ToxR regulon [89] 
 hpuA (AF031495) N. gonorrhoeae Hemoglobin binding outer membrane proteins [90] 
 hmbR, hpuAB (AF105339, U73112) N. meningitidis Hemoglobin receptors [91] 
Genomic rearrangement     
Site-specific fimA (Z37500) Escherichia coli Fimbrial expression [92] 
inversion ONOFF omp1 (U02462) Dichelobacter nodusus Major outer membrane protein [93] 
 vspA (L81118) Moraxella bovis Surface lipoprotein antigens [94] 
 hsd1 (AF003541) Mycoplasma pulmonis DNA restriction and modification properties [95] 
ONa/OFFb  ONb/OFFa Hin (V01370)  Salmonella spp. Flagellar expression [96] 
 piv (M34367) Maraxella lacunata Type IV fimbriae [97] 
Recombinational pilE (AF043652) N. gonorrhoeae/N. meningitides Fimbrial expression [98] 
deletion ON   OFF vsg genes  Trypanosoma spp. Variable surface glycoproteins [99] 
 vsp (AF396970 and AH008162) M. bovis Surface lipoproteins [94] 
 vsp/vlp (AF049852) Borrelia spp. Surface proteins [100] 
Spontaneous 
duplications 
ONOFF 
cap3, cap8, tts (Z12159, AJ239004, 
AJ131985) 
pheN (U95300) 
Streptococcus pneumonia 
Pseudomonas tolaasii 
Capsule production 
Secondary metabolism/morphology 
[101] 
[39] 
Differential  agn43 (U24429) E. coli Autoaggregation [102] 
methylation pap (X03391) E. coli Pilus expression [103] 
ON OFF pef (AB041905) Salmonella typhimurium Filmbrial expression [104] 
Unprogrammed variation     
Spontaneous  vir locus Bordetella bronchiseptica Virulence factors [105] 
mutation ONOFF gacA/S (AY236957) Pseudomonas sp. PCL1171 Secondary metabolism and exo-enzymes [21] 
Mechanism unknown  Pseudomonas aeruginosa Motility/flagella/biofilm formation [41] 
  Pseudomonas brassicacearum Root colonization/flagella/exo-enzymes [40] 
  Pseudomonas fluorescens WCS365 Root colonization [42] 
  P. fluorescens F113 Root colonization/motility/biofilm formation [106] 
  Azospirillum lipoferum Motility and assimilation of certain sugars [107] 
             LPS: lipopoly saccharide; LOS: lipo-oligo saccharide; ABC: ATP-binding cassette. 
Chapter 2 Review of literature  
 
 
25 
 
Gene conversion is the most versatile of all mechanisms of recombinational forms of 
antigenic variation. A second form of variation based on genomic rearrangement, uses 
deletion for example, when regulating variation of type IV pili in N.gonorrhoeae [108] and 
the expression of the surface protein in Borrelia spp. [100]. Gene duplication and gene 
transfer further create a large number of potential proteins to express. These combinations can 
enable bacteria to produce up to 10
7
 variant proteins [109]. Examples of traits regulated via 
genomic rearrangement are presented in Table 2.1. 
Differential methylation 
Variation by differential methylation is described as an epigenetic phenomenon because phase 
variation occurs in the absence of a change in DNA sequence. It involves differentially 
methylated sequences in the regulatory regions of the phase-varying gene or operon. Since the 
expression state is heritable but reversible and since regulation is not caused by a DNA 
sequence change, it is epigenetic by definition. The essential feature of the DNA methylation-
dependent phase variation system is that the methylation state of a target sequence at a 
specific site in the chromosome affects the DNA binding of a regulatory protein that directly 
regulates transcription. 
The mechanism of differential methylation is extensively studied in the regulation of P. 
fimbrial (pyelonephritis-associated pili and Pap-related fimbriae) expression in uropathogenic 
E. coli. Fimbriae undergo reversible phase variation (ON-OFF) at 37C, while at the 
temperatures below 26C, expression is shut off [110]. The phase variation event at 37C is 
controlled at the transcriptional level by differential methylation of two GATC sites (GATC-I 
and GATC-II). This methylation is regulated by the competitive action of deoxyadenosine 
methyltransferase (Dam) and leucine-responsive regulatory protein (Lrp): when GATC-I is 
methylated and GATC-II is unmethylated, the cells are phase OFF and in phase ON cells, 
GATC-I is unmethylated and GATC-II is methylated [110]. Examples of genes controlled via 
differential methylation are presented in Table 2.1. 
Unprogrammed variation 
Random unprogrammed variation is based on the introduction of mutation due to imperfect 
replication and the subsequent removal of these mutations, coinciding with a switch back to 
the wild-type situation. One of the drawbacks of a mechanism stimulating diversification 
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based on imperfect replication is a high mutation load. Higher organisms had to evolve a 
mechanism of mutation while controlling the mutation rate using mechanisms of mutation 
like mismatch repair pathways [80]. Most organisms use this strategy to create diversity. 
Examples of spontaneous mutations in phase variation, switching genes ON and OFF are 
presented in Table 2.1.  
2.1.4 Significance for aquaculture 
The mechanisms and ability of phase variation in bacteria under in vitro and in vivo 
conditions indicated that bacteria could alter their phenotypic traits, such as morphologies, 
antigenic and virulence factors for their thrive, survival and protection against biotic and 
abiotic stressors. Understanding phenotypic variation involved in bacterial diseases in 
aquaculture animals might have potential implications in the management of diseases in this 
sector. Until now, studies on the importance of phase variation in vibriosis in aquatic animals 
such as shrimp and fish are scarce. However, understanding the mechanism of phenotypic 
variation is vital in identifying and foreseeing the species that may cause future outbreaks. 
Recognizing the role of phenotypic diversity may also prevent potential harmful invading 
species and aid in the development of control measures against infectious diseases caused by 
bacteria in aquaculture.   
Moreover, understanding processes of phenotypic variation and the response of the bacterial 
population to environmental stresses are fundamental to develop adequate disinfection 
protocols and therapeutic treatments. The knowledge of the determinant of phenotypic 
variation can be of great significance to solve real problems, such as multi-antimicrobial 
resistance, to design therapeutic approaches and for vaccine development for clinical diseases 
[26]. 
2.2 The innate immune system in invertebrates 
In an aquatic ecosystem, crustaceans share their environment together with invading parasites 
and pathogens. Therefore, crustaceans must have an efficient immune system to defend 
themselves against invading pathogens.  
The defense system of crustaceans includes a physical barrier namely the exoskeleton and the 
alimentary tract, and cellular and humoral innate defense reactions. The physical barriers are 
the first line of defense to combat pathogenic microorganisms. Once a pathogen overcomes 
Chapter 2 Review of literature  
27 
 
the physicochemical barrier of the cuticle, the cellular and the humoral innate defense system 
reactions occur instantly, allowing elimination or decrease of invading pathogens (Figure 2.6) 
[111]. The cellular immune reactions are mediated by circulating blood cells (which in 
crustaceans are known as hemocytes) that are capable of neutralizing and/or eliminating 
pathogens by phagocytosis, or entrapping them in hemocyte aggregates, nodules or 
encapsulation, whereas the humoral responses involve the synthesis and release of several 
immune proteins, such as antimicrobial peptides (AMPs), proteinase inhibitor, production of 
reactive oxygen and nitrogen metabolites, complex enzymatic cascades leading to 
melanization and clotting proteins [112].  
 
Figure 2. 6 Crustacean cellular and humoral immune-reactions after a microbial challenge 
(Source [111]). 
HH= hyaline hemocytes, GH = granular hemocytes 
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2.2.1 Pattern recognition receptors (PRRs) in crustacean 
PRRs recognize the presence of pathogens by binding to molecular patterns rather than to a 
specific component of a given pathogen. These molecular patterns, called pathogen-associated 
molecular patterns (PAMPs) include lipopolysaccharide (LPS) from the outer membrane of 
Gram-negative bacteria, peptidoglycan (PGC) and lipoteichoic acid (LTA) from Gram-
positive bacteria, and glucans from fungal cells [113]. Moreover, the patterns can be 
polynucleotides, such as bacterial and viral unmethylated CpG DNA, single-strand and 
double-strand RNA from viruses [114]. The recognition process can trigger the innate 
immune response in crustaceans. To date, 11 types of PRRs have been identified in shrimp, 
for instance, β-1,3-glucanase-related proteins, β-1,3-glucan-binding proteins, C-type lectins, 
scavenger receptors, galectins, fibrinogen-related proteins, thioester-containing proteins, 
down syndrome cell adhesion molecules, serine protease homologs, trans-activation response 
RNA-binding protein and Toll like receptors [115]. The Down syndrome cell adhesion 
molecule (dscam) is also involved in neural development [116]. The typical domain structure 
of dscam is highly conserved within arthropods and vertebrates. Previous studies based on the 
genomic analysis showed that dscam gene of Daphnia pulex and P. leniusculus can generate 
up to 13,000 and 22,000 different unique isoforms, respectively, by alternative splicing of 
variable exons [117, 118]. Obviously, dscam can produce pathogen-specific splice form 
variants with specific binding capabilities after immune challenge or infection resulting in 
actively recognized and ingested of this foreign agent by phagocytic hemocytes [119]. In 
Drosophila, dscam has been confirmed as a receptor involved in phagocytosis through its 
ability to bind foreign cells. Dong et al. [119] reported that transient silencing of Anopheles 
gambiae dscam depleted the mosquito resistance to bacterial infection. In addition, recently 
another important PRR which received more attention is the lipopolysaccharide and β-1, 3-
glucan binding protein (lgbp). It is a pattern recognition receptor for lipopolysaccharide and 
β-1, 3-glucan, the latter being present in Gram-negative bacteria and fungi. In crustacean, the 
binding of LGBP to lipopolysaccharide or β-1, 3-glucan has been documented to activate the 
proPO system of the freshwater crayfish, P. leniusculus [120]. Recently, Amparyup et al. 
[121] found that PmLGBP transcripts are expressed in the hemocytes of Penaeus monodon 
after V. harveyi infection. The recombinant protein (rPmLGBP) could enhance the 
phenoloxidase activity of a hemocyte suspension in the presence of LPS and β-1, 3-glucan.  
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In addition, the innate immune system is activated by endogenous substances released by 
damaged or dying cells, called damage-associated molecular patterns (DAMPs). High-
mobility group box 1 (hmgb1) and heat shock protein 70 (hsp70) are DNA and protein 
chaperons respectively. These molecules are considered as extracellular signaling molecule 
and damage associated molecular proteins during inflammation and various cellular 
processes. Extracellular Hmgb1 and hsp70s have been documented to be involved in 
activation of cell surface innate immune receptors, through Toll-like receptors upon contact 
with pathogenic biotic stressors, thereby affecting many aspects of the host immune responses 
[122]. Hsp70 is an immune modulator and can be up-regulated after infection. Heat shock 
proteins are involved in the folding and unfolding of other proteins and are induced when the 
host is exposed to high temperatures or other stress factors. Hsp70 can be both intracellular 
providing cytoprotection through protein folding, and extracellular, facilitating immune 
responses [123]. Hsp70 is known to be a molecular chaperon but it seems also to mediate 
humoral and cellular innate immune responses [124]. 
2.2.2 Melanization and prophenoloxidase activating system (proPO system) 
The prophenoloxidase (proPO) activating system plays an important role in the crustacean 
immune system as it is considered to be one of the major immune defense mechanisms 
against foreign particles or molecules for invertebrate animals [125]. The recognition of the 
microbial PAMPs (elicitor) by PRRs activates the serine proteinase cascade and eventually 
culminates in the proteolytic cleavage of inactive proPO to the active PO enzyme, this results 
in the production of the polymeric melanin and its accumulation at the site of infection or 
around the surface of foreign microorganisms. 
Melanization plays crucial role in defense reactions, such as wound healing encapsulation, 
sequestration of microbes, and the production of toxin intermediates, that are may kill 
invading microorganisms [126]. The melanization reaction can be observed at the site of 
cuticle injury or on the surface of invading parasite or pathogens. This melanotic reaction 
occurs due to the synthesis and deposition of melanin mediated by proPO activation (Figure 
2.7) [127].  
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Figure 2. 7 Schematic view of the prophenoloxidase (proPO)-activating system in arthropods 
(Source [128]).  
During microbial infection, non-self molecules that act as PAMPs are recognized by appropriate 
PRRs, leading to the activation of the serine proteinase cascade, and resulting in a final clip-domain 
serine proteinase designated as proPo-activating enzyme (PPAE). Subsequently, the inactive proPO 
zymogen is converted to active phenoloxidase (PO), by PPAE to produce quinones, which can cross-
link neighboring molecules to form melanin around invading microorganisms. 
In crayfish, the PO has been suggested to be involved in the defense of the host against 
Aeromonas hydrophila infection. Thus, silencing of crayfish proPO leads to increased 
bacterial growth, lower phagocytosis, lower PO activity, lower nodule formation, and higher 
mortality when the animals are infected with Aeromonas. In contrast, depletion of pacifastin, 
an inhibitor of the crayfish proPO activation cascade, resulted in lower bacterial growth, 
increased phagocytosis, increased nodule formation, higher phenoloxidase activity and 
delayed mortality [129].  
The melanization cascade (the proPO activating system) was indicated to be associated with 
factors stimulating cellular defense by aiding phagocytosis [127]. Mavrouli et al, [130] 
reported that proPO can bind to the outer membrane of some hemocytes, enhancing the 
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melanization response. Another study indicated that PO might be involved in the blood 
clotting process, promoting the cellular defense reaction and enhancing the efficiency of 
plasma coagulation following Anopheles gambiae [131]. 
Upon the activation of the proPo system in crayfish, peroxinectin, a cell adhesion factor that 
functions as peroxidase and opsonin are generated [132]. Peroxinectin is produced in the 
blood cells, stored in granules and released during degranulation [133]. The formation of 
peroxinection is activated by lipopolysaccharide and β -glucan. It activates the proPO 
cascade and promotes phagocytosis or encapsulation [116]. It was reported that peroxinectin 
might produce hypohalic acid from hydrogen peroxide produced by SOD and consequently, it 
functions as an efficient microbial attack system to invading microorganisms [134]. Recently, 
Sivakamavalii et al. [135] suggested that peroxinectin was involved in the regulatory 
mechanism of PO enzyme synthesis in the shrimp Fenneropenaeus indicus. 
Melanization induced by activation of the proPO system plays an important role in the 
immune defense. However, the production of quinone in the melanization process can be 
harmful to the animal [136]. Therefore, this process requires melanization inhibitors, for 
example, melanization inhibitor protein (mip) to regulate unwanted production of quinones 
[137]. The study of Angthong et al. [138] on Penaeus monodom suggested that upon V. 
harveyi infection the Pmmip protein is first released from the tissue into hemolymph and then 
degraded to allow melanization to occur for eliminating the bacteria. In addition, serpin - 
another proteinase inhibitor that functions as a negative regulator of the proPO cascade by 
inhibiting the serine proteinases has been reported to occur in insects and crustaceans [127].  
2.2.3 Antimicrobial peptides (AMPs) 
Antimicrobial peptides or proteins (AMPs) are one of the major components of the innate 
immune defense and are widespread in nature, from bacteria to mammals. AMPs are 
primarily known as “natural antibiotics” because of their rapid and efficient antimicrobial 
effects against a broad range of microorganism, including Gram-positive and Gram-negative 
bacteria, yeast, fungi, protozoa and viruses [111, 139].  
Basically, AMPs predominantly act by disrupting the membrane integrity of the cell target. 
The cationic portion of the peptide is first attracted to the negatively-charged bacterial and 
fungal cell walls and/or membranes. Subsequently, the peptide inserts into and permeabilizes 
the microbial cell membranes through its hydrophobic portion. This results in the destruction 
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of the microorganism via membrane destabilization and/or pore formation [140]. In addition, 
other evidence suggested that AMPs could be translocated into the cytoplasm of the 
microorganism, where they act on specific intracellular targets. Once inside, the peptides 
interfere with several essential metabolic functions, such as protein, nucleic acid and cell wall 
syntheses, leading to bacterial death [140, 141].  
During the past few years, AMPs have been intensively studied in crustaceans, including 
astacidin 1, astacidin 2 and crustin1-3. In freshwater crayfish, these peptides were shown to 
markedly inhibit the growth of both Gram-positive and Gram-negative bacteria [142]. Anti-
lipopolysaccharide factors (ALFs) is one type of the AMPs in penaeid shrimps [143]. AFLs 
were first isolated from the hemocytes of horsehoe crabs (Tachlypleus tridentatus, Limulus 
polyphemus) and from the shrimp P. monodon. Being one of the six ALFs in P. monodon, 
AFLPm3 is the most abundant isoform and it showed bactericidal effect on Gram-negative 
and Gram-positive bacteria and it can bind to the main bacterial cell wall components of 
Gram-negative and Gram-positive bacteria, i.e. LPS and lipoteichoic acid respectively during 
a V. harveyi infection. These results suggested that AMPPm3 performs its antibacterial 
activity by binding to components of the bacterial cell wall with a high affinity [144]. Jaree et 
al. [145] showed that the recombinant (rALFPm3)  could  bind to V. harveyi, inhibit growth 
and effectively kill V. harveyi through altering the bacterial membrane permeability. 
2.2.4 Coagulation 
A coagulation system is the first line of defense and it is considered as part of the whole 
invertebrate immune system. Clotting plays an important role in prevention of blood loss and 
in the initiation of the wound healing process in crustaceans. It is also critical in forming a 
secondary barrier to infection by immobilizing bacteria/fungi and hence promoting their 
killing.  
Two different coagulation mechanisms have been characterized in invertebrates: 1) the 
hemocyte-derived clotting cascade in the horseshoe crab (Tachpleus tridentatus) [146] and 2) 
the transglutaminase (TGase)-dependent clotting reaction in freshwater crayfish, 
(Pacifastacus leniusculus)  [147]. The proteins participating in the horseshoe crab clotting 
system are all stored in the hemocytes and upon activation they are released form the 
cytoplasmic L-granules into the hemolymph through rapid exocytosis. The horseshoe crab 
clotting system is a proteolytic cascade and it is activated by microbial cell wall components, 
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subsequently leading to the activation of the proclotting enzyme and resulting in conversion 
of a soluble protein (coagulogen) into an insoluble aggregate (coagulin) [146]. In crustacean, 
clotting works through the polymerization of the clotting protein catalyzed by a Ca
2+
 ion 
dependent transglutaminase (TGase), which is released from hemocytes upon activation by 
foreign microorganism or tissue damage [147] (Figure 2.8). TGase and clottable protein have 
been suggested to be involved in the blood coagulation system of many crustaceans, such as 
shrimps, lobsters and freshwater giant prawns. A higher mortality rate was observed in TGase 
and clotting protein depleted infected shrimps, illustrating the crucial role of these two 
molecules in shrimp immune protection against microbial challenge [148]. 
 
Figure 2. 8 Proposed clotting system in shrimp and its association with the activation of 
AMPs (Source [149]). 
2.2.5 Cellular immune response 
Cellular immune responses are regulated by circulating blood cells or hemocytes that are 
capable of neutralizing and/or eliminating pathogens by phagocytosis or entrapment in 
hemocyte aggregates or nodules, or by encapsulating larger microorganisms such as certain 
parasites [150]. Nodule and capsule formation become melanized, through the action of 
phenoloxidase [125]. Phagocytosis is one of the earlier immune responses in invertebrates. It 
is initiated by the attachment of the phagocyte to the target particle, followed by cytoskeleton 
modification, and finally internalization and destruction of the engulfed target within 
phagosomes.  
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In crustaceans, the hemocytes originate from the hematopoietic tissue and mature hemocytes 
can be divided into three cell types based on their structural and functional features: hyaline 
cells (HCs), semigranular cells (SGCs) and granular cells (GCs). Each of them has different 
biological functions (Table 2.2). Recently, hemocytes of penaeid shrimp (Litopenaeus 
vannamei) were separated into five subpopulations (Figure2.9) [151]. 
Table 2. 2 Hemocyte types and known biological functions (source: [152]) 
Hemocyte type Function in immunity 
Hyaline cell Phagocytosis 
Semigranular cell Encapsulation 
Phagocytosis (limited) 
Storage and release of the proPO system 
Cytotoxicity 
Granular cell Storage and release of the proPO system 
Cytotoxicity 
Phagocytosis plays an important role in host defense against invading pathogens and in the 
removal of apoptotic cells produced during development. Several receptor proteins involved 
in phagocytosis have been well documented such as members of the scavenger receptor 
family [153], the epidermal growth factor (EGF)-domain protein Eater [154], complement-
like opsonins, and the immunoglobulin super family (IgSF)-domain protein down syndrome 
cell adhesion molecule (Dscam) [155]. In Drosophila, it was observed that suppression of 
NimC1 – a putative phagocytosis receptor known to be present in Drosophila plasmatocytes 
would inhibit the phagocytosis of Staphylococcus aureus [154]. Recently, scavenger receptors 
(SRs) that are known to be involved in innate immunity through recognizing pathogen-
associated molecular patterns (PAMPs) and in pathogenesis of diseases through interaction 
with damage-association molecular patterns (DAMPs). It has been shown that after 
knockdown of B scavenger receptor from kuruma shrimp, Marsupenaeus japonicus (MjSR-
B1), both bacterial clearance and phagocytotic ability of M. japonicas against V. anguillarum 
were impaired, and several phagocytosis-related genes were down-regulated. Overexpression 
of MjSR-B1led to enhanced bacterial clearance, phagocytosis rate and up-regulation of 
phagocytosis-related and antimicrobial peptide genes [156]. 
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Figure 2. 9 Analysis of individual P. vannamei hemocyte band by in vitro culture, H&E 
staining and flow cytometry (Source [151]).  
Subpopulation 1 (sub 1) showed cells that attached strongly to glass, had an average diameter size, 
containing little or no basophilic granules in the cytoplasm and high nucleus: cytoplasmatic ratio 
(N:C). Subpopulation 2 (sub 2) enclosed cells that did not attach or attached very weakly to glass, had 
a small diameter size, contained few small basophilic cytoplasmatic granules and had a very high N:C 
ratio. The dispersed cell fraction enclosed two cells types, cells of subpopulation 3 (sub 3) and cells of 
subpopulation 4 (sub 4). Sub 3 cells behaved similarly to sub 2 cells but had a higher N:C ratio and 
diameter. Sub 4 cells behaved similarly to subpopulation 5 (sub 5) cells but the granularity was lower 
and the diameter was the biggest.  
 
2.3. Gnotobiotic Artemia culture (GART) system 
Artemia franciscana was used as a model organism throughout this PhD study. Artemia 
franciscana is a small branchiopod crustacean found almost worldwide in nature saline lakes 
and solar salt works. They are used worldwide as live feed in aquaculture production. It has 
been used as a model organism for host-microbial studies among others. They are unique 
organism that can produce dormant cysts or encapsulated embryos, called cysts, when 
conditions are unfavorable. These cysts can be stored during a long period of time in a dry 
state, making them readily available on the market. When brought back into favorable 
conditions, the cyst, if out of diapause, will hatch within 24 h and can used as live feed for 
culturing other species or for scientific purposes [157]. 
The rational for using a GART system is to eliminate the possibility of microbial interference 
in mechanistic studies [158]. In GART system, axenic Artemia were obtained following 
decapsulation and hatching (section 4.2.2). GART system offers a unique way to study host-
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microbe interactions without interference of unknown microbial communities that are 
naturally present in the rearing environment. Being small animals with a short life cycle, they 
allow for an easy integration of experimental approaches and molecular analysis [159]. 
 
 
 
37 
 
 
 
Chapter 3 
 
 
 
Redrafted after: 
Nguyen Thi Xuan Hong
1, 2
, K Baruah
1
, D Vanrompay
3
 and P Bossier
1 
1
 Laboratory of Aquaculture & Artemia Reference Center, Ghent University, Rozier 44, 9000 
Ghent, Belgium 
2
 Faculty of Aquaculture, Hue University of Agriculture and Forestry, 102 Phung Hung 
Street, Hue City, Vietnam 
3 
Laboratory for Immunology and Animal Biotechnology, Ghent University, Coupure links 
653, 9000 Ghent, Belgium 
 
Journal of Fish Diseases 
 
 
 
Characterization of phenotype variations of 
luminescent and non-luminescent variants of 
Vibrio harveyi wild type and quorum sensing 
mutants 
 
CHAPTER 3: CHARACTERIZATION OF PHENOTYPE VARIATIONS OF LUMINESCENT AND NON-
LUMINESCENT VARIANTS OF VIBRIO HARVEYI WILD TYPE AND QUORUM SENSING MUTANTS 
 38 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Chapter 3 Characterization of phenotype variations  
 
39 
 
ABSTRACT 
Vibrio harveyi, a luminescent Gram-negative motile marine bacterium, is an important 
pathogen responsible for causing severe diseases in shrimp, finfish and molluscs leading to 
severe economic losses. Non-luminescent V. harveyi obtained by culturing luminescent 
strains under static and dark condition were reported to alter the levels of virulence factors 
and metalloprotease gene and luxR expression when compared to their luminescent variants. 
We conducted an in vitro study aiming at the characterization of virulence-related phenotypic 
traits of the wild type V. harveyi BB120 strain and its isogenic quorum sensing mutants before 
and after switching to the non-luminescent status. We measured the production of caseinase, 
haemolysin and elastase and examined swimming motility and biofilm formation. Our results 
showed that switching from the luminescent to the non-luminescent state changed the 
phenotypic physiology or behavior of V. harveyi resulting in alterations in caseinase and 
hemolytic activities, swimming motility, and biofilm formation. The switching capacity was 
to a large extent independent from the quorum sensing status, because quorum sensing 
mutants were equally capable of making the phenotypic switch.   
Keywords: phenotype switch, virulence factor, Vibrio harveyi, luminescent, non-luminescent. 
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3.1 Introduction  
Vibrio harveyi is a luminescent Gram-negative motile marine bacterium widely distributed in 
the marine environment [7]. This bacterium is a major pathogen responsible for causing life-
threatening vibriosis in the wild and in cultured aquatic animals such as shrimps, finfish and 
molluscs. In particular, at early live stages, the infection leads to severe economic losses and 
marked impacts on biodiversity [7, 160]. V. harveyi is known to exist as free-swimming single 
cells, adhered to abiotic surfaces as a constituent of biofilm consortia, and in association with 
a host, as a pathogen of marine animals [161].  
Several studies have shown that the pathogenicity of V. harveyi is associated with 
extracellular compounds, and the production of some of these compounds is regulated by 
quorum sensing [11, 162, 163]. By definition, quorum sensing or cell-to-cell communication 
between bacteria refers to a mechanism by which bacteria coordinate certain phenotypic 
behaviors (such as virulence factor production) by secreting, detecting and responding to 
small signal molecules [164]. V. harveyi uses a multi-channel quorum sensing system with 
three quorum sensing signal molecules: harveyi autoinducer 1 (HAI-1), autoinducer 2 (AI-2) 
and cholerae autoinducer 1 (CAI-1), which act synergistically in virulence gene regulation 
[165-167]. The signal molecules are detected at the cell surface by distinct membrane-bound 
receptors feeding a shared phosphorylation/dephosphorylation signal transduction cascade. 
Central in this signal transduction cascade is the LuxO protein. At low concentrations of the 
signal molecules, LuxO is phosphorylated and indirectly inhibits the production of the 
transcriptional regulator protein LuxR. Conversely, LuxO becomes dephosphorylated in the 
presence of high concentrations of signal molecules, leading to the translation of the luxR 
mRNA. The LuxR protein, finally, regulates the transcription of quorum sensing target genes 
[168].  
Bioluminescence in V. harveyi is another phenotypic characteristic that is regulated by 
quorum sensing [169]. The biochemistry and genetics of bioluminescence have been 
extensively investigated [170, 171]. However, its biological role in non-symbiotic bacteria 
remains elusive. Bioluminescence consumes 20% of the cellular energy [172], and 
consequently, it must confer a considerable selective advantage on non-symbiotic bacteria or 
else it would have been lost during evolution. One of the assumptions is that V. harveyi emits 
light to stimulate DNA repair [170]. Interestingly, V. harveyi bioluminescence has also been 
shown to be involved in the detoxification of reactive oxygen species such as H2O2, thus 
playing a protective role against oxidative stress [173]. As H2O2 is an important part of the 
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innate immune defense mechanism in eukaryotic hosts against infections [174], 
bioluminescence could also be considered as a virulence factor or innate immune evasion 
strategy. In a previous study, we obtained non-luminescent variants of luminescent V. harveyi 
strains by culturing the latter under static conditions in the dark and found that these non-
luminescent variants were less virulent towards brine shrimp (Artemia franciscana) larvae 
than their luminescent counterparts [49]. In a second study, we found that the non-
luminescent variants produced lower mRNA levels of the quorum sensing master regulator 
luxR, and the vhp metalloprotease (known to be regulated by quorum sensing) [69].  
Virulence factors are utilized by bacteria to evade the host immune system, to cause diseases 
and resist to antibiotics. Here we aimed at characterizing the production of virulence factors, 
including caseinase, haemolysin, elastase, as well as the swimming motility, and biofilm 
formation in isogenic luminescent and non-luminescent variants of V. harveyi wild type and 
quorum sensing mutants. These virulence factors have often been studied in Vibrio spp. and 
serve as credible biomarkers to detect and describe virulence of Vibrio [175], and their 
associated lethality towards  different hosts in vivo [11, 176]. 
3.2. Bacteria strains and growth conditions  
3.2.1 Bacterial strains and growth conditions  
V. harveyi strains used in this study are shown in Table 3.1. The strains were stored in 20% 
glycerol at -80 °C. Rifampicin resistant (RR) strains were produced by inoculating one fresh 
single colony from Marine Agar (MA, Difco laboratories, MI, USA) plates (28 
o
C for 24 h) in 
a 100 mL Erlenmeyer flask containing 10 mL Marine Broth (MB) 2216 (Difco laboratories, 
MI, USA) and incubating the flask at 28 
o
C for 24 h. Bacterial cultures (50 L) were 
transferred to a 10 mL MB containing 0.5 mg L
-1
 of rifampicin (R3501, Sigma-Aldrich, 
USA). The culture was incubated at 28 
o
C for 24 - 48 h. The following days, sub-cultures 
were made in MB with increasing concentration of rifampicin (50-100 mg L
-1
). When the 
bacteria were grown in the final rifampicin concentration of 100 mg L
-1
, bacterial 
supernatants were inoculated on MA containing 100 mg L
-1
 of rifampicin, and incubated 
overnight at 28 
o
C for obtaining single colonies.  
Autoclaved Aeromonas sp. LVS3 bacteria were used as feed source for Artemia [158]. LVS3 
was grown in MB. Overnight grown LVS3 in MB was centrifuged at 2200 x g for 15 min. 
The supernatant was discarded, and the pellet was re-suspended in filtered autoclaved 
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seawater (FASW). The bacterial densities were determined spectrophotometrically at an 
optical density (OD) of 550 nm assuming that an OD of 1.0 corresponds to 1.2 x 10
9
 cells mL
-
1
 (McFarland standard; BioMerieux, France). Subsequently, the cell suspension was 
autoclaved at 121 °C for 20 min. 
3.2.2 Selection of non-luminescent variants  
Non-luminescent variants (RR-NL) were selected as described previously [49]. Briefly, one 
single freshly grown luminescent colony (RR-L) was inoculated in a 250 mL Erlenmeyer 
flask containing 5 mL MB. The culture was kept in the dark under static conditions for 2 or 3 
days. Subsequently, the medium was discarded and the Erlenmeyer flask was rinsed with 
FASW to remove the motile cells. The cells attached to the bottom of the flask were collected 
by adding 1 mL FASW, and collected by shaking.  Re-suspended cells were inoculated on 
MA plates supplemented with 100 mg L
-1 
of rifampicin, and incubated for 24 h at 28 °C to 
check for the presence of the dark colonies. In case no non-luminescent colonies were 
detected, fresh MB was added to the Erlenmeyer and the above-described procedure was 
repeated until a non-luminescent strain was found. 
3.2.3 Measurement of bioluminescence  
Overnight grown bacterial cultures were diluted to an OD of 0.2 at 600 nm. Subsequently, 
200 µL aliquots were transferred into the wells of a black 96-well, flat-bottomed sterile 
polystyrene microtiter plate. The bioluminescence was measured by using a Tecan Infinite 
200 microplate reader (Tecan, Switzerland)[14]. 
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Table 3. 1 Bacterial strains used in this study  
Strain Relevant feature References/Sources 
BB120 Wild type, luminescent [177] 
BB120 RR-L Rifampicin-resistant luminescent  This study 
BB120 RR-NL Rifampicin-resistant nonluminescent This study 
BB152  Mutation in LuxM (AI-1 synthase), luminescent [169] 
BB152 RR-L Rifampicin–resistant luminescent  This study 
BB152 RR-NL Rifampicin-resistant nonluminescent This study 
MM30 Mutation in LuxS (AI-2 synthase), luminescent [178] 
MM30 RR-L Rifampicin–resistant luminescent.  This study  
MM30 RR-NL Rifampicin-resistant nonluminescent This study 
MM77 Mutation in LuxM (AI-1 synthase) and LuxS 
(AI-2 synthase), luminescent 
[179] 
MM77 RR-L Rifampicin-resistant luminescent.  This study 
MM77 RR-NL Rifampicin-resistant nonluminescent.  This study 
JMH603 Mutation in CqsA (CAI-1), luminescent [161] 
JMH603 RR-L Rifampicin resistant luminescent.  This study 
JMH603 RR-NL Rifampicin-resistant nonluminescent This study 
JMH606 Mutation in LuxM (AI-1 synthase) and CqsA 
(CAI-1) 
[161] 
JMH606 RR-L Rifampicin-resistant luminescent.  This study 
JMH606 RR-NL Rifampicin-resistant nonluminescent.  This study 
JMH634 Mutation in LuxM (AI-1 synthase), LuxS (AI-2 
synthase) and CqsA (CAI-1), luminescent 
[161] 
JMH634 RR-L Rifampicin-resistant luminescent.  This study 
JMH634 RR-NL Rifampicin-resistant nonluminescent This study 
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3.2.4 Caseinase and haemolysin activities, and swimming motility 
The caseinase and haemolysin activities were measured as described by Natrah et al. [11]. 
The caseinase agar plates were prepared by mixing double strength MA with 4% skim milk 
powder suspension (Oxoid, Basingstoke, Hampshire, UK), each sterilized separately at 121°C 
for 5 min prior to mixing. Hemolytic assay plates were prepared by supplementing MA with 
5% defibrinated sheep blood (Oxoid, Basingstoke, Hampshire, UK). Swimming motility 
assay plates were prepared by supplementing MB with 0.3% agar [180]. Overnight grown 
bacterial cultures were diluted to an OD600 of 0.5. Subsequently 10 µL was spotted in the 
middle of each test plate. For caseinase and haemolysis activities, clearing zones surrounding 
the bacterial colonies were measured after 2 days of incubation. Swimming motility zones 
were measured after 24 h of incubation. 
3.2.5 Elastase activity 
Elastolytic activity in all bacterial strains was determined as described by Visca et al. [181], 
utilizing elastin Congo red (Sigma-Aldrich, USA) as substrate. The bacterial cultures were 
centrifuged, supernatants filter sterilized (0.22 µm), and then, the sterile filtrates (150 µL) 
were transferred to Eppendorf tubes. Subsequently, 20 mg of elastin Congo red and 850 µL of 
100m M Tris-Cl/1 mM CaCl2 solution (pH 7.5) were added. The mixtures were incubated 
overnight at room temperature with continuous shaking. Finally, insoluble particles were 
removed by centrifugation at 13 000 x g for 1 min and the supernatant was used for measuring 
the absorbance at 495 nm. 
3.2.6 Quantification of biofilm formation 
Biofilm formation was quantified as described previously [182] with some modifications. 
Briefly, strains were grown in MB overnight at 28 °C until an OD600 of 1 and then diluted in 
fresh MB to an OD600 of approximately 0.1. Aliquots (200 µL) were transferred, in triplicate, 
into the wells of a sterile polystyrene microtiter plate. Non-inoculated wells receiving only 
MB were used as negative controls. The plate was covered with a lid and incubated at 28 °C 
for 24 h under static conditions. The bacterial suspensions were aspirated and each well was 
rinsed three times with 300 µL of sterilized distilled water. After that, the biofilms were fixed 
with 150 µL of methanol for 20 min. The plate was air-dried, and the biofilms were stained 
with 150 µL of crystal violet solution (1%) for 15 min at room temperature, washed in 
running water and dried at room temperature. One hundred and fifty µL of 95% ethanol was 
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gently added to each well and then incubated at room temperature for 30 min without shaking. 
The OD570 was measured using a Tecan Infinite 200 microplate reader. 
3.2.7 Protein extraction and DnaK detection  
Bacterial strains were cultured overnight in MB-medium containing 100 mg L
-1
 of rifampicin 
at 28 °C under constant shaking (150 min
-1
). The cultures (OD600: 0.8-1) were centrifuged at 
4000 x g for 15 min. The pellets obtained were rinsed once with FASW (35 g L
-1
). Bacteria 
were homogenized by rapid agitation with 0.1 mm diameter glass beads in cold buffer K (150 
mM sorbitol, 70 mM potassium gluconate, 5 mM MgCl2, 5 mM NaH2PO4, 40 mM HEPES, 
pH 7.4) containing a protease inhibitor cocktail (Sigma-Aldrich, Inc. USA). Subsequent to 
centrifugation at 2200 x g for 1 min at 4 °C, supernatant protein concentrations were 
determined by the Bradford method [183]. Supernatants (30 µg protein) were then combined 
with loading buffer, vortexed, heated at 95 °C for 5 min, centrifuged at 4000 x g for 1 min and 
then electrophoresed in 10% SDS-PAGE gels. HeLa cells (Enzo Life Sciences, USA) (12 µg) 
served as a positive control and for calculating the amount of DnaK in each sample. Proteins 
were transferred to polyvinylidene fluoride membranes (BioRad Immun-BlotTM PVDF). 
After incubation in blocking buffer (phosphate-buffer saline containing 0.2% (v/v) Tween-20 
and 5% (w/v) bovine serum albumin) for 1 h, the membrane was incubated with rabbit 
polyclonal antibody raised against the ATPase domain of E. coli DnaK (a generous gift from 
Dr. Bernd Bukau, ZMBH) and then with horseradish peroxidase conjugated goat anti-rabbit 
IgG at recommended dilutions of 1:2500 and 1:5000, respectively. Membranes were treated 
with Immune-star
TM
 WesternC
TM
 chemiluminescence reagent (Biorad, Belgium), and 
analyzed by the ChemiDoc MP Imaging System (Biorad, Belgium). The relative signal 
intensity was quantified by densitometry using Biorad Image Lab™ Software version 4.1.  
3.2.8 Brine shrimp Artemia challenge tests 
After 28 h of incubation, groups of 20 nauplii were transferred to sterilized 40 mL glass tubes 
containing 20 mL of FASW (35 g L
-1
). Artemia were fed once with 10
7
 cells
 
mL
-1
 autoclaved 
LVS3. Simultaneously, they were challenged with different vibrio species at 10
7 
cells mL
-1
. 
The survival of Artemia was scored at 48 h post challenge. The relative percentage of survival 
(RPS) of Artemia was calculated as described by Amend [184]. Each treatment was carried 
out in quadruplicate. All manipulations were performed under a laminar flow hood in order to 
maintain the axenity of cyst and nauplii. The axenity of the control (to which no live bacteria 
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added) was checked at the end of the experiment by inoculating 100 µL of the culture water 
on fresh MA plate. The plates were incubated at 28 °C for 3 days.  
3.2.9 Statistical analysis 
Significant differences in the phenotypes between the luminescent and non-luminescent 
variants and between the luminescent wild type BB120 with the other luminescent quorum 
sensing mutant strains were analyzed by independent sample student’s t-tests. Differences 
were considered statistically significant when P < 0.05.   
3.3 Results 
3.3.1 Luminescence  
The luminescence of the luminescent (L) and non-luminescent variants (NL) of wild type V. 
harveyi and its quorum sensing mutants was verified prior to the analysis of additional 
phenotypic characteristics. The luminescence of the non-luminescent variants was 
significantly low compared to the respective luminescent variants (Table 3.2).  
Table 3. 2 Luminescence (counts/sec) of the isogenic luminescent and non-luminescent 
variants of V. harveyi wild type and quorum sensing mutants 
Bacterial 
strains 
Features Luminescent Non-luminescent 
BB120 Wild type 28 x 10
5 
17 
BB152
 
Inactive HAI-1 synthase 19 x 10
5 
21 
MM30 Inactive AI-2 synthase 17 x 10
5 
26 
MM77
 
Inactive HAI-1 & AI-2 synthase 21 x 10
2 
22 
JMH603
 
Inactive CAI-1 synthase 15 x 10
4 
215 
JMH606
 
Inactive HAI-1 & CAI-1 synthase 60 x 10
2 
31 
JMH634
 
Inactive HAI-1, AI-2 & CAI-1 synthase 34 x 10
3 
202 
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3.3.2 Caseinase activities  
Among the luminescent variants, the wild type V. harveyi BB120 and the mutant BB152 
showed the highest caseinase activity and the activity of their caseinase was statistically the 
same. The mutants JMH603, JMH606 and JMH634 showed a significantly lower caseinase 
activity which also differed significantly from the caseinase activity of the wild-type V. 
harveyi BB120 (Table 3.3). In addition, there was also a significant difference in the caseinase 
activity between the luminescent wild type BB120 and the luminescent mutants MM30 and 
MM77. 
Comparison between the luminescent and non-luminescent variants showed that the caseinase 
activity of the luminescent variants of BB120, BB152, MM77 and JMH634 was significantly 
higher than their respective non-luminescent variants, whereas the luminescent variants 
JMH603 and JMH606 exhibited significantly lower caseinase activity than their 
corresponding non-luminescent variants. Among all the bacterial strains, the non-luminescent 
variant of the signal molecule synthase triple mutant JMH634 showed the lowest caseinase 
activity. 
3.3.3 Hemolytic activity  
In the luminescent group, most of the mutants of the wild-type BB120 strain had hemolytic 
activity significantly lower from the wild-type BB120 strain. Maximum activity was recorded 
in the luminescent BB152 (inactive HAI-1 synthase) (Table 3.4). The other luminescent 
strains MM30, MM77, JMH603, JMH606 and JMH634 showed a significantly lower 
hemolytic activity than the one of the wild type BB120. Result also showed that the hemolytic 
activity in all the non-luminescent variants was significantly inactivated (P < 0.05).  
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Table 3.3 Caseinase activities of the luminescent and non-luminescent variants of V. harveyi wild type and quorum sensing mutants 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Data are expressed as mean ± standard deviation (SD) of four replicates. Values are presented with one digit after the comma, not as an indication of the 
accuracy of the measurement, but in order to be able to see the actual SD. Values in the same column with (*) are significantly different from the wild type 
luminescent BB120 and diamonds  () indicate significant difference between luminescent variant and its respective non-luminescent variant (independent-
samples t-test, P < 0.05).  
 
 
 
 
 
 
Strain 
 
Features Luminescent variants Non-luminescent variants 
Clearing zone 
(mm) 
Colony 
diameter 
(mm) 
Ratio Clearing 
zone (mm) 
Colony 
diameter 
(mm) 
Ratio 
BB120 Wild type     22.0 ± 1.0
 
12.0 ± 0.0 1.8 ± 0.1 18.0 ± 0.5 12.0 ± 0.0 1.5 ± 0.0 
BB152 Inactive HAI-1 synthase 22.0 ± 0.6 12.0 ± 0.0 1.8 ± 0.0 20.0 ± 0.0 12.0 ± 0.0 1.7 ± 0.0 
MM30 Inactive AI-2 synthase 20.0 ± 0.7 12.0 ± 0.0 1.7 ± 0.1*
 
20.0 ± 0.4 12.0 ± 0.0 1.7 ± 0.0
 
MM77 Inactive HAI-1 & AI-2 
synthase  
18.0 ± 0.4 12.0 ± 0.0 1.5 ± 0.0* 16.0 ± 0.0 12.0 ± 0.0 1.3 ± 0.0 
JMH603 Inactive CAI-1  synthase 16.0 ± 0.8 12.0 ± 0.0 1.3 ± 0.1* 20.0 ± 0.6 12.0 ± 0.0 1.6 ± 0.0 
JMH606 Inactive HAI-1 & CAI-1 
synthase 
15.0 ± 0.0 12.0 ± 0.0 1.3 ± 0.0* 17.0 ± 0.4 12.0 ± 0.0 1.4 ± 0.0 
JMH634 Inactive HAI-1, AI-2 & 
CAI-1 synthase 
16.0 ± 0.0 12.0 ± 0.0 1.3 ± 0.0* 12.0 ± 0.0 12.0 ± 0.0 1.0 ± 0.0 
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Table 3.4 Hemolytic activities of the luminescent and non-luminescent variants of V. harveyi wild type and quorum sensing mutants 
 
 
 
 
 
 
 
 
 
 
 
Data are expressed as mean ± standard deviation (SD) of four replicates. Values are presented with one digit after the comma, not as an indication of the 
accuracy of the measurement, but in order to be able to see the actual SD. Values in the same column with (*) are significantly different from the wild type 
luminescent BB120 and diamonds  () indicate significant difference between luminescent variant and its respective non-luminescent variant (independent-
samples t-test, P < 0.05).  
 
 
Strain 
 
Features Luminescent variants Non-luminescent variants 
Clearing zone  
(mm) 
Colony 
diameter 
(mm) 
Ratio Clearing 
zone (mm) 
Colony 
diameter 
(mm) 
Ratio 
BB120 Wild type 17.0 ± 0.5 10.0 ± 0.0 1.7 ± 0.1 10.0 ± 0.5 10.0 ± 0.0 1.0 ± 0.0 
BB152 Inactive HAI-1 synthase 18.0 ± 0.6 10.0 ± 0.0 1.8 ± 0.1* 10.0 ± 0.0 10.0 ± 0.0 1.0 ± 0.0 
MM30 Inactive AI-2 synthase 16.0 ± 0.5 10.0 ± 0.0 1.6 ± 0.1*
 
10.0 ± 0.0 10.0 ± 0.0 1.0 ± 0.0 
MM77 Inactive HAI-1 & AI-2 
synthase  
16.0 ± 0.5 10.0 ± 0.0 1.6 ± 0.1* 10.0 ± 0.0 10.0 ± 0.0 1.0 ± 0.0 
JMH603 Inactive CAI-1  synthase 16.0 ± 0.8 10.0 ± 0.0 1.6 ± 0.0* 10.0 ± 0.6 10.0 ± 0.0 1.0 ± 0.0 
JMH606 Inactive HAI-1 & CAI-1 
synthase 
15.0 ± 0.0 10.0 ± 0.0 1.5 ± 0.1* 10.0 ± 0.0 10.0 ± 0.0 1.0 ± 0.0 
JMH634 Inactive HAI-1, AI-2 & 
CAI-1 synthase 
15.0 ± 0.0 10.0 ± 0.0 1.5 ± 0.1*
 
10.0 ± 0.0 10.0 ± 0.0 1.0 ± 0.0 
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3.3.4 Elastase activity 
Elastase activity was observed in both the luminescent and non-luminescent strains of the 
wild-type BB120 and its isogenic mutants. In the luminescent group, the elastase activity of 
the wild-type BB120 appeared to be highest and was not significantly different from the 
BB152 (Figure 3.1). The luminescent mutants MM30, MM77, JMH603, JMH606 and 
JMH634 had significant lower elastase activity than the wild-type BB120. Lowest elastase 
activity in the luminescent group was recorded in the mutant MM77. Results also showed that 
there was no significant difference in the elastase activity between the luminescent variants 
and the corresponding non-luminescent variants except for the mutants BB152 (inactive HAI-
1 synthase) and MM77 (inactive HAI-1 and AI-2 synthase) (Figure 3.1).  
 
Figure 3. 1 Elastase activity of the luminescent and non-luminescent variants of Vibrio 
harveyi wild type and quorum sensing mutants.  
 
Data are expressed as mean  standard deviation of three replicates. Values in the same column with 
(*) are significantly different from the wild-type luminescent BB120, and diamonds () indicate 
significant difference between luminescent variant and its respective non-luminescent variants 
(independent-samples t-test, P < 0.05). 
 
3.3.5 Swimming motility  
The swimming motility of all the non-luminescent variants was significantly higher than of 
their corresponding luminescent variants (Table 3.5).  
0
0.05
0.1
0.15
0.2
0.25
BB120 BB152 MM30 MM77 JMH603 JMH606 JMH634
E
la
st
a
se
 (
O
D
4
9
5
) 
Bacterial strains 
RR-L RR-NL
   
*    *  
 *  
   *  
  *  
   
Chapter 3 Characterization of phenotype variations  
 
52 
 
Table 3.5 Relative percentage of swimming motility of the non-luminescent variants of V. 
harveyi wild type and quorum sensing mutants 
 
Strain Feature Non-luminescent 
variants (%) 
BB120
 
Wild type 130.0 ± 0.6 
BB152 Inactive HAI-1 synthase 180.0 ± 1.5 
MM30 Inactive AI-2 synthase 200.0 ± 3.8 
MM77 Inactive HAI-1 & AI-2 synthase  380.0 ± 3.6 
JMH603 
Inactive CAI-1 synthase 
150.0 ± 0.8 
JMH606
 
Inactive HAI-1 & CAI-1 synthase 120.0 ± 5.5 
JMH634
 
Inactive HAI-1, AI-2 & CAI-1 
synthase 
110.0 ± 0.6 
 
The value of the swimming motility (in %) (mean of four replicates) of each non-luminescent 
(NL) variant was expressed relative to the swimming  motility of the luminescent variant. 
Motility values in the NL strains were all significantly higher (independent-samples t-test, P < 
0.05). 
 
3.3.6 Biofilm formation 
In the luminescent group, the wild type BB120 exhibited the highest level of biofilm formation 
(Figure 3.2). However, it was not significantly different from biofilm formation by the mutants 
MM30, JMH603, JMH606 and JMH634. The non-luminescent BB152, MM30, MM77 and 
JMH603 variants had a significantly (P < 0.05) higher capacity to form biofilms than their 
corresponding luminescent variants.  
3.3.7 Induction of DnaK  
Result showed the presence of DnaK (bacterial equivalent heat shock protein 70) in all the 
bacterial strains but at different levels (Figure 3.3). Both the luminescent and non-luminescent 
variants of the JMH634 (inactive HAI-1, AI-2 and CAI-1 synthase) had the highest level of 
DnaK whereas the inactive AI-2 synthase MM30 strain (both luminescent and non-luminescent 
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variants) had the lowest level (Figure 3.3). The DnaK level in the luminescent mutants BB152 
(inactive HAI-1 synthase) and MM77 (inactive HAI-1 and AI-2 synthase) was significantly lower 
than in their corresponding non-luminescent variants. In contrast, the luminescent JMH603 
mutant (inactive CAI-1 synthase) had a significantly higher DnaK level than its corresponding 
non-luminescent variant.  
 
 
Figure 3. 2 Biofilm formation of the luminescent and non-luminescent variants of Vibrio harveyi 
wild type and quorum sensing mutants. Data are expressed as mean  standard deviation of three 
replicates. Values in the same column with (*) are significantly different from the wild-type 
luminescent BB120, and diamonds () indicate significant difference between luminescent 
variant and its respective non-luminescent variants (independent-samples t-test, P < 0.05). 
 
 
Figure 3. 3 Induction of DnaK of the luminescent and non-luminescent variants of Vibrio 
harveyi wild type and quorum sensing mutants. Data are expressed as mean  standard deviation 
of three replicates. Values in the same column with (*) are significantly different from the wild-
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type luminescent BB120, and diamonds () indicate significant difference between luminescent 
variant and its respective non-luminescent variants (independent-samples t-test, P < 0.05). 
3.3.8 Survival of Vibrio-challenged Artemia 
The virulence of luminescent and non-luminescent variants of the wild type V. harveyi BB120 
and its quorum sensing mutant strains was confirmed by an experimental infection in gnotobiotic 
brine shrimp (Artemia franciscana). Artemia challenged with the wild type BB120 (luminescent 
or non-luminescent variants) had the lowest survival. The survival of Artemia challenged by 
luminescent variants of the wild type strain BB120 and its isogenic mutants was lower than the 
survival of the Artemia challenged by their non-luminescent counterparts, but significant 
differences were not observed except for the mutant strain BB152 (inactive HAI-1 synthase) 
(Table 3.6). The survival rates in Artemia challenged with the non-luminescent BB152 were 4.5 
times greater than in their corresponding luminescent variants. 
Table 3.6 Survival of Artemia nauplii at 48h post challenge with wild type BB120 and its 
isogenic quorum sensing mutant strains 
 
Bacterial 
strains 
Features Luminescent 
(%) 
Non-luminescent 
(%) 
BB120 Wild type 14 ± 3
 
21 ± 5 
BB152
 
Inactive HAI-1 synthase 15 ± 2 68 ± 7 
MM30 Inactive AI-2 synthase 73 ± 11*
 
87 ± 9 
MM77
 
Inactive HAI-1 & AI-2 synthase 70 ± 6*
 
87 ± 7 
JMH603
 
Inactive CAI-1  synthase 72 ± 7*
 
80 ± 5 
JMH606
 
Inactive HAI-1 & CAI-1 synthase 87 ± 10*
 
96 ± 6 
JMH634
 
Inactive HAI-1, AI-2 and CAI-1 synthase 91 ± 10*
 
97 ± 6 
 
Data are expressed as mean ± standard deviation of five replicates. Values in the same column with (*) are 
significantly different from the wild type luminescent BB120 and diamonds  () indicate significant 
difference between luminescent variant and its respective non-luminescent variant (independent-samples 
t-test, P < 0.05).  
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3.4 Discussion and conclusion 
Microorganisms can adapt to environmental changes, such as variation in chemical composition, 
local temperature, or illumination by sensing the changes and responding appropriately, for 
example, by switching phenotype or behavior [51, 54, 185, 186]. In this study, we showed that 
luminescent phenotypes of wild type V. harveyi strain and their quorum sensing mutants switch 
to non-luminescence when cultured in the dark under static condition. The underlying cause(s) 
behind such a non-luminescent phenotype in the non-luminescent variants remains unresolved. 
Similar phenotypic shifts have been described previously [11, 49, 69]. In a previous study, Phuoc 
et al. [49], aimed to verify whether the phenomenon of the non-luminescent phenotypes in V. 
harveyi and V. campbellii cultured under similar static conditions was linked to quorum sensing 
molecule production. To verify this assumption, the authors used wild type V. harveyi and mutant 
strains (with mutations in the HAI-1 and AI-2 quorum sensing pathway) and found that the 
luminescent mutant variants were still able to switch to non-luminescent variants. In fact, the 
quorum sensing molecules (HAI-1 and AI-2) were still present in cultures of non-luminescent V. 
harveyi BB120 and V. campbellii, indicating that the non-luminescent phenotype was not caused 
by inability of the strains to produce these quorum sensing molecules. Perhaps a mutation or gene 
rearrangement of the quorum sensing system or in the regulatory protein (such as quorum sensing 
master regulator LuxR) might be involved in the creation of the non-luminescent status [69].  
Having observed such a phenotypic switch in response to change in the culture conditions, we 
next verified whether any changes occur in the production of virulence factors in all tested 
variants. Our results indicated that switching from luminescent variant of the wild type V. harveyi 
and its quorum sensing mutants to their respective non-luminescent variants significantly 
influenced multiple aspects of their phenotypic behavior. The type of influence (positive or 
negative) differed depending on the virulence factor and also on the mutation in quorum sensing 
signal molecules. Caseinase activity in both the luminescent and non-luminescent variants of the 
wild type V. harveyi strain and its quorum sensing mutants was positively regulated by quorum 
sensing, possible by CAI-1, being the main quorum sensing signal molecules influencing the 
production of caseinase, as the inactive CAI-1 synthase strains showed a significant lower 
caseinase activity in comparison to other quorum sensing mutant strains. This result coincides 
with the finding of Natra et al. [11] who showed that caseinase activity in V. harveyi is quorum 
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sensing dependent. Our result also indicated that most of the luminescent variants had a 
significant higher caseinase activity than their corresponding non-luminescent variants. Similar 
results were obtained for the hemolytic activity: non-luminescent variants showed a significant 
reduced hemolytic activity relative to their luminescent variants. 
Motility and biofilm formation are important virulence factors in bacterial pathogens. In some 
species, motility is only important in the initial phase of the infection as it promotes contact 
dependent adhesion to host cells. In other bacteria motility needs to be established and 
maintained during the infection. Biofilm formation is known to be mediated by several factors, 
such as quorum sensing, cyclic di-GMP, pilli, flagella and exopolysaccharide. The ability to 
create a biofilm could assist bacteria to become more resistant to environmental stresses, such as 
bacteriophage infection, antibiotic and other antimicrobial agents [55, 187]. We found a 
relationship between motility and biofilm formation in most of the non-luminescent variants. In 
fact, most of the non-luminescent strains showed a significant higher capacity of biofilm 
formation and a significantly improved swimming motility. These results are consistent with the 
finding of Watnick & Kolter [188], who showed that mobility is the major contributor to biofilm 
formation in V. cholerae EI Tor. Perhaps the motile non-luminescent variants spend a significant 
part of their cellular energy on the formation of the motile apparatus and for its rotation [189],  
leaving less energy for the production of other virulence factors, such as caseinase and 
hemolysin. Josenhans & Suerbaum [189], stated that motile pathogenic bacteria have the ability 
to switch motility on and off as required and are even able to alter between a motile or sessile life 
style in the same host and habitat, depending on their growth condition. In Vibrio, conditions 
inducing a shift from the non-luminescent stage back to luminescence have not been described 
yet. 
Several studies demonstrated the important role of Hsps in regulating the virulence of pathogens 
[190, 191]. For instance, Hoffman & Garduno [192], reported that DnaK of the ulcer-causing 
bacterium, Helicobacter pylori, mediates attachment to host gastric epithelial cells. The increased 
expression of this DnaK following acid shock correlates with both increased bacterial adhesion 
and inflammation of the gastric mucosa. Chakrabarti et al. [193], described a possible 
interference of DnaK with virulence factor production by V. cholera. Our results showed a 
phenotypic shift from bioluminescence to non-luminescence was not associated with a clear 
alteration in the DnaK level. Additionally, DnaK production by the wild type BB120 and its 
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quorum sensing mutants was quorum sensing independent, indicating that different unknown 
factor(s) might be regulating the production of DnaK in these strains.  
This study also confirmed that concomitant with the loss of luminescence, the non-luminescent 
variants appeared to be less virulent towards Artemia (Table 3.5). The lower production level of 
various virulence factors might explain the lower virulence of the non-luminescent variants in our 
challenge test. Results of the in vivo test also revealed that AI-2 and CAI-1 signal molecules were 
the crucial signaling factors affecting the virulence of V. harveyi towards Artemia. This is in line 
with the results of an earlier study of our group [14]. 
Overall results indicated that switching to the non-luminescent state could change the phenotypic 
physiology or behavior of V. harveyi resulting in altered caseinase and hemolysin activities and 
in improved swimming motility and biofilm formation. The phenotype switching capacity was to 
a large extent independent from the quorum sensing status, because quorum sensing mutants 
were equally capable of performing the phenotypic switch.   
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4.1 Introduction 
Vibrio harveyi, a marine bacterium that belongs to the Vibrio clade, is considered as one of the 
most important bacterial pathogens in aquaculture, affecting a wide range of cultured marine 
organisms, including fish, crustaceans and molluscs [7]. Many studies carried out on crustaceans 
have reported that the expression levels of immune-related genes in these organisms were 
markedly elevated in response to V. harveyi infection [138, 194-196]. The invertebrate 
crustaceans, unlike vertebrate, rely solely on their only defense system i.e. the innate immunity, 
which is essential for host defense to eliminate the invader. The innate immune system has two 
principle components: the cellular and humoral, which are activated upon immune challenge. 
These two components work synergistically to detect, eliminate and combat foreign organisms. 
The cellular component involves those processes mediated by hemocytes, such as encapsulation, 
nodule formation and phagocytosis. Whereas the humoral components involve the cell free 
components of the hemolymph including clotting cascade, anti-oxidant defense enzymes like 
super-oxidase dismutase, peroxidase, catalase and nitric oxide synthase, defensive enzymes like 
lysozyme, acid phosphatase and alkaline phosphatase, reactive oxygen and nitrogen intermediates 
and antimicrobial peptides [128]. 
The innate immune system recognizes self and non-self molecules by a limited number of 
germline-encoded receptors called pattern recognition receptors (PRRs). PRRs are proteins that 
are present on the cell membrane or in the cytoplasm as sensor for any type of pathogens. PRRs 
recognize pathogens by binding to molecular patterns/structures rather than to a specific 
component of a given pathogen. These molecular patterns, called pathogen-associated molecular 
patterns (PAMPs) are usually the polysaccharides and glycoproteins on the surface of microbes, 
such as lipopolysaccharide (LPS) from Gram-negative bacteria, peptidoglycan (PGN) and 
lipotechoic acid (LTA) from Gram-positive bacteria, and glucans from fungal cells. The 
recognition process leads to the rapid induction of cellular and humoral responses by the host 
[115]. However, Vance et al. [197] reported that the response of the host towards pathogens is 
not only limited to recognition of microbial structures but also to recognition of distinct 
pathogen-induced processes that contribute to the progression of disease. The authors also 
proposed that recognition of pathogen-induced events would provide the host with strategies for 
distinguishing a virulent organism from one that has lower disease-causing potential. For 
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example, it has been suggested that the host could sense translocated PAMPs as a signal for 
cytosolic access. In fact, as an example, translocated PAMPs sensed in the cytosol are flagellin. 
Since deliver of flagellin to the host cell is strictly dependent on type III or IV secretion systems, 
the cytosolic presence of flagellin is a strong signal to the immune system that a pathogen (as 
opposite to the commensal) is present [197]. 
Recently, a number of genes involved in the shrimp innate immune response have been identified 
and characterized, including those of pattern recognition receptors [115, 198], proteins associated 
with cell adhesion activity [199] and proteins involved in blood coagulation [200] like proteinase 
inhibitors, proPO activation or cytokine activation [138, 201]. Our previous study showed that 
the non-luminescent variants of the wild type V. harveyi BB120 and its quorum sensing mutant 
JMH634 respond differently in terms of virulence factor production and virulence towards 
Artemia compared to its parental luminescent strains [65]. In this study, the gnotobiotic Artemia 
model organism (GART) system is used to verify the hypothesis that phenotypic variation in V. 
harveyi, resulting in differences in vitro virulence factors production and virulence to Artemia in 
luminescent and non-luminescent of the wild type V. harveyi and a quorum sensing mutant, affect 
the defense system of Artemia. For that, germ-free Artemia were challenged with the luminescent 
and non-luminescent variants of the V. harveyi wild type strain and a triple quorum sensing 
mutant and the transcript levels of key genes related to innate immunity in Artemia were 
determined. The following genes were studied: lipopolysaccharide and β-1,3-glucan binding 
protein (lgbp), down syndrome cell adhesion molecule (dscam), peroxinectin (pxn), 
prophenoloxidase (proPO), transglutaminase (tgase), ferritin (ftn), melanin inhibition protein 
(mip) and serpin (spn).  
4.2 Material and methods  
4.2.1 Bacterial strains and growth conditions 
V. harveyi strains used in this study are shown in Table 4.1. The strains were stored in 20% 
glycerol at -80 C. Rifampicin resistant (RR) strains were produced as described by Hong et al. 
[65]. 
Autoclaved Aeromonas sp. LVS3 bacteria were used as feed for Artemia [158]. LVS3 were 
grown in Marine Broth (MB) 2216 (Difco laboratories, MI, USA), centrifuged at 2200 x g for 15 
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min. The supernatant was discarded and the pellet was re-suspended in filtered autoclaved 
seawater (FASW; 35g/L, Aquarium Systems, Sarrebourg, France). Subsequently, the cell 
suspension was autoclaved at 121 C for 20 min. The bacterial densities were determined 
spectrophotometrically at an optical density (OD) of 600 nm assuming that an OD of 1.0 
corresponds to 1.2 x 10
9
 cells mL
-1
 (McFarland standard; BioMerieux, France).  
Table 4.1 Bacterial strains and their relevant feature  
Strain Relevant feature       References 
BB120 RR-L Rifampicin-resistant luminescent  [65] 
BB120 RR-NL Rifampicin-resistant non-luminescent [65] 
JMH634 RR-L Rifampicin-resistant luminescent.  [65] 
JMH634 RR-NL Rifampicin-resistant non-luminescent [65] 
 
4.2.2 Axenic hatching of Artemia 
Axenic hatching of Artemia cysts was performed following decapsulation and hatching 
procedures as described previously [202]. Briefly, 4 g of Artemia cysts originating from the Great 
Salt Lake, Utah, USA (EG
®
 Type, batch 21452, INVE Aquaculture, Dendermonde, Belgium) 
were hydrated in 89 ml of sterile distilled water for 1 h. Sterile cysts and nauplii were obtained 
after decapsulation via using 3.5 mL NaOH (32%) and 50 mL NaOCl (50%). The reaction was 
stopped after 2 min by adding 70 mL Na2S2O3 (10 g/L). Thereafter the decapsulated cysts were 
washed with sterile FASW artificial seawater and then suspended in 1 L glass bottles containing 
FASW, and then incubated at 28°C for 28 h with constant illumination of approximately 27 
µE/m
2
.sec for hatching. After 28 h of incubation, the axenicity of the hatched Artemia nauplii 
was verified both by spread plating (100 ml) and by adding (500 µl) hatching water on Marine 
Agar and in Marine Broth (Difco, Detroit, USA), respectively followed by incubation at 28°C for 
5 days [202]. Bottles containing non-sterile nauplii were excluded from the experiment. 
4.2.3 Artemia challenge test  
After 28 h of incubation at 28 C, swimming nauplii at the instar II stage were collected, counted 
volumetrically and then transferred into 1 L glass bottles containing sterile artificial seawater. 
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The bottles were placed in a rectangular tank containing water maintained at 28
0 
C using a 
thermostatic heater with constant illumination (approximately 27 µE/m2.sec.) and aeration. The 
nauplii were fed once with 10
7
 cells mL
-1
 of autoclaved LVS3. Simultaneously, they were 
challenged with luminescent (group 1) or nonluminescent (group 2) variants of Vibrio at 10
6
 cells 
mL
-1
. Artemia nauplii that were non-challenged (group 3) were used as control. Three replicates 
were maintained for each group. Samples containing 0.1 g of live nauplii were harvested from 
each glass bottle at 6 and 12 h post challenge, rinsed in sterile distilled water, immediately frozen 
in liquid nitrogen and preserved at -80 C for further analysis. 
4.2.4 Quantitative real-time reverse transcription PCR  
Total RNA was extracted from different Artemia samples using the SV Total RNA Isolation 
System (Promega, Leiden, The Netherlands) according to the manufacturer’s instructions. The 
RNA quantity was measured spectrophotometrically (NanoDrop Technologies, Wilmington, DE, 
USA) and adjusted to 500 ng L-1 in all samples and the RNA samples were stored in -80 C for 
subsequent use. 
Reverse transcription was done with the RevertAid
TM 
H minus First strand cDNA synthesis kit 
(Fermentas, Fisher Scientific, Erembodegem, Belgium) according to manufacturer’s instructions. 
Briefly, 9 L of reaction mixture containing 4 L of 5x reaction buffer (0.25 mol-1 of Tris –HCl 
pH 8.3, 0.25 mol
-1
 of KCl, 0.02 mol
-1
 of MgCl2, 0.05 mol
-1
 of DTT), 2 L of 0.01 mol-1 of dNTP 
mix, 20 units of ribonuclease inhibitor, 200 units of RevertAid H minus M-MuLV Reverse 
Transcriptase (Fisher Sciencetific, Erembodegem, Belgium), 1 L of random hexamer primer. 
Then, 500 ng of RNA was added to the reaction mixture. Subsequently, the reaction mixture was 
incubated for 5 min at 25 C followed by 60 min at 42 C. The reaction was terminated by 
heating at 70 C for 5 min and then cooled to 4 C. Complementary deoxyribonucleic acid 
(cDNA) samples were checked by polymerase chain reaction (PCR) and stored at -20 C for 
further use. 
The primers used for analyses of proPO, tgase and ftn genes were previously described by Niu et 
al. [203]. For the genes pxn, dsam, lgbp, cal, spn, ef1, specific primers were designed using the 
Artemia Genome database (Sony, not published). Amplification products were re-sequenced to 
confirm homology with the genes identified in Pacifastacus and/or other invertebrate. Evidence 
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for their functionality awaits further research. Primers were designed using the online software 
Primer Express® Software v3.0.1 (Primer 3, IDT) and obtained from Eurogentec (Seraing, 
Belgium). 
Quantitative reverse transcription real-time PCR was used to quantify the gene expression level 
in Artemia. The reaction was carried out with Maximal
®
 SYBR Green/ROX qPCR master Mix 
(Fisher Scientific, Erembodegem, Belgium) and was carried out in an StepOne Real-Time PCR 
System thermal cycler (Applied Biosystems, Gent, Belgium) in a total volume of 25 L, 
containing 12.5 L of 2 x SYBR green master mix, primer (concentration see Table 4.2) and 2 
L of template cDNA. The thermal cycling consisted an initial denaturation at 95 C for 10 min 
followed by 40 cycles of denaturation at 95 C for 15 s and primer annealing and elongation at 60 
C for 1 min. Melting curve analysis was done to check for the amplification of untargeted 
fragments. Data acquisition was done with the STEPONE software. 
Based on the result of the optimalisation experiment, the amplification efficiency of the reference 
and target genes were found to be equal allowing to analyze real-time PCR data with the 2
-ΔΔCT
 
method [204]. The expression was normalized to the endogenous control (EF1) by calculating 
CT: 
Ct = Ct target – Ct EF1 
and expressed relative to calibrator sample by calculating Ct: 
Ct = Ct - Ct calibrator 
The sample of unchallenged Artemia at 6 h was used as calibrator. The relative expression was 
then calculated as 
Relative expression = 2
-ΔΔCT
 
4.2.5 Statistical analysis 
All statistical analyses were performed using the Statistical package for the Social Sciences 
(SPSS) version 20.0 using a significant level of 5%. Homogeneity of variances and normality of 
data were not fulfilled for an ANOVA analysis. The data was log transformed prior subject to 
statistical analysis. All treatments were compared to the control and to each of the other 
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treatments individually using independent samples t-test for each time point. Per time point, a 
matrix was obtained with an overview of all the results from the independent samples t-test. 
 
Table 4.2 Real-time quantitative RT-PCR primers  
Gene Efficiency Primer 
concentration 
Annealing 
temperature 
Strand Primer sequence (5’-3’) 
efα1 2.0 0.20M 
 
60C 
 
F 
R 
GGTCGGGGTTGAAACTGGTAT 
AGGGATTCGTGGGCATTT 
ftn 2.2 0.20M 60C F 
R 
TCCAAGGATTATCCGATGAACA 
ATGACCAAGTGAGTGCTTCTTCT 
tgase 2.2 0.20M 60C F 
R 
CCCCACAAGAACCATCTGAAG 
TCTCTCCGTGTCTCTCCAAAAG 
proPO 2.2 0.20M 60C F 
R 
TCTGCAAGGAGGATTTAAGGA 
TGACTGAAAGGAGATGGGAC 
lgbp 2.0 0.20M 50C F 
R 
GTGGACTGATGCTGAATG 
TGGTGGTCCAGATGATAC 
pxn 2.0 0.20M 60C F 
R 
GAGCTACCGATGAAGATCCAG 
CGTTTCCTGAACAGCGAATAAA 
dscam 1.9 0.25M 51C F 
R 
CATAGTCCAAGAGTGAATG 
GCCACATATTCAGTTAGAA 
mip 2.0 0.20M 54C F 
R 
CGTGGTAATGCTAGTGA 
CACCATCCACCTTCATA 
spn 2.0 0.20M 62C F 
R 
AAACCAGGCTTGCCGTT 
GCCGTGATTATTGTCCTTTGC 
 
4.3 Results and discussion 
This study aimed to verify that differences in in vitro virulence factors production or virulence to 
Artemia in luminescent and non-luminescent V. harveyi as a result from phenotypic variation that 
affects the defense system of Artemia. To verify the proposed hypothesis, germ-free Artemia and 
virulent/non-virulent strains of V. harveyi (for details, see Table 4.1) were used as host-pathogen 
model system. As readouts of host immune responses, a battery of key immune-related genes, 
including the lgbp, dscam, proPo, ftn, tgase, pxn, mip, and spn were analyzed. The germ-free 
Artemia culture system was employed for such test because it is a crucial tool that allows 
eliminating the possible interference of different microbial communities that exists in 
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environment and furthermore facilitates in studying the effects of interaction between the host 
and the tested bacteria. Under this experimental condition, it was observed that there was a 
significant alteration in the transcription levels of the immune receptors and a few downstream 
genes known to be involved in the humoral and cellular innate immune response in Artemia in 
response to challenge with luminescent or non-luminescent variants of the wild type V. harveyi 
and their corresponding mutants (Table 4.3 & 4.4).  
Table 4.3 Overview of the statistically significant results for the tested immune-related genes in 
Artemia larvae. The effects of a challenge with L or NL V. harveyi on gene transcription are 
shown.  
                 120L 120NL 634L 634NL 
Gene 6 h 12 h 24 h 6 h 12 h 24 h 6 h 12 h 24 h 6 h 12 h 24 h 
lgbp        - -  - -  - 
dscam  - -  - - - - - - - - 
proPO - - -  - -  - - - - - 
fnt   -  - - - - - -  - 
tgase - - -  - - - - - - - - 
pxn - - -  - - -  -   - 
mip   -   -   -   - 
spn -  -   - -     - 
: significant up-regulation of the gene compared to the control at this time point 
: significant down-regulation 
-: no significant difference between the treatment and the control  
 
PRRs are involved in the first step of immune responses in invertebrates by binding to highly 
conserved pathogen structures, such as peptidoglycan and lipopolysaccharide (LPS) from bacteria 
or to danger associated molecular patterns, such as Hsp70 and Hmgb1 [122]. In this study we 
investigated the transcriptional level of two important PRRs in invertebrates i.e. 
lipopolysaccharide and β-1,3-glucan binding protein (lgbp) and down syndrome cell adhesion 
molecule (dscam). 
The lipopolysaccharide and β-1,3-glucan binding protein (lgbp), also known as Gram-negative 
bacteria-binding protein (GNBP), is a pattern recognition receptor that can recognize and bind 
lipopolysaccharide (LPS) and -1,3-glucan. In invertebrates, lgbp plays vital roles in the innate 
immune defense against Gram-negative bacteria and fungi. It induces the cell and humoral 
mediated immune responses like encapsulation, phagocytosis, nodule formation, clotting, 
synthesis of antimicrobial peptides and activation of the prophenoloxidase (proPO) system. A 
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recent study showed that the expression of lgbp in shrimp Penaeus monodon increased at 24 h 
post injection with pathogenic bacterium Vibrio harveyi [121]. Another PRR is dscam, which is a 
hypervariable protein created by alternative splicing, involved in both general innate immunity 
and pathogen-specific immune response in invertebrate [205].  
Table 4.4 Summary of significant differences in immune-related genes expression 
Gene 120L vs. 120NL 120L vs. 634L 634L vs. 634NL 
6 h 12 h 24 h 6 h 12 h 24 h 6 h 12 h 24 h 
lgbp            - - - 
dscam  - - - - - - - - 
proPO   - -  - - - - - 
ftn  - -  - - - - - 
tgase  - - - - - - - - 
pxn  - - -  - - - - 
mip  - -  - - - - - 
spn   -     -  
: significant up-regulation 
: significant down-regulation 
-: no significant difference 
 
Significant differences in the expression levels of lgbp among the different groups were observed 
at different time points post challenge (Figure 4.1A). At 6 h post challenge, the expression level 
in the group exposed to luminescent or non-luminescent wild type V. harveyi BB120 was 
significantly down-regulated compared to the control. There was a significant difference in lgbp 
expression level between the Artemia challenged with luminescent BB120 and its non-
luminescent variant (BB120NL) or luminescent JMH634. However, at 12 h, expression level of 
lgbp was significantly up-regulated in the BB120L-challenged group compared to the BB120NL 
and JMH634L-challenged groups, and control group, whereas in all the other (treated) groups, 
there was a significant down-regulation in the expression level. At 24 h, the BB120L-challenged 
group exhibited significant increase in the expression level of lgbp compared to all other groups.  
The expression pattern of dscam showed significant decrease at 6 h post challenge in the BB120L 
and BB120NL compared to the JMH634-exposed group and control group. However, the 
expression level of dscam in the group exposed to either luminescent or non-luminescent variants 
of the mutant JMH634 was not significantly different from that of the control. No significant 
differences among the groups were observed either at both 12 and 24 h time points (Figure 4.1B).  
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Next, we analyzed the expression of a set of four genes related to humoral and cellular immune 
system: proPO, ftn, tgase and pero, as these immune components were previously reported to be 
involved in inducing resistance in invertebrate against bacterial infection [206]. As shown in 
Figure 4.2A, at 6 h post challenge, the group challenged with BB120NL exhibited a significant 
decrease in the proPO expression level compared to the un-challenged control group and to the 
group challenged with either luminescent BB120 strain (Figure 2A). The expression level of 
proPO significant down-regulated in the JMH634-exposed groups relative to the BB120L, and 
there is no significant difference in gene expression in these treatment groups (JMH634L and 
JMH634NL). No significant differences were observed among the groups at both 12 and 24 h 
time points (Figure 4.2A). 
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(A) 
 
(B) 
 
 
 
Figure 4. 1 Relative expression of lgbp (A) and dscam (B) genes in Artemia larvae.  
The larvae were challenged with luminescent (L) or non-luminescent (NL) of the wild type BB120 and its 
quorum sensing mutant JMH634 or not. The unchallenged Artemia larvae served as control. Sample was 
collected for lgbp and dscam gene expression at 6, 12 and 24 h post challenge. The expression was 
calculated relative to the ef1 gene; expression in unchallenged Artemia at 6 h was set at 1 and the other 
data points were normalized accordingly. Error bars indicated the standard deviation. Different 
letters/numbers (small and capital for 6 and 12 h, respectively and number for 24 h) were indicated for 
significant differences among groups (P<0.05).   
  
The ftn gene showed different expression pattern at different time points post challenge (Figure 
4.2B). At 6 h post challenge, the expression level of ftn was significant decreased in the Artemia 
exposed to either BB120L or BB120NL relative to the control and JMHL634-exposed groups. 
There was a significant difference in ftn gene expression between the BB120L and BB120NL-
exposed group while no significant difference between the JMH634L and JMH634NL was 
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observed. However, at 12 h post challenge, there was no significant difference in ftn gene 
expression among Vibrio-exposed groups. At 24 h post challenge, no significant differences 
among the groups were observed (Figure 4.2B). This result is accordance with the finding of Ong 
et al [207], they reported that mRNA expression of the horseshoe crab ftn was up-regulated 3 h 
after challenged with Pseudomonas aeruginosa, and the plasma ferritin disappeared between 6-
48 h post challenge. This result suggested that during infection, ferritin might be concealed 
intracellularly as it withholds iron from the invading pathogen. 
Similar to what was observed for ftn at 6 h post challenge, the expression level of tgase in 
Artemia challenged with BB120NL was significantly low compared to the control and to the 
BB120L-exposed group (Figure 2C). No significant differences were observed between BB120L 
and JMH634 treatment groups.  No significant differences were observed among the groups at 
both 12 and 24 h time points (Figure 4.2C).  
Pxn-encoding gene-pxn is a molecule first isolated and described from the fresh water crayfish P. 
leniusculus and this protein combines being a cell adhesion ligand and a peroxidase. In addition, 
crayfish pxn is also an opsonin, a degranulation and an encapsulation-promoting factor [133]. 
Pxn is a proPO system-associated protein and plays a crucial role in cellular defense for 
encapsulation enhancement in crustacean. For example when a foreign particle enters the 
hemolymph, hemocytes recognize the foreign intruder as non-self and change from non-adhesive 
to adhesive cells, strongly adhering to the foreign target, and subsequently form a multilayer 
sheath of cells during encapsulation [208, 209]. Previous studies observed that pxn gene was up-
regulated significantly in white shrimp Litopenaeus vannamei and Fenneropenaeus indicus when 
the shrimp was infected through injection by V. alginolyticus or V. harveyi, respectively [195, 
209].  
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Figure 4.2 Relative expression of proPo (A), ferritin (B), tagse (C) and pero (D) genes in 
Artemia larvae. The larvae were challenged with luminescent (L) or non-luminescent (NL) of the wild 
type BB120 and its quorum sensing mutant JMH634 or not. The unchallenged Artemia larvae served as 
control. Sample was collected for proPo, ferritin, tagse and pero gene expression at 6, 12 and 24 h post 
challenge. The expression was calculated relative to the ef1 gene; expression in unchallenged Artemia at 
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6 h was set at 1 and the other data points were normalized accordingly. Error bars indicated the standard 
deviation. Different letters/numbers (small and capital for 6 and 12 h, respectively and number for 24 h) 
were indicated for significant differences among groups (P<0.05).    
As showed in Figure 4.2D, 6 h post infection, expression level of pxn was significantly lower in 
the Artemia challenged with BB120NL compared to its luminescent variant (BB120L) and to the 
control. The pxn expression level was not significant different among BB120L, JMH634L and 
JMH634NL-exposed groups (Figure 4.2D). 12 h post challenge, expression of pxn by the 
BB120L and BB120NL remained at the same level compared to the control. However, in the 
mutant JMH634-challenged group, expression levels of pxn were significantly increased 
compared to the BB120L-challenge group and to the control group but no significant difference 
was observed among these treatments (Figure 4.2D). 
Melanization plays an crucial role in defense reactions, such as wound healing encapsulation, 
sequestration of microbes, and the production of toxin intermediates, that are speculated to kill 
invading microorganism [126]. Melanin synthesis is essential for defense and development but 
must be tightly controlled because systemic hyperactivation of the proPO system, excessive 
formation of quinones, and inappropriate excessive melanin synthesis are also deleterious to the 
hosts [137]. The melanization inhibition protein (mip) is involved in regulation of excessive 
production of quinones [138]. 
A study carried out by Angthong et al. [138] showed that mip was expressed in all the examined 
tissues in Penaeus monodon except hemocytes. The expression of this gene was very low during 
the larval stages and hardly present in eggs and at the nauplii stage upon V. harveyi challenge. 
In the present study, we found that a significant increase in the expression level of mip was 
detected in the JMH634L and JMH634NL-exposed groups relative to the BB120L and to the 
control group but no significant difference among the latter treatments was observed (at 6 h) 
(Figure 4.3A). Subsequently, the expression level of this gene was down-regulated significantly 
in all groups compared to the control at 12 h. Our result supports the findings of Angthong et al. 
[138], who suggested that upon V. harveyi infection the mip protein in Penaeus monodon 
(PmMIP) is first released from the tissues into the hemolymph whereafter the mip protein is 
being degraded during the bacterial infection to allow melanization.  
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Figure 4.3 Relative expression of mip (A) and serpin (B) genes in Artemia larvae.  
The larvae were challenged with luminescent (L) or non-luminescent (NL) of the wild type BB120 and its 
quorum sensing mutant JMH634 or not. The unchallenged Artemia larvae served as control. Sample was 
collected for mip and serpin gene expression at 6, 12 and 24 h post challenge. The expression was 
calculated relative to the ef1 gene; expression in unchallenged Artemia at 6 h was set at 1 and the other 
data points were normalized accordingly. Error bars indicated the standard deviation. Different 
letters/numbers (small and capital for 6 and 12 h, respectively and number for 24 h) were indicated for 
significant differences among groups (P<0.05).    
 
The spn gene encoding the protein spn is involved in a number of biological processes, such as 
blood coagulation, complement activation, fibrinolysis, angiogenesis, inflammation, tumor 
suppression and hormone transport [210]. The spn protein in arthropod from hemolymph are 
likely to function in protecting their hosts from infection by pathogens or parasites through 
inhibiting fungal or bacterial proteinases or regulating endogenous proteinases involved in 
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coagulation, proPO activation, or cytokine activation [211]. In this study, the pattern of spn gene 
expression was different in different challenge groups (at 6 h) (Figure 4.3B). The decrease of spn 
expression gene at 6 h post challenge with either BB120L or BB120NL might indicate that low 
synthesis of spn and high expression of relevant serine proteinase occurred during this period. 
This phenomenon might be caused by the involvement of the serine proteinases in wound 
healing, proPO activity, phagocytosis and other defense responses after bacterial challenge [129]. 
Then the expression of spn gene remained significantly low at 12 h in these treatment groups 
compared to the control after that it slightly increased towards the end of the experiment. It 
corresponds to the re-increased synthesis of spn to inhibit over-expressed serine proteinase, as 
observed in Fenneropenaeus chinensis [201]. In contrast, for the Artemia challenged with 
JMH634 groups, the trend of the spn gene expression was inversely. 
Overall, different patterns of gene expression were observed in different challenge groups at 
different time points. , BB120L and BB120NL are virulent to Artemia, and switching from L to 
NL status reduced a number of virulence factors in the wild type BB120 strain in vitro (Chapter 
3) (but increased swimming) and in vivo condition [49, 65, 69]. In the present study, exposure to 
the BB120NL variant significantly decreased the mRNA level of Artemia in all tested genes at 6 
h in comparison to its parental luminescent strain (BB120L). Based on the previous results and 
on this study, it is suggested that the higher production of virulence factors such as luminescence, 
caseinase and haemolytic activity as observed in the BB120L, might be involved in the induction 
at the transcriptional level of these genes in Artemia. But apparently the increased expression of 
all these genes does not need to be sustained except for the lgbp gene. It is unclear why sustained 
expression of the lgbp gene is needed in the BB120L challenge in the absence of higher 
expression of genes downstream in the defense.   
The strain BB120L and JMH634L appeared to be virulent and non-virulent towards Artemia in 
the challenge test, respectively (Chapter 3). In addition, production of some virulence factors was 
higher in vitro in the BB120L relative to JMH634L (Chapter 3). It has been shown that bacterial 
pathogens have co-evolved with their host, displaying remarkable refined molecular mechanism, 
often ending in highly specialized bio-chemical reactions between the microbe and its target 
cells. As a result, bacteria manipulate diverse host cellular processes for the benefit of the 
microbe but not for the host [212]. In many cases bacterial virulence factors require complicated 
secretion systems allowing the toxins or adhesins to be presented in the right context and at the 
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accurate time on the bacterial cell [213]. Interestingly, T3SS is known to be a potent virulence 
mechanism that involved in invasion, proliferation, and causing disease. T3SS is shared by a 
broad spectrum of pathogenic Gram-negative bacteria that interact with host by injecting effector 
proteins into the cytosol of host cells [212]. It has been reported that in V. harveyi, T3SS is 
regulated by quorum sensing [214], so probably, in the triple quorum sensing mutant JMH634L 
the T3SS is inactivated and no cellular damage can be induced by JMH634L exposure. 
Also here (yet not at 6h) expression of the lgbp gene is sustained in the challenge with a more 
virulent strain. Early upon BB120L exposure, proPO expression is upregulated relative to 
JMH634L, which might be logic for a more virulent strain.  Yet other effector genes such as ftn 
and pxn are down-regulated later on. Hence a dynamic differential regulation is displayed here. 
Mip and spn are upregulated later on, which might be needed to regulate for instance 
phenoloxidase activity induced by the virulent strain. For the case JMH634L and JMH634NL, 
both strains are non-pathogenic to Artemia in the challenge test although some differences in in 
vitro virulence factors was noticed between these strains (Chapter 3). Most of the tested genes 
(except the spn gene) exhibited no significant difference in gene expression between these 
treatment groups at either time point. This might be the consequence of the fact that both strains 
are non-pathogenic and might not be able to inflict cellular damage or they are subject to host 
phagocytosis without further negative consequences.   
It has not been possible yet to demonstrate that non-luminescent strains are capable to switch 
back to luminescent strains, neither in vitro nor in vivo. Yet it is possible that this is happening as 
the BB120L strains produces more virulent factors which could be beneficial in the infection 
process. Since BB120L and BB120NL are not significantly different in virulence towards 
Artemia (Chapter 3) such a back switch from non-luminescent to luminescent could be assumed 
on that basis. It is difficult to imagine what the effect could be of such a back-switch at the level 
of the host. One can assume that there would be little difference in host response or merely a 
delay in response because of a slower infection process. This could explain why the BB120L 
strain induces a more rapid response only in the beginning and little difference in expression level 
is found later upon exposure. Confirmation that a back-switch in vivo is present needs to be 
addressed.    
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In conclusion, virulence factors are an integrated multifactor system or products expressed by a 
pathogen that are essential for allowing the pathogen to replicate in the host and cause clinical 
symptoms [213]. Virulence factors are not constitutively expressed and their production tightly 
depends on the environmental conditions faced by the bacterium. Depending on the stage of 
infection, in the intestinal lumen, inside epithelial cells or professional phagocytes, or in the 
bloodstream, the set of virulence factors expressed in these different conditions has to vary 
accordingly. Exposure to the virulent or non-virulent of the luminescent and non-luminescent 
wild type BB120 and its quorum sensing mutant significantly altered the host defense response in 
term of immune-related gene expression in Artemia.  Results of this study provide evidence that 
alternation of in vitro virulence factors such as luminescence and the enzyme activities caused by 
phenotypic variation might contribute to the pathogen-induced processes and host-pathogen 
interaction, by which bacteria can modulate host defense reaction according to the pathogenic 
invader. Virulent strains or strains producing more virulent factors induce proPO expression only 
early on upon exposure while spn/mip are upregulated later on, probably to regulate 
phenoloxidase activity. The lbgp gene was overexpressed within the experimental time frame. 
This is unexpected in view of the fact that most of the test effector genes are down-regulated 
towards the end of the experiment. Difference in gene expression dynamics of the BB120L and 
B120NL strains leads to the assumption that the non-luminescent strains may switch back to the 
luminescent strains after infection, but that remains speculative. 
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5.1 Introduction 
Vibrio harveyi is a ubiquitous, bioluminescent marine bacterium which causes vibriosis in both 
marine vertebrates and invertebrates, leading to significant losses in the global aquaculture 
industry [7, 215]. Bacterial infection process includes three steps: colonization, adhesion and 
initial multiplication of the pathogen to the host surface, and then its penetration inside the body 
through one or several portals. Then, invasion of the pathogen inside the host organs and/or the 
circulatory system concurs with the expression of virulence factors, followed by exit of the 
pathogen and transmission of the disease [216]. The main mode of virulence of Vibrio spp. is the 
production of extracellular products that damage the cuticle and organs of the animals. The 
extracellular products include gelatinase, caseinase, phospholipase, haemolysin, elastase, 
chitinase, alkaline proteases, cysteine proteases, alkaline metal chelator-sensitive proteases, 
serine proteases, metalloproteases and siderophores [217, 218]. 
In response to a Vibrio infection, the host employs protective immune, repair and stress 
mechanisms to maintain cellular homeostasis and integrity, and to limit pathogenicity [219]. 
However, pathogenic Vibrio spp. evade host defensive mechanisms by using different strategies. 
For instance, Vibrio spp. evade stress caused by the host antimicrobial peptides (AMPs) by 
releasing their outer membrane vesicles to create a protective membranous shield. In V. cholerae, 
as another example, the resistance-nodulation-cell-division superfamily (RND) efflux pumps are 
particularly important in transporting AMPs out of the cytoplasm[220]. In V. vulnificus, evasion 
was done through surface expression of capsule polysaccharides that help bacteria to avoid 
phagocytosis by macrophages [221].  
Iron is a vital nutrient required for several important biological cellular processes, ranging from 
growth and DNA replication to oxygen transport and protection against oxidative stress [222]. 
Iron is also an essential element for bacterial pathogens, as these organisms have to acquire iron 
within their (vertebrate) hosts in order to replicate and cause infection. In V. vulnificus, a novel 
iron acquisition system has been found i.e. vep20. It is a host specific virulence gene that encodes 
vep20, an iron-regulated outer membrane protein that is involved in iron acquisition not only in 
eel but also in human [223] . These strategies enable the bacteria to survive, and thus to colonize 
skin and internal tissues [224, 225]. 
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Hsp70 and hmgb1 proteins are molecular chaperone for protein and DNA, respectively. As part 
of the innate immunity response, hmgb1 can be actively released from multiple cell types 
including macrophages, monocytes, and endothelial cells [226]. Hmgb1 can also be passively 
released from necrotic or damaged cells [227]. Hmgb1 released by activated immune cells and 
injured or necrotic cells, plays an important role in host responses to both types of threat: 
infection and sterile injury. Thus, it is a critical mediator in a final common pathway to morbidity 
and mortality during infection and sterile injury. Presently, hmgb1 has been considered as a 
therapeutic target for inflammatory diseases caused by injury or infection [228]. Novel methods 
for enhancing the availability of heat shock proteins (hsps) within the host have been developed 
either by supplying exogenous prokaryotic hsps derived from bacteria or by supplying exogenous 
eukaryotic hsp. Sung et al. 2008 [159] demonstrated that up-regulation of endogenous hsp70 in 
brine shrimp Artemia franciscana was associated with enhanced resistance to Vibrio infection. 
Moreover, similar results were observed by feeding the Artemia franciscana with E. coli, 
overproducing prokaryotic hsps or by feeding bacteria that overproduce heat shock proteins by 
exposure to a non-lethal heat shock [229]. These studies suggested that feeding hsp70 might be a 
viable alternative to use of antibiotics to control vibriosis and other infections in Artemia 
franciscana. 
Recently, a few studies have indicated that pathogenic bacteria evade host defense mechanisms 
during infection by limiting translation of host mRNAs which encode proteins that mediate 
defense responses [230, 231]. In particular, it has been suggested that pathogenic bacteria 
produce virulence factors such as type III secretion system (T3SS) effector proteins, which are 
important components of the infection process, and by introducing these effectors directly into 
the cytoplasm of the host, bacteria suppress host’s protein translation. For example, 
Pseudomonas entomophila induces a significant transcription of the gene encoding for the host 
AMP daptomycin, but it blocks the translation of daptomycin mRNA to a functional protein [193, 
232].  
V. harveyi have been reported to regulate their pathogenicity by producing a wide variety of 
virulence factors, and the production of these factors are regulated by quorum sensing signal 
molecules [11, 163]. V. harveyi uses a multichannel quorum sensing system with three quorum 
sensing signal molecules viz. Harveyi Autoinducer 1 (HAI-1), Autoinducer 2 (AI-2) and 
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Cholerae Autoinducer 1 (CAI-1), which act synergistically in regulating the production of 
virulence factors [165, 166]. Among others, luminescence in V. harveyi is an important virulence 
factor that is regulated by quorum sensing [169]. V. harveyi luminescence has also been shown to 
be involved in the detoxification of reactive oxygen species such as H2O2 produced by the host, 
thus playing a protective role against oxidative stress [173]. As H2O2 is an important part of the 
immune mechanisms in eukaryotic hosts against infections [174], bioluminescence is considered 
as an immune-evasive strategy. In a previous study, we obtained non-luminescent variants of 
luminescent V. harveyi strains by culturing the latter under dark and static conditions and found 
that some of these non-luminescent variants were less pathogenic towards gnotobiotically-
cultured brine shrimp (Artemia franciscana) than their luminescent counterparts [49, 65].  
In this study, using the gnotobiotic Artemia model organism (GART) system, we aimed to 
determine whether isogenic V. harveyi strains with different levels of virulence or in vitro 
virulence factor production inflict damages and cause disease in Artemia by interfering with the 
mRNA translational machineries of the host defense system. We used the GART system to 
conduct this study since here Artemia can be cultured under germ free environment and a 
controlled population of pathogens with different virulence levels can be added. This system is a 
crucial tool for such studies because it allows eliminating the interference of the microbiota that 
is naturally present in any type of (aquatic) environment and facilitates in determining 
exclusively the action of the pathogen of interest on the host [158, 233]. 
5.2 Material and methods  
5.2.1 Bacterial strains and growth conditions 
Both luminescent and non-luminescent variants of V. harveyi strains were used (Table 1). These 
strains are rifampicin-resistant (RR) and were produced as previously described [65]. Briefly, 
single colonies of each strain picked from Marine Agar (MA, Difco laboratories) plates were 
cultured in 10 mL Marine Broth (MB) 2216 (Difco laboratories) in a 100 mL Erlenmeyer flask. 
After incubation at 28 C for 24 h, 50 µL of the each culture was taken by micropipette and 
transferred to a 10 mL MB containing 0.5 mg L
-1
 of rifampicin (Sigma-Aldrich, USA). The 
cultures were incubated at 28 C for 24-48 h. In the following days, subcultures were made in 
MB, increasing the rifampicin concentration gradually from 1, 2, 4, 8, 16, 32, 64 to finally 100 
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mg L
-1
. When bacteria cultures were growing well in the final concentration of rifampicin (100 
mg L
-1
), they were inoculated on MA plates containing 100 mg L
-1
 rifampicin for obtaining 
single colonies. For long-term storage, the stock was preserved in 20% glycerol at -80 °C. 
Autoclaved Aeromonas sp. (LVS3) was used as feed for Artemia (Marques et al. 2006). LVS3 
were grown by inoculating one colony from a MA plate (28 °C for 24 h) in a 50 mL Erlenmeyer 
flask containing 20 mL MB and incubating the flask at 28 °C for 24 h. The grown LVS3 was 
centrifuged at 2200 x g for 15 min, supernatant discarded, and the pellet was washed and 
resuspended in filtered autoclaved sea water (FASW). Bacterial densities were determined 
spectrophotometrically as described previously [233]. Subsequently, the cell suspension was 
autoclaved at 121 °C for 20 min.  
Table 5. 1 Vibrio harveyi strains. 
Strain Relevant feature References 
BB120 RR-L Wild type, rifampicin-resistant luminescent  [65] 
BB120 RR-NL Wild type, rifampicin-resistant non-luminescent [65] 
JMH634 RR-L Mutation in LuxM (AI-1 synthase), LuxS (AI-2) 
synthase) and CqsA (CAI-1), rifampicin-resistant 
luminescent.  
[65] 
JMH634 RR-NL Mutation in LuxM (AI-1 synthase), LuxS (AI-2) 
synthase) and CqsA (CAI-1), rifampicin-resistant 
non-luminescent 
[65] 
 
5.2.2 Axenic hatching of Artemia 
Axenic hatching of Artemia cysts was carried out following decapsulation and hatching 
procedures as described previously [202]. Briefly, 4 g of Artemia cysts originating from the Great 
Salt Lake, Utah, USA (EG
®
 Type, batch 21452, INVE Aquaculture, Dendermonde, Belgium) 
were hydrated in 89 ml of sterile distilled water for 1 h. Sterile cysts and nauplii were obtained 
after decapsulation using 35 mL NaOH (32%) and 50 mL NaOCl (50%). The reaction was 
stopped after 2 min by adding 70 mL Na2S2O3 (10 g/L). Thereafter the decapsulated cysts were 
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washed with sterile artificial seawater (35g/L, Aquarium Systems, Sarrebourg, France) and then 
suspended in 1 L glass bottles containing sterile artificial seawater, and then incubated at 28°C 
for 28 h with constant illumination of approximately 27 µE/m
2
.sec for hatching. After 28 h of 
incubation, the axenicity of the hatched Artemia nauplii was verified both by spread plating (100 
ml) and by adding (500 µl) hatching water on Marine Agar and in Marine Broth (Difco, Detroit, 
USA), respectively followed by incubation at 28°C for 5 days [202]. Bottles containing non-
sterile nauplii were excluded from the experiment. 
5.2.3 Artemia challenge test  
Live axenic nauplii at the instar II stage were collected, counted volumetrically and then 
distributed into 1-L glass bottles containing sterile artificial seawater.  The bottles were placed in 
a rectangular tank containing water maintained at 28°C using a thermostatic heater with constant 
illumination (approximately 27 µE/m2.sec.) and aeration. The nauplii were fed once with 10
7
 
cells mL
-1
 of autoclaved LVS3. The nauplii were challenged with luminescent (group 1) or non-
luminescent (group 2) variants of Vibrio at 10
6
 cells mL
-1
. Artemia nauplii that were non-
challenged (group 3) were used as control. Three replicates were used for each group. Samples 
containing 0.1 g of live nauplii were harvested from each glass bottle at 6 and 12 h post 
challenge, rinsed in sterile distilled water, immediately frozen in liquid nitrogen and preserved at 
-80°C for further analysis.  
5.2.4 Analysis of heat shock protein 70 (hsp70) and high mobility group box 1 (hmgb1) gene 
expression by quantitative real-time PCR (qRT-PCR)  
Total RNA was extracted from the Artemia nauplii (0.1 g) using the SV Total RNA Isolation 
System (Promega, Leiden, The Netherlands) according to manufacturer’s instruction. First strand 
cDNA was synthesized from 1 µg total RNA using the RevertAid™ H minus First strand cDNA 
synthesis kit (Fermentas Gmbh, Germany) following the manufacturer’s guidelines. The 
expression of hsp70 and hmgb1 genes was analyzed by qRT-PCR using the following two primer 
pairs (hsp70: forward - CGATAAAGGCCGTCTCTCCA, reverse - 
CAGCTTCAGGTAACTTGTCCTTG; hmgb1: forward- GGATGAAAGCAAACCCCGTg, 
reverse - GTGCTCTTCTCTGCAAGTCTG). qRT-PCR was carried out in a total volume of 25 
µl, containing 9.8 µl of nuclease free water, 0.2 µM of each primer, 12.5 µl of Maxima SYBR 
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Green qPCR Master mix (Fermentas, USA) and 2 µl (1000 ng) of cDNA template. The qRT-PCR 
was performed using a One Step qRT-PCR instrument (Applied Biosystems) and the following 
protocol: denaturation (10 min at 95
°
C); 40 cycles of amplification and quantification (15 s at 
95
°
C, 30 s at 60
°
C, and 30 s at 72°C); melt curve analysis (55-95
°
C with a heating rate of 0.10°C 
s-1 and a continuous fluorescence measurement) and finally cooling to 4°C. Melt curve analysis 
was done to check for the application of untargeted fragments. Data acquisition was done with 
the STEPONE software. Upon optimization, the amplification efficiency of the reference gene 
(elongation factor, EF1) and target genes were found to be equal. Therefore, qRT-PCR data 
were analyzed using the 2
-ΔΔCT
 method for calculation of relative gene expression (fold-changes) 
(Livad and Schmittgen, 2001). The expression was normalized to the endogenous control 
(elongation factor, EF1: forward – GGTCGGGTTGAAACTGGTAT, reverse - 
AGGGATTCGTGGTGCATTT) by calculating CT (= Ct target – Ct EF1), and expressed relative to 
calibrator sample by calculating Ct (= Ct - Ct calibrator). A sample of non-challenged Artemia 
at 6 h was used as calibrator. The relative expression was then calculated as Relative expression 
= 2
-ΔΔCT
.  
5.2.5 Protein extraction and analysis  
Sampled Artemia nauplii (0.1 g) were homogenized in cold buffer K (150 mM sorbitol, 70 mM 
potassium gluconate, 5mM MgCl2, 5 mM NaH2PO4, 40 mM HEPES, pH 7.4) (Clegg et al. 2000) 
supplemented with a protease inhibitor cocktail (Sigma-Aldrich

, USA) as recommended by the 
manufacturer. After centrifugation at 2200 x g for 1 min at 4
°
C, the supernatant was collected and 
the protein concentration was determined as previously described (Bradford, 1976). Loading 
buffer was added to the supernatants which were subsequently vortexed, heated at 95°C for 5 min 
and finally electrophoretically separated by SDS-PAGE (10% and 8-16% polyacrylamide gel for 
hsp70 and hmgb1, respectively) using 30 µg of protein per lane. Heat shocked HeLa cells (human 
cervical adenocarcinoma cell line; Enzo Life Sciences, USA) (12 µg) were loaded on to one well 
to serve as a positive control and for calculating the relative amount of target proteins in the 
sample. Proteins were then transferred to a polyvinylidene fluoride membrane (BioRad Immun-
Blot™ PVDF) using a semi-dry blotting device (Biorad). The membranes were incubated with 
blocking buffer [50 ml of 1x phosphate buffered saline containing 0.2% (v/v) Tween-20 and 5% 
(w/v) bovine serum albumin] for 60 min at room temperature followed by a primary cross-
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reactive antibody for human hsp70 (1:5000; Affinity BioReagents Inc., USA) [123] or a primary 
cross-reactive antibody for human hmgb1 (1:2500; Affinity Abcam, ab18256, United Kingdom). 
The membranes were then incubated with horseradish peroxidase conjugated donkey anti-mouse 
IgG (1: 2500; Affinity BioReagents Inc., USA) and horseradish peroxidase conjugated goat anti-
rabbit IgG secondary antibodies (1:10000; Sigma, USA) for hsp70 and hmgb1, respectively. The 
membranes were then treated with enhanced chemiluminescence reagent (GE healthcare, UK) 
and the signals were detected by a ChemiDoc MP Imaging System (Biorad, Belgium). The signal 
intensity as quantified for Hela cells was set as 1 and the signal intensity in the samples as 
determined by densitometry, was expressed relative to the Hela cell signal (Biorad Image Lab™ 
Software version 4.1, USA). 
5.2.6 Statistical analysis 
All statistical analyses were performed using the Statistical package for the Social Sciences 
(SPSS) version 20.0 using a significant level of 5%. Homogeneity of variances and normality of 
gene expression data were not fulfilled for an ANOVA analysis. The data were log transformed 
prior subject to statistical analysis. All treatments were compared to the control and to each of the 
other treatments individually using independent samples t-test for each time point respectively. 
Per time point, a matrix was obtained with an overview of all the results from the independent 
samples t-test. 
Protein analysis data were analyzed by one-way analysis of variance (ANOVA) followed by 
Tukey’s multiple range tests using the statistical software Statistical Package for the Social 
Sciences (SPSS) version 20.0.  
5.3 Results and discussion 
When challenged with a pathogen, the host tries to maintain cellular integrity by triggering an 
immune response to restrict pathogen growth while repairing any tissue damage [234]. Previous 
studies suggested that pathogenic microorganisms (a bacteria, viruses) prevent both of these 
processes by arresting the protein synthesis in the host. For instance, in response to Pseudomonas 
entomophila infection, Drosophila significantly increased in the expression of antimicrobial 
peptides and repair pathways such as epithelium renewal and gut structure at transcriptional level. 
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However, P. entomophila evade the protective responses of Drosophila by blocking the synthesis 
of the protective molecules at the translational level [193]. In this study, using the germ-free 
Artemia as the host, we investigated whether pathogenic V. harveyi strains cause disease in 
Artemia by interfering with the host protective mechanisms. To this end, we exposed the germ-
free Artemia to luminescent and non-luminescent wild type V. harveyi BB120 and its isogenic 
quorum sensing mutant JMH634 and then analyzed the transcription and translation profiles of 
heat shock protein 70 (hsp70) and the high-mobility group box-1 protein (hmgb1) in Artemia. We 
focused on hsp70 and hmgb1 proteins because these two proteins are associated with both repair 
and immune mechanisms to fight against pathogenic stressors [219, 235] (and also because 
antibodies are available by now). More specifically, hsp70 and hmgb1 proteins upon induction 
play key roles in defining the resistance of organisms against stressors [235] by performing 
multifaceted functions, such as acting as molecular chaperone for protein and DNA, respectively, 
functioning as danger associated molecular pattern (DAMP) during inflammation and various 
cellular processes [236, 237], and/or participating in the activation of cell surface innate immune 
receptors, thereby modulating many aspects of host’s immune responses [238, 239].  
Strain JMH634L is less virulent to Artemia, compared to BB120L. This coincides with reduced 
in vitro production of some of the listed virulence factors. At 6 h post exposure hsp70 gene 
expression is up-regulated by JMH634L, while protein production is down-regulated. At 12 h 
post exposure there are no significant differences in production level of Hsp70 protein between 
the BB120L-exposed group and the JMH634-exposed group (Figure 5.1 & 5.2). Next, using 
these 2 strains to expose Artemia nauplii, results showed that there is no significant difference in 
Hmgb1expression but production of this protein is up-regulated by JMH634L relative to BB120L 
at both time points (Figure 5.3 & 5.4). The latter is an indication for the fact that a virulent strain 
BB120L would be able to down-regulate protein production. Yet this result is not equaled by the 
analysis of the gene expression and protein production profile of hsp70. 
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Figure 5. 1 Relative expression of the Hsp70 gene in Artemia larvae.  
The larvae were either challenged with luminescent (L) or non-luminescent (NL) wild type V. harveyi 
BB120 (120) or its isogenic quorum sensing mutant JMH634 (634). Unchallenged Artemia larvae sampled 
at 6 h served as control. Samples were collected for Hsp70 gene expression at 6 and 12 h post challenge. 
The expression level of the Hsp70 gene at 6 h in the control group was set as 1.  Results, which are mean 
of 3 biological replicates, are presented relative to the expression of the Artemia elongation factor α 1 
(efα1) gene. Bars indicate standard deviation of 3 biological replicates. Different letters (small and capital 
letters for 6 and 12 h, respectively) were used for significant differences among groups (P<0.05). 
 
In addition, strain BB120NL is as virulent as BB120L in the Artemia challenge test. Most of the 
virulence factors are down-regulated in vitro by the L to NL switch, except for swimming 
motility which is very strongly up-regulated in BB120NL (Table 5.2). Hsp70 gene expression in 
Artemia challenged with BB120NL is down-regulated only at 6 h post exposure whereas the 
hsp70 protein production is not affected. As observed in Figure 5.3 & 5.4, hmgb1 gene 
expression is down-regulated at 6 h only, while its protein production is up-regulated at 12h by 
BB120NL-exposure. 
In Table 5.2, data previously published on phenotypic differences among these 4 strains are 
summarized.  
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Table 5. 2 Summary of differences in in vitro virulence factors production and expression and 
production of hsp70 and hmgb1 in Artemia challenged with luminescent and non-luminescent 
BB120 and JMH634 strains [65].  
 120L vs. 634L 120L vs. 120NL 634L vs. 634 NL 
Caseinase      
Heamolysin    
Elastase  - - 
Biofilm formation -  - 
Swimming motility -   
DnaK content  - - 
Luminescence    
Artemia survival  - - 
Hsp70 gene (6 h)   - 
Hsp70 protein (6 h)  - - 
Hsp70 gene (12 h) - - - 
Hsp70 protein (12 h) - - - 
Hmgb1 gene (6 h) -  - 
Hmgb1 protein (6 h) 
Hmgb1 gene (12h) 
 - - 
Hmgb1 protein (12 h)   - 
: significant increase  
: significant decrease 
-: no significant difference 
 
Moreover, strain JMH634NL is just as strain JMH634L non-virulent to Artemia. In vitro most of 
the virulence factors are down-regulated in JMH634NL relative to JMH634L, except for 
swimming motility which is strongly up-regulated (Table 5.2). There are no significant 
differences in hsp70 expression and protein production at either time point. A similar result was 
obtained for hmgb1. 
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Figure 5. 2 Relative production of Hsp70 protein in Artemia larvae at 6 h and 12 h post 
challenge. Bars indicate standard deviation of 3 biological replicates. Different letters (small and 
capital letters for 6 and 12 h, respectively) were used for significant differences among groups 
(P<0.05).      
In case of JMH634NL and JMH634L, both having a low virulence (limited Artemia mortality), 
Artemia exposed to either JMH634L or JMH634NL did not display a difference in gene 
expression level or protein production. So most likely these 2 strains do not impose infection 
pressure and hence no cellular damage is induced, resulting in an absence of regulation for these 
2 genes.  
Interpretation of the differences observed in the BB120L and BB120NL-exposed groups 
comparison is less straightforward. Little is known about the importance and dynamics of in vivo 
expression of the virulence factors. Yet, the BB120L strain seems to up-regulate expression of 
both hsp70 and hmgb1 genes with no associated increase in protein. Again this observation 
indicates that exposure to a more virulent strain will induce gene expression, while not 
necessarily resulting in increased protein production.   
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Figure 5. 3 Relative expression of Hmgb1 gene in Artemia larvae.  
The larvae were either challenged with luminescent (L) or non-luminescent (NL) wild type V. harveyi 
BB120 (120) or its isogenic quorum sensing mutant JMH634 (634). Unchallenged Artemia larvae sampled 
at 6 h served as control (CT). Samples were collected for hmgb1 gene expression at 6 and 12 h post 
challenge. The expression level of the hmgb1gene at 6 h in the control group was set as 1.  Results, which 
are the mean of 3 biological replicates, are presented relative to the expression of Artemia elongation 
factor α 1(efα1) gene. Bars indicate standard deviations of 3 biological replicates. Different letters (small 
and capital letters for 6 and 12 h, respectively) were used for significant differences among groups 
(P<0.05). 
In addition, it is possible that just before or during infection non-luminescent cells switch back to 
luminescent cells. This is a speculation as we could never isolate luminescent cells from non-
luminescent culture  (Hong et al. unpublished). Yet phenotypic switches are possible in vivo 
during the infection process. Recently V. campbellii cells with different morphology were 
observed after phagocytosis by shrimp hemocytes (35). Assuming that such a phenotypic switch 
would indeed be necessary for infection, then non-luminescent might infect Artemia with an 
unknown amount of delay (relative to luminescent cells) because of the (short) time needed to 
make that switch. Yet at least in vitro their motility is much higher. So that might facilitate them 
to reach the locus of infection faster than luminescent cells. Such a scenario might have a 
complex impact on the dynamics of gene expression and protein production.  
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Figure 5.4 Relative production of Hmgb1 protein in Artemia larvae at 6 h and 12 h post 
challenge. Bars indicate standard deviation of 3 biological replicates. Different letters (small and 
capital letters for 6 and 12 h, respectively) were used for significant differences among groups 
(P<0.05). 
In another case, BB120L and JMH634L are virulent and non-virulent to Artemia, respectively. 
Artemia exposed to BB120L seems to reduce the protein production of hmgb1 while the gene 
expression not affected. Probably, inhibition of host protein synthesis might be one of the 
virulence strategies of pathogenic bacteria to survive and cause disease after infection. This 
phenomenon has also been revealed in many recent studies [193, 231]. For example, the secreted 
ligand, Upd3 was not produced in Drosophila infected with P. entomophila despites the strong 
induction of the upd3 gene. This study indicated that the uncoupling between protein and 
messenger RNA (mRNA) amount was indeed due to an inhibition of translation and not a general 
decrease in protein stability since it mainly affected proteins synthesized de novo upon infection 
(Upd3) but not protein produced prior to infection [193]. 
In conclusion, exposure of Artemia to pathogenic V. harveyi might be associated with modulation 
of the synthesis of hsp70 and hmgb1 proteins. At 12 h post infection either with BB120L or 
BB120NL, a significant down-regulation in the level of hsp70 and hmgb1 production was 
observed despite of the equal expression level of these genes compared to the control. This down-
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regulation of hsp70 and hmgb1 protein levels might link to the decreased resistance of Artemia 
against V. harveyi. Owing to the fact that a battery of immune factors are involved in inducing 
resistance in the host against V. harveyi, further studies are warranted to determine the effect of 
pathogenic factors on the translational machineries of the host defense system and to confirm our 
findings with additional strains. Also, because the results point towards a strong dynamic 
response (eventually further confounded by the possibility of a back-switch by NL strains) it 
might be needed in the future to perform a much more regular and sustained sampling. 
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6.1 Introduction 
High mobility group box 1 (hmgb1) is an ancient, highly conserved and ubiquitous protein 
present in the nuclei and cytoplasm of nearly all cell types. The name of this protein is based on 
its ability to migrate quickly during electrophoresis. Hmgb family contains hmgb1, 2 and 3, from 
which hmgb1 is the most abundant (more than 1 million molecules/cell). Hmgb1 protein is 
virtually identical (> 99%) for all mamals, mostly present in the nucleus, where it bends DNA 
and promotes protein assembly on a specific DNA target [240]. Hmgb1 is a non-histone DNA-
binding protein. During cellular stress, it localizes to the cell cytosol and can exit the cell through 
loss of membrane integrity or active secretion. Once it is free from the cells, it acts as damage-
associated molecular pattern (DAMP) molecule to activate innate immune receptors and drive 
inflammatory responses [241]. 
Generally, hmgb1 is not tightly bound to chromatin therefore it passively diffuses from necrotic 
cells. During apoptotic cell death, under-acetylation of histones and chromatin condensation 
cause irreversible attachment of Hmgb1 to the chromatin. In contrast, the acetylation status of 
Hmgb1 itself is not changed during apoptosis. Consequently, hmgb1 is sequestrated inside the 
nucleus in apoptosis cells, thus contributing to the anti-inflammatory response exerted by these 
cells under physiological conditions [242]. Hmgb1 consists of two fairly rigid, L-shaped DNA-
binding domains, each referred to as an ‘HMG box’ [243] and unstructured tail that ends with 30 
consecutive negatively charged amino acids. The tail interacts with the HMG boxes and may 
modulate their intermolecular interaction [244]. In nucleus, hmgb1 support the structure of the 
chromatin and is involved in the transcriptional regulation of genes. Recently, intracellular 
hmgb1 has been supposed to be involved in autophagy and in inflammation activation [245]. 
Extracellular hmgb1 is involved in immune responses and it is considered as a prototypic alarm 
signal [246]. This is the first report on full sequence of the hmgb1 gene in Artemia franciscana 
and overexpression of hmgb1 recombinant protein in E. coli. Results of this study can be used for 
further studies on functionality of hmgb1 gene and protein in Artemia. 
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6.2 Material and methods  
6.2.1 RNA isolation and cDNA synthesis 
Total RNA was extracted from Artemia franciscana larvae using the SV Total RNA Isolation 
System (Promega, Leiden, The Netherlands) according to manufacturer’s instruction. The RNA 
quantity was measured spectrophotometrically (NanoDrop Technologies, Wilmington, DE, USA) 
and adjusted to 500 ng L-1 in all samples and the RNA samples were stored in -80 C for 
subsequent use. 
Reverse transcription was done with the RevertAid
TM 
H minus First strand cDNA synthesis kit 
(Fermentas, Fisher Scientific, Erembodegem, Belgium) in accordance to the manufacturer’s 
instructions. Briefly, a 20 L of reaction mixture containing 4 L of 5x reaction buffer (0.25 mol-
1
 of Tris –HCl pH 8.3, 0.25 mol-1 of KCl, 0.02 mol-1 of MgCl2, 0.05 mol
-1
 of DTT), 2 L of 0.01 
mol
-1
 of dNTP mix, 20 units of ribonuclease inhibitor, 200 units of RevertAid H minus M-MuLV 
Reverse Transcriptase (Fisher Sciencetific, Erembodegem, Belgium), 1 L of Oligo-dT primer 
(Table 1) and 500 ng of total RNA. Subsequently, the reaction mixture was incubated for 5 min 
at 25 C followed by 60 min at 42 C. The reaction was terminated by heating at 70 C for 5 min 
and then cooled to 4 C. Complementary deoxyribonucleic acid (cDNA) was then used as 
template for isolating Hmgb1 using RACE method. 
6.2.2 Isolating of the full coding sequence of ArtHmgb1 
The 5'UTR and HMGB1 3'UTR sequence of ArtHmgb1 were obtained via RACE method (Rapid 
Amplification of cDNA ends). The gene-specific primers (Hmgb1F and Hmgb1R) were designed 
from cDNA database of Artemia franciscana genome project (The project of Artemia Reference 
Center, Ghent University) (Table 6.1). The HMGB1F primer was combined with adaptor primer 
to amplify the 3'UTR sequence of Hmgb1 by PCR reaction from cDNA sample. The HMGB1R 
primer was used to amplify the 5'UTR sequence as instruction of SMARTer RACE 5’/3’ Kit 
from Clontech, USA. 
Briefly, 2 L of the first strand cDNA were used as template for 50l PCR reaction, containing 
0.5M HMGB1F primer and 0.5M adaptor primer, 10 L of 5X Reaction buffer; 1 L of 10 
mM dNTP; 1 L of Taq DNA polymerase  (EP0701, Thermo Fisher Scientific, USA). DNA free 
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water were added to the reaction mixture to the final volume of 50 L. The PCR thermal cycle 
was followed by denaturation for 3 minutes s at 95 C subsequently, 30 cycles of annealing step 
were carried out for 30 s at 95 C; 30 s at 58 C; 60 s at 72 C. The reaction was extended for 10 
min at 72 C and then cooled to 4 C. 
The HMGB1R primer was used as gene specific primer to amplify the 5'UTR sequence as 
instruction of SMARTer RACE Kit (Clontech, USA). Briefly, the cDNA for isolating of 5'UTR 
sequence was prepared by SMARTer RACE 5’/3’: The 20 l cDNA reaction contains 4 L 5X 
First-Strand Buffer, 0.5 L DTT (100 mM) 1 L dNTPs (20 mM) 5’-CDS Primer A, 10 L total 
RNA, 1 μl of the SMARTer II A Oligonucleotide, 0.5 μl RNase Inhibitor (40 U/μl), 2.0 μl 
SMARTScribe Reverse Transcriptase (100 U) flowing by incubation at 42°C for 90 minutes. 
Subsequently, PCR reaction was carried out to amplify 5'UTR sequence: 1 μl cDNA, 5 μl PCR 
buffer, 1 μl dNTPs (10mM), 5.0 μl 10X UMP primer (Clontech Kit), 0.5mM HMGB1R primer 
and 0.25 μl Taq DNA polymerase. The PCR thermal cycle was followed by denaturation for 3 
minutes s at 95 C subsequently, 30 cycles of annealing step was carried out for 30 s at 95 C; 30 
s at 55 C; 60 s at 72 C. The reaction was extended for 10 min at 72 C and then cooled to 4 C. 
The PCR products of 3’UTR and 5’UTR sequences were purified from agarose gel using 
Wizard
®
 SV gel and PCR Clean-up System (Promega) and then ligated into the pGEM
®
-T easy 
vector (Promega) using T4 ligase (LigaFast™ Rapid DNA Ligation System, Promega). The 
recombinant vectors were transformed into the TOP10 chemically competent E. coli 
(ThermoFisher Scientific, Belgium), the positive clones were selected through ampicillin 
resistance selection and PCR cloning analysis using gene specific primer combining with vector 
primer (T7 and SP6 primer, Table 6.1). The recombinant vector bearing the 5'UTR and 3'UTR 
sequence from positive transformant clones were purified by Wizard® Plus SV Minipreps DNA 
Purification System kit (Promega) for sequencing both strands, using T7 and SP6 primer. The full 
length of hmgb gene was assembled by Vector NTI software (Invitrogen, USA) from the 
obtained 5'UTR and 3'UTR sequences.  
6.2.3 Cloning of the full-length ArtHmgb1 cDNA 
The PCR products were purified from agarose gel using Wizard
®
 SV gel and PCR Clean-up 
System (Promega, Belgium) and then ligated into the pGEM
®
-T easy vector (Promega, Belgium). 
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The recombinant vectors were transformed into the TOP10 chemically competent E. coli 
(ThermoFisher Scientific, USA), the positive clones were selected through ampicillin resistance 
selection and PCR cloning analysis using gene specific primer combining with vector primer (T7 
and SP6 primer, Table 6.1). The recombinant vector bearing the 5'UTR and 3'UTR sequence 
from positive transformant clones were purified by Wizard® Plus SV Minipreps DNA 
Purification System kit (Promega) for sequencing both strands, using T7 and SP6 primer. The full 
length of ArtHmgb1 gene was assembled by Vector NTI software (Invitrogen, USA) from the 
obtained 5'UTR and 3'UTR sequences.  
Table 6.1 Primer sequences used in this study 
Name 
Primer sequence (5’-3’) Brief information 
HMGB1R 
GTGCTCTTCTCTGCAAGTCTG Gene specific primer for 
RACE 
HMGB1F 
GGATGAAAGCAAACCCCGTG Gene specific primer for 
RACE 
Adapter 
primer 
CTGACCTGAAGTTCATCTGCTTTTTTTTTTTTTTTTT Oligo (dT) for cDNA 
synthesizing 
T7  TAATACGACTCACTATAGGG Phage promotor primer on 
the vector for sequencing 
SP6 TATTTAGGTGACACTATAG Phage promotor primer on 
the vector for sequencing 
HMGB1-
BamHI-F 
GCACGGATCCATGCCACGCTCTAAGGATG Gene-specific primer for 
recombinant protein 
HMGB1-
SalI-R 
GCGCTCGTCGACTTACTCGTCATCCTCTTCCTCC Gene-specific primer for 
recombinant protein 
 
6.2.4 Sequence characterization and multiple sequences alignment 
The amino acid sequence information for homology analysis is shown in Table 6.2. The 
nucleotide and protein sequence similarity were conducted with Blast algorithm at the National 
Center Biotechnology Information (NCBI, http://www.ncbi.nlm.gov/blast/). Multiple sequence 
alignment of Hmgb1 protein was performed with ClustalW multiple alignment program 2.1 
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(http://www.ch.embnet.org/software /ClustalW.html). The protein phylogeny analysis was done 
on web platform http://www.phylogeny.fr. 
Table 6. 2 Species and accession number of Hmgb1 genes used in the homology analysis. 
 
Species 
Accession number 
Homo sapiens 
CAG33144 
Bos Taurus 
NP_788785 
Gallus gallus 
NP_990233 
Sus scrofa 
NP_999228 
Salmo salar 
ACM09402 
Danio rerio 
CAX12897 
Lampetra fluviatilis 
CAA67363 
Lipopenaeus vannamei 
ADQ43366 
Litopenaeus vannamei 
ADQ43367 
 
6.2.5 The recombinant expression of ArtHmgb1 
Base on the obtained full length of ArtemiaHmgb1, two primers HMGB1-BamHI-F and 
HMGB1-SalI-R (Table 6.) were designed to allow amplifying the entire ORF of ArtHmgb1 and 
cloned into pET28a(+) expression vector at the BamHI/SalI sites (Table 6.1). The open reading 
frame (ORF) of ArtHmgb1 was amplified by PCR using Phusion High-Fidelity DNA Polymerase 
(F-530S, Thermal scientific, USA). Briefly, 50 L PCR reaction contains 5 L of  5X Phusion 
HF buffer, 1 L  of dNTPs ( 10mM), 0.5 L of  Phusion DNA polymerase (2U/L), 0.5 M of 
each gene-specific primer and cDNA sample as template. The thermal cycling conditions were : 1 
cycle of denaturation for 30 seconds at 98 C; 35 cycles of 10 seconds each at 98 C, 20 seconds 
at 60 C, 2 minutes at 72 C; 1 cycle of extension for 10 minutes at 72 C. Finally, the reaction 
was cooled at 4 C. The PCR product was gel-purified with Wizard
®
 SV Gel and PCR Clean-up 
System (Promega, Belgium) and then digested with BamHI (# R0136S, NEB, USA) and SalI (# 
R0138S, NEB, USA) subsequently cloned into the expression vector pET28a(+) at BamHI/SalI 
sites (Novagen, Gemany). The recombinant expression vector (pER28a-artHMGB1) was 
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transformed into TOP10 chemically competent cells. The positive transformants were screened 
by PCR with primers T7 and HMGB1-SalI-R (Table 6.1) and then confirmed by further 
nucleotide sequencing. Finally, the purified pER28a-ArtHmgb1 was transformed into 
Rosetta
TM
(DE3) chemically competent cells (#70954-3, Novagen, Gemany) for protein 
expression. The pET28a(+) vector without insert fragment was designed as A(-) and used as 
negative control. The negative transformants were designed as A1 and the positive transformants 
were designed as A2 and incubated in liquid Luria-Bertani (LB) broth medium containing 
50mgmL
-1
 Kanamycin (K1377, Sigma, USA) and 34 mg mL
-1
 Chloramphenicol (C0378, Sigma, 
USA) at 37°C with shaking at 220 rpm overnight. The bacterial supernatant were upscaled in the 
fresh LB broth containing 50mg mL
-1
 Kanamycin (K1377, Sigma, USA) and 34 mg mL
-1
 
Chloramphenicol (C0378, Sigma, USA) at 37°C with shaking at 220 rpm for 2 more h. When the 
culture media reached OD600 of approximately 0.5-0.7, the cell were induced with isopropyl-β-D-
thiogalactopyranoside (IPTG, Sigma-Aldrich, Inc, USA) at 0.5 mmol L
-1
 and incubated for an 
additional 4 h. The bacterial supernatant were collected by centrifugation at 4000 x g, rinsed 
twice with sterile demi water and then stored at -80 °C for further experiment. 
6.2.6 Protein extraction and detection 
The induced and non-induced A2 bacterial strain were homogenized by rapid agitation with 0.1 
mm diameter glass bead in cold buffer K (150mM MgCl2, 5 mM NaH2PO4, 40 mM HEPES, pH 
7.4) containing a Protease inhibitor cocktail (Sigma-Aldrich, Inc, USA). Subsequently to 
centrifugation at 2200 g for 1 min at 4 C, supernatant protein concentrations were determined by 
the Branford method (Bradford 1976). Supernatant (30 g protein) were then combined with 
loading buffer, vortexed, heated at 95 C for 5 min, centrifuged at 4000 g for 1 min and then 
electrophoresed in 8 -16 % SDS-PAGE gels. HeLa (heat shocked) cells (Enzo Life Sciences, 
USA) (12 g) served as a positive control and for calculating the relative  amount of hmgb1 
protein in each sample. Proteins were then transferred to polyvinylidene fluoride (PVDF) 
membranes (BioRad Immune-Blot
TM
 PVDF) for antibody probing. After incubation in blocking 
buffer (50 mL of 1 x phosphate buffered saline containing 0.2% (v/v) Tween-20 and 5% (w/v) 
bovine serum albumin) for 1 h at room temperature followed by incubation with primary 
antibodies for hmgb1 either “HMGB1 (1:2500; Affinity Abcam, ab18256, United Kingdom) or 
ARP59013-P5050 (1:1000; Holzel diagnostika, Germany). The membranes were then incubated 
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with horseradish peroxidase conjugated goat anti-rabbit IgG secondary antibody (1:10000; 
Gentaur BVBA, Belgium). The membranes were then treated with enhanced chemiluminescence 
reagent (GE healcare, UK) and the signals were detected by a ChemiDoc MP Imaging System 
(Biorad, Belgium). The relative signal intensity was quantified by densitometry with Biorad 
Image lab
TM
 Software version 4.1. 
6.3 Results and discussion 
6.3.1 Cloning of ArtHmgb1 
ArtHmgb1 was a 912 bp fragment, with an open reading frame (ORF) of 603 bp (Figure 1.6). The 
gene encoded a protein of 200 amino acids with a calculated molecular weight of 26.7 kDa. The 
alignment of the amino acid sequence of ArtHmgb1 with other known Hmgb1s revealed a 
conserved acid tail in the amino acid sequence of ArtHmgb1 and confirmed that Hmgb1 proteins 
are highly conserved between vertebrates and invertebrates (Figure 2.6) 
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Figure 6.1 Nucleotide and deduced amino acid sequences of ArtHmgb1.  
The nucleotides are numbered along the right margin. The ORF is shown in bold letters, the 5´ 
and 3´-UTRs are shown in un-bold letters. The two HMG domains are shaded. The gene-specific 
primers HMGB1F and HMGB1R for the RACE method are underlined.   
 
Human                        MGKGDP-----KKPRGKMSSYAFFVQTCREEHKKKHPDASVNFSEFSKKC  
Cow                          MGKGDP-----KKPRGKMSSYAFFVQTCREEHKKKHPDASVNFSEFSKKC  
Chicken                      MGKGDP-----KKPRGKMSSYAFFVQTCREEHKKKHPDASVNFSEFSKKC  
Pig                          MGKGDP-----NKPRGKMSSYAFFVQTCREEHKKKHPDSSVNFAEFSKKC  
Salmon                       MGK-DP-----RKPRGKMSSYAYFVQTCREEHKKKHPEASVNFSEFSKKC  
Zebrafish                    MGK-DP-----NKPRGKTSSYAFFVQTCREEHKKKNPGTSVNFSEFSKKC  
Lamprey                      MGKGDP-----KKPKGKMSSYAYFVQTCREEHKKKNPEASVNFAEFSKKC  
L.vannamei                   MPRGRPRGVAAEKPRGRMTAYAFFVQTCRTEHKKLHPDENVQFAEFSRQC  
L.vannameib                  MPRAK---LVDSKPRGRMSAYAFFVQTCREEHKKKHPDENVVFSEFSRKC  
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Artemia                      MPRSK----DESKPRGKLTAYAFFVQTCREEHKRKHPDENVVFAEFSKKC  
                             * :         **:*: ::**:****** ***: :*  .* *:***::* 
 
Human                        SERWKTMSAKEKGKFEDMAKADKARYEREMKTYIPPKGETK--------K  
Cow                          SERWKTMSAKEKGKFEDMAKADKARYEREMKTYIPPKGETK--------K  
Chicken                      SERWKTMSSKEKGKFEDMAKADKLRYEKEMKNYVPPKGETK--------K  
Pig                          SERWKTMSAKEKSKFEDMAKSDKARYDREMKNYVPPKGDKK--------G  
Salmon                       SERWRTMSAKEKGKFEDLAKLDKMRYEREMRSYIPPKGEKK--------K  
Zebrafish                    SERWRTMSSKEKGKFEEMAKTDKVRYDREMKNYVPPKGAKGG-------K  
Lamprey                      SERWKTMSEKEKTRFEDMAKVDKVRYDREMKTYVPPKGERGS-------R  
L.vannamei                   SERWKTMSDKEKKKFHDMAEDDKKRYDEEMKDFVPSPGAGRRGRRARGRR  
L.vannameib                  AERWKTMTDKEKDRFYDMADKDKARYDTEMKGYR-GPRTPRVSRKRRNR-  
Artemia                      AERWKTMNEKERDRFHKMAEQDKARFETEMKDYTPAEGAKGRGGKGSKRK  
                             :***:**. **: :* .:*. ** *:: **: :                  
 
Human                        KFKDPNAPKRPPSAFFLFCSEYRPKIKGEHPGLSIGDVAKKLGEMWNNTA  
Cow                          KFKDPNAPKRPPSAFFLFCSEYRPKIKGEHPGLSIGDVAKKLGEMWNNTA  
Chicken                      KFKDPNAPKRPPSAFFLFCSEFRPKIKGEHPGLSIGDVAKKLGEMWNNTA  
Pig                          KKKDPNAPKRPPSAFFLFCSEHRPKIKSEHPGLSIGDTAKKLGEMWSEQS  
Salmon                       RFKDPNAPKRPSSAFFIFCADFRPQVKGETPGLSIGDVAKKLGEKWNNLT  
Zebrafish                    KKKDPNAPKRPPSAFFVFCSDHRPKVKGDNPGISIGDIAKKLGEMWSKLS  
Lamprey                      KKKDPNAPKRPPSAFFIYCAEYRSKVRAENPGLTIGSIAKKLGEMWNNAP  
L.vannamei                   P-KDPNKPKRALSAFFYYANDERPKVRAANPDFSVGEVAKELGRQWNELG  
L.vannameib                  --KDPNAPKRALSAFFWFCNDERAKVRAANPDMGVGDVAKQLGAAWSNTP 
Artemia                      AKKDPNAPKRALSAFFWFCNDERSKVKADQPGLGVGDVAKELGRRWADVD  
                               **** ***. **** :. : *.:::.  *.: :*. **:**  * .   
 
Human                        ADDKQPYEKKAAKLKEKYEKDIAAYRAK--GKPDAAKKGVVKAEKSKKKK 
Cow                          ADDKQPYEKKAAKLKEKYEKDIAAYRAK--GKPDAAKKGVVKAEKSKKKK  
Chicken                      ADDKQPYEKKAAKLKEKYEKDIAAYRAK--GKVDAGKKVVAKAEKSKKKK 
Pig                          AKDKQPYEQKAAKLKEKYEKDIAAYRAK--GKGEAGKKGPGRPTGSKKKN  
Salmon                       AEDKVPYEKKAARLKEKYEKDITAYRNK--GKVP-------VSMPAKAAA  
Zebrafish                    PKEKSPYEQKAMKLKEKYEKDVAAYRAK--GGKPDGAKKGGPGRPAGKKA  
Lamprey                      ADEKSIYERKTAKLKEKYDKDMASYRSK--GKVET------SKVASKPAS  
L.vannamei                   EDEKVKYEKLAEEDRARYDREMTAYKFG--GASPQ------KKMKASNGH  
L.vannameib                  PEAKAKYEALAASDKERYEKEMKAFKEGNFGAKKH------KTMNAPN--  
Artemia                      EKAKKRYEEMASKDKKRYEVEIAAYKKK--LAAPA------KNGAAAE--  
                              . *  **  :   : :*: :: :::                   :     
 
Human                        EEEEDEEDEEDEEEEEDEEDEDEEEDDDDD- 215 
Cow                          EEEEDEEDEEDEEEEEDEEDEEEEEDDDDE- 215 
Chicken                      EEEEDEDEDEEDEEDEEEEEEEEEDDDDDE- 215 
Pig                          EPE-DEEEEEEEEEDEDEEEEDEDEE----- 210 
Salmon                       PAKDDDDDDDDDEDEDDDDDDDEDDE----- 203 
Zebrafish                    EADDDDDEDEDEEDEEEEDEEDEDDDDE--- 213 
Lamprey                      KQRDDDDDEDDDEEDDEDEDEDDDDDDE--- 208 
L.vannameia                  PVDADPEDDEDEVGGEEDDEDDVSDEGSEDE 222 
L.vannameib                  --EDDDEEEESESEEEEEEEDDE-------- 206 
Artemia                      -----DEDEEDE----EEEEDDE-------- 200 
                                   ::::.:    ::::::          
 
Figure 6.2. Multiple sequence alignment of ArtHmgb1 protein with other Hmgb1s deposited in 
GenBank  
The (*) indicated positions where all sequences share the same amino acid residue. Similar amino 
acids are shared by (: and .) .Gaps are indicated by dashes to improve the alignment.  
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6.3.2 Recombinant protein expression in E.coli 
The recombinant vector pET28(+)/ArtHmgb1 was transformed in E. coli strain Rosetta
TM
(DE3) 
competent cells. After IPTG induction, the whole-cell lysate was separated by SDS-PAGE, and a 
distinct band of ArtHmgb1 was revealed with a molecular weight of appropriately 26.7 kDa 
(Figure 3.6). Different antibodies were used to detect the ArtHmgb1 recombinant protein. The 
result of Western blotting showed that the ArtHmgb1 gene was up-regulated in the ITPG-induced 
A2 strain, yielding a polypeptide of approximately 26.7 kDa visible on the PVDF membrane 
probed with either HMGB1 (Figure 4.6 A) or ARP59013-P5050 (Figure 4.6 B) antibodies. 
 
Figure 6.3 ITPG induced overproduction of Artemia Hmgb1 protein.  
Protein extracted from E. coli strain was resolved in SDS-PAGE gel and then stained with 
Coomassie blue. Molecular mass standards in kDa are on the left. 1: non-induced of vector 
without insert fragment A(-); 2: induced of vector without insert fragment A(-); 3: non-induced of 
negative colony (A1); 4: induced of the negative colony (A1); 5: non-induced of positive colony 
(A2); 6: induced of positive colony (A2).   
 
 
Figure 6.4 ITPG induced overproduction of Artemia Hmgb1 protein.  
Protein extracted from E. coli strain A2 induced with ITPG was transferred to polyvinylidene 
fluoride membrane and either probed with HMGB1 (A) or ARP59013-P5050 (B) antibody. 
A B 
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Thirty microgram of bacteria protein was loaded in each land. Molecular mass standards in kDa 
are on the left. 1: induced positive colony (A2); 2: non-induced positive colony (A2); 3: induced 
negative colony (A1); 4: non-induced negative colony (A1). 
 
As show in Figure 6.5 Hmgb1 protein from Artemia samples either challenged with JMH634L or 
JHM634NL was detected by the same antibody HMGB1 that also worked with the ArtHmgb1 
recombinant protein overexpressed in E.coli. In all protein samples from Artemia Hmgb1 were 
detected on the PVDF membrane at an approximate size of 38.5 kDa. 
 
Figure 6.5 Expression of Hmgb1 protein in Artemia. Artemia either challenged with JMH634 
luminescent (1, 2, and 3) or JMH634 non-luminescent variant (4, 5, 6) for 6 h.  
Protein extract from different groups was transferred to polyvinylidene fluoride membrane and 
probed with HMGB1 antibody to Artemia Hmgb1. Thirty microgram of Artemia protein was 
loaded in each lane. Molecular standards in kDa are on the left.   
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Figure 6.6 Phylogenetic tree of Hmgb1 protein from invertebrates and vertebrates.  
The tree was constructed by an NJ algorithm using the http://www.phylogeny.fr website based on 
the multiple sequence alignment by ClusterX. 
 
Hmgb1 proteins were subjected to phylogenetic analysis using the neighbor-joining (NJ) method 
by http://www.phylogeny.fr website. The phylogenetic tree illustrates that using available Hmgb1 
proteins, they can be divided into 2 classes, namely invertebrates and vertebrates.  
In conclusion, Hmgb1 plays an important role in maintaining nucleosome structures, 
transcription, and inflammation.  They have been identified in many vertebrates and invertebrates 
[247].  In this study, the full-length cDNA of Hmgb1 was cloned from Artemia franciscana. The 
deduced polypeptide of ArtHmgb1 consisted of 200 amino acids, and it calculated molecular 
weight was 26.7 kDa, which is highly conserved to those from vertebrates and invertebrates. 
The conserved function domains of ArtHmgb1 showed high similarity with other identified 
Hmgb1s and the phylogenetic relationship collectively suggested that ArtHmgb1 was a novel 
member of invertebrate Hmgb1 family, and it could have similar functions to those from 
vertebrates and other invertebrates. In Artemia a protein with a higher apparent molecular mass of 
38.5 kDa was detected. At least according to the website of one manufacturer this is a probability 
and may be the consequence of differential glycosylation (http://www.abcam.com/recombinant-
human-hmgb1-protein-ab167718.html). It is not known why glycosylation of Hmgb1 would be 
so different in HeLa cells relative to Artemia.  
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7.1 Phenotypic variation in vitro conditions  
Bacteria have to survive in different niches and in the presence of various stresses, such as 
starvation, temperature shocks, pH alterations, UV exposure, predation, antimicrobial agents 
challenge (antibiotics, biocides and disinfectants) and immune host defences [248]. The ability of 
a bacterium to survive and accommodate sudden changes in the conditions is termed as adaptive 
response and strongly depends on its genetic content. However, these survival strategies are often 
only used by part of a bacterial population. These responses heterogeneity could help bacteria to 
utilize different niches within an ecosystem, and even has potential to increase the overall fitness 
of the species. 
Phenotypic variation mostly involves colony morphology change, biofilm phenotypic variation, 
virulence and persistence of bacteria.  
One of the most important roles of phenotypic variation is to cope with dynamic environments. In 
fact, the conventional perspective on microbial adaptation to fluctuating environments is that 
individuals sense environmental cues and respond to them through signal transduction and the 
regulation of gene expression, thereby attaining a phenotype that performs well in the current 
environmental condition. However, it is likely that this strategy – sensing and responding – is not 
always possible, such as when the number of the possible environmental conditions that an 
organism encounters is so large or when environmental impact arises so rapidly that organisms 
can not express phenotypic features that would accommodate the impact fast enough [249]. In 
these cases, organisms can evolve to express these protective features probabilistically and with a 
low probability, independently of environmental cues. At any point in time, the majority of the 
population will not express the features; these individuals will grow well in the absence of 
environmental impacts but poorly during impacts. A minority of the individuals in a clonal 
population will express these features, and they will potentially grow more slowly in the absence 
of environmental impacts if these features are costly to express but will survive environmental 
impacts (Figure 7.1). Through this process, phenotypic variants are produced, and allows 
organism to persist in fluctuating environments [249]. For example, growth rate heterogeneity in 
a population of E. coli contributes to survival on exposure to antibiotics. A small subpopulation 
of the cells (known as persisters) in clonal populations grows very slowly or not at all, and these 
cells have a higher chance of surviving sudden exposure to antibiotics. The slow growth that 
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confers tolerance to antibiotics can be caused by a range of different exterior and interior factors, 
including nutrient shifts or expression of virulence genes [250].  
                     a 
 
 
 
 
Figure 7.1 Persistence in fluctuating environments (Source [249]). 
a. A genotype that expresses two different phenotypes (blue and green cells) can persist in an 
environment that fluctuates between two states (light blue and light green) in which only 
individuals that express that matching phenotype can survive. 
b. Salmonella typhimurium exhibit two different phenotypic variants in the expression of the 
flagellin gene flicC, and this allows S. typhimurium to persist in an environment that fluctuates 
between favouring flagellation (flicC ON) and selecting against it (flicC OFF) [251]. 
Phenotypic variation has been shown to influence bacterial virulence and also microbial 
resistance. The small colony variants (SCVs) that has been isolated from several types of 
respiratory and urinary infections are the best example of how phenotypic variation can alter the 
antimicrobial resistance profile and virulence ability and their great adaptability in such different 
environments [252, 253]. In a previous study, non-luminescent variants of luminescent V. harveyi 
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strains were obtained by culturing the luminescent variant under static condition in the dark, and 
it was found that these non-luminescent variants were less virulent towards brine shrimp 
(Artemia franciscana) larvae than their luminescent counterparts [49]. In another study, it was 
found that the non-luminescent variants had lower mRNA transcript levels of the quorum sensing 
master regulator luxR, and the vhp metalloprotease (known to be regulated by quorum 
sensing)[69]. Chapter 3 of this thesis is an extension of the above studies wherein it was aimed to 
investigate the association in terms of virulence factors expression between the non-luminescent 
variants and their “parental” luminescent strains of V. harveyi and their quorum sensing mutant 
strains.  In the present study (Chapter 3) the production of virulence factors, including caseinase, 
haemolysin and elastase, as well as the swimming motility and biofilm formation were 
characterized. Our results indicated that switching from luminescent variant of the wild-type V. 
harveyi and its quorum sensing mutants to their respective non-luminescent variants significantly 
influenced multiple aspects of their phenotypic behaviour resulting in altered caseinase and 
haemolytic activities and improved swimming motility and biofilm formation. The phenotypic 
variation capacity was to a large extent independent from the quorum sensing status, because 
quorum sensing mutants were equally capable of making the phenotypic switch. These findings 
suggest that V. harveyi could change its cell morphology, virulence factors and persistence in the 
natural ecosystem as well to adapt the fluctuation in the environment. However, the 
environmental conditions and mechanisms that regulate this switching are not elucidated. In 
addition, whether these non-luminescent variants would be recognized by host and how the host 
would respond to the exposure and subsequent infection caused by the different variants of the V. 
harveyi need to be verified. Experiments were conducted to try to answer these questions in the 
subsequent chapters (Chapter 4 & Chapter 5). 
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Figure 7.2  Phenotypic variation in bacteria 
Infections caused by pathogenic bacteria that have the ability to form biofilms (biofilm infection) 
are difficult to treat, and in vitro susceptibility tests have shown that biofilms are considerably 
more resistant than planktonic cells to the action of antibiotics [252]. In addition, the enhanced 
antibiotic resistance of biofilms has been attributed to the presence of an exopolysaccharide 
matrix, a slow growth rate, spatial heterogeneity and biofilm-specific drug-resistant or drug-
tolerant physiologies including the presence of persister cells and small colony variants. In the 
present study (Chapter 3), the biofilm formation was higher in the luminescent wild type BB120 
compared to that of its luminescent quorum sensing mutant strains. Switching from luminescent 
to non-luminescent variants seemed to enhance the biofilm formation in most of the non-
luminescent variants of the V. harveyi.  Also in some quorum sensing mutants switching towards 
the NL status reduced the virulence towards Artemia franciscana. Although in this study the 
topic of persisters was not studied, it is conceivable that in the NL population more persisters are 
around making this population of NL variants more resistant to antibiotics [65]. However this is 
hypothetical and could be the topic of further investigation. 
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The notion of phenotypic variation has changed how we look at microbial populations. Microbial 
cells are individuals that differ from each other in terms of their behavior and their properties. 
Phenotypic variants can have important functions and can provide individuals and groups with 
new functionality. Several studies have suggested that phenotypic variation is an important aspect 
of the biology of microorganism in their natural environment and that it contributes to 
functionally relevant biological diversity in microbial populations. It hence contributes to the 
concept of differential properties and behaviors of individual cells [254, 255]. An overview of 
different aspects influenced by phenotypic variation of bacteria in general is illustrated in Figure 
7.2. 
7.2 Phenotypic variation in the host 
Pathogens try to evade host’s immunity to survive after infection. There are various potential 
strategies. Bacteria can switch hosts and become free-living some of the time, or they can find 
sites within a host that are “privileged” or hidden from host immunity. Moreover, they can try to 
alter antigen display to avoid recognition. Pathogens commonly interact with hosts through 
proteins or other macromolecules in their cell surface; those that elicit immune response within 
the host are considered as antigens. [255]. These surface-exposed proteins can have a variety of 
functions including transporter, porins, receptors, colonizing factors, enzymes, which in addition 
might contribute to evading the host immunity [51]. For example, in Neisseria spp., the 
expression of outer membrane proteins that are involved in iron acquisition, including the 
siderophore receptor FetA in N. gonorrhoeae [256]  and two hemoglobin receptors in N. 
meningitides [257] contribute to the bacterial evasion of immune system.  
The innate immune response is assumed to be activated by pathogen-associated molecular 
patterns (PAMPs), for instance, lipopolysaccharide (LPS) from Gram-negative bacteria, 
peptidoglycan (PGN) and lipotechoic acid (LTA) from Gram-positive bacteria, and glucans from 
fungal cells. However, it has been suggested that the innate immune response can also be 
stimulated by host signals commonly associated with infection, such as damage-associated 
molecular patters (DAMPs), for instance, DNA, ATP, uric acid, DNA binding proteins (hmgb1), 
alarmins or endogenous adjuvants. In fact, damage-induced responses play a significant role in 
the host response to pathogens, keeping in mind that the inflicted damage might in part by due to 
the host response rather than the pathogen. This self-inflicted damage may amplify the immune 
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response. Therefore, many pathogens appear to go to considerable lengths to avoid host damage 
[197]. For example, pathogens are able to manipulate downstream signaling pathways to prevent 
responses downstream of PAMP recognition [258] and several bacterial pathogens have efficient 
mechanisms for down-regulating flagellin expression within the host. 
Over the last decade, many studies reported that the response to invading microorganisms is 
stimulated by recognition of PAMPs. Recently, Vance et al. [197] suggested that beside PAMPs 
hosts may recognize distinct pathogen-induced processes that contribute to the progression of 
disease. This recognition would provide the host different strategies for distinguishing a virulent 
organism from one that has lower disease-causing potential. The host could then escalate immune 
responses to a level commensurate with the attack being mounted. Based on these evidences, in 
the present study (Chapter 4) we investigated the mRNA expression level of a few important 
immune-related genes in order to verify the hypothesis that change in the production of virulence 
factors in V. harveyi by phenotypic variation plays a role in host’s recognition, consequently 
modulating the host’s immunity. Based on the result of a previous study (Chapter 3) four 
bacterial strains: luminescent and non-luminescent of the wild type BB120 (120L; 120NL) that 
were virulent towards Artemia and the triple mutant JMH634 (is the strain lacks three quorum 
sensing systems) and both the luminescent and non-luminescent variants of this strain that 
previously shown to cause no pathogenic effect on Artemia [49, 65]. In this study, we found that 
exposure with the virulent strain (BB120L) could significantly affect the expression level of most 
tested genes: lgbp, dsacm, proPo, ferritin, mip, serpin in comparison with that in the Artemia 
exposed to the non-virulent strain JMH634L (Table 4.3). As observed in the previous study 
(Chapter 3), the production of virulence factors such as caseinase, heamolysis, elastase, 
luminescent, DnaK content was significant different between the virulent bacterial strain 
(BB120L) and the non-virulent strain (JMH634L) (Table 5.3). In addition, the production of 
extracellular enzymes, for example, proteases, phospholipase has been considered as another 
pattern of pathogenesis that may liberate host ligands that are sensed by the innate immune 
system or produced cellular damage that trigger host responses [197]. Taking all together, we 
suggested that these pattern of pathogenesis might have the potential to allow the immune system 
to distinguish the pathogenic strain (BB120L) from the non-pathogenic strain (JMH634L). 
In Gram-negative bacteria, LPS is the main constituent of the outer membrane. LPS consist of a 
lipid A moiety, a core of polysaccharide, and an O antigen. LPS variability among species and 
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serotypes occurs mainly in the O antigen, especially in the identity and number of sugars in the 
polysaccharide chain. LPS, also referred as endotoxin, is a powerful stimulant of the immune 
system due to the lipid A moiety, which is a pathogen-associated molecular pattern recognized 
specifically by toll-like receptor 4 (TLR4) [259]. The chemical identity of LPS is defined by the 
addition of side groups, for example as a result of the activity of glycosyltransferases or by the 
addition of phosphorylcholine (ChoP). These traits can vary within a clonal population as a result 
of phase variation of one or more enzymes involved in the modification [51]. For example, the 
pathogen Porphyromonas gingivalis can produce a variety of at least 12 different lipid A 
molecules, resulting in stimulatory, invisible or antagonistic varieties to TLR4 [260].  
Phagocytosis plays a key role in the innate immune response to restrict the spread of infectious 
diseases. Microorganisms internalized by phagocytosis are sequestered in phagosomes, which are 
initially inapt at killing and degrading pathogens. These phagosomes acquire their microbicidal 
properties through a complex maturation process involving sequential fusion with endocytic 
organelles, leading to the formation of phagolysosomes [261]. Several bacteria have evolved 
specific strategies to adapt and survive in their hosts by avoiding the harsh environment of 
phagolysosomes [262, 263]. 
Like many other bacterial processes, intracellular replication is heterogeneous: infection of 
tissue-cultured host cells with a clonal population of bacteria frequently results in variable 
numbers of bacteria in each host cell.  For example, study on intracellular trafficking undertaken 
by Leptospira interrrogans (pathogenic strain) and L. biflexa (non-pathogenic strain) in mouse 
bone marrow-derived macrophages showed that the delayed clearance of L. interrogans in 
murine macrophages was observed, indicating that L. interrogans has a capability to survive and 
replicate within these cells. Although bone marrow-derived macrophages could degrade L. 
biflexa as well as L. interrogans, a population of L. interrogans was able to survive and replicate. 
Furthermore, L. biflexa were completely degraded at 24 h post infection but L. interrogans were 
observed releasing in the extracellular medium. Results of this study suggested that pathogenic L. 
interrogans are able to survive, replicate and exit from mouse macrophages, enabling their 
eventually spread to target organs [264]. The heterogeneity of intracellular replication of bacterial 
pathogens might be caused by bacterial and host factors, as well as the variable intracellular 
microenvironments inhabited by these pathogens [265]. 
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Similarly, during the infection of Salmonella typhimurium bacteria in mice, Saicedo et al. found 
that most bacteria were found in intracellular location 3 days after inoculation. Using a panel of 
antibodies that bound to cells of different lineages, the authors have shown that the vast majority 
of S. typhimurium bacteria reside within macrophages. They suggested that in Salmonella SPI-2 
type III secretion system is required for replication within splenic macrophages, and sifA(-) and 
SPI-2 are involved in maintenance of the vacuolar membrane and intracellular replication in vivo 
[266]. 
A primary characteristic of many pathogens is the ability to deliver microbial molecules into the 
host cells cytosol by which bacteria can access, replicate in the cytosol and cause disease in the 
host. One of the best examples of this mechanism is the type III secretion system (T3SSs) that is 
encoded by numerous of Gram-negative bacterial pathogens [267].  
T3SSs form needle-like pores through the inner and outer membranes of bacteria that deliver 
bacterial proteins, usually enzymes from the cytoplasm of bacteria directly into their target 
eukaryotic host cells. The secreted proteins are referred as “effectors”. Once in the host cells, the 
effectors perform a variety of functions, including modifying host signaling and immune 
responses that contribute to pathogenesis [268]. V. harveyi possesses a T3SS and it is known to 
be regulated by quorum sensing [214]. The T3SS-secreted effector Vopz that is essential for V. 
parahaemolyticus pathogenicity. Vopz plays distinct, genetically separate roles in enabling 
intestinal colonization and cause disease [269]. Extracellular pathogens, such as Yersinia can 
utilize T3SSs to deliver effectors that block the uptake of bacteria into cells; conversely, 
intracellular pathogen such as Samonella can utilize T3SSs to enter cells and establish 
intracellular compartments that support replication [267]. It is worth noting that while the 
apparatus of the T3SSs itself is conserved across species, the effectors and their activities from 
each system differ widely in their mechanism of action. These effectors are typically potent 
proteins that mimic or capture an endogenous eukaryotic activity to disrupt the cellular response 
to infection [270]. Bacterial pathogens lacking T3SSs often encode evolutionarily unrelated 
systems that nevertheless fulfill the same basic function. Moreover, in the case of Gram-positive 
bacteria, some pore-forming toxins such as streptolysin O may serve as portals for the injection 
of bacterial molecules into the host cell cytosol (Figure 7.3). Some pore-forming toxins deliver 
not just a few effectors to the cytosol but are also involved in phagosome disruption, allowing an 
entire pathogen to access the cytosol. For example, in the case of Listeria monocytogenes a pore-
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forming toxin named listeriolysin O, was required to escape the phagosome, replicate in the 
cytosol, and cause disease in hosts [271]. Therefore secretion or pore forming systems are sensed 
by host cells via detection of the physical damage associated with the outer membrane 
compositions of the bacterium penetrating the plasma or phagosomal membranes. Difference in 
the production of the virulence factors that was observed in the non-luminescent variants and its 
luminescent parental strain might cause distinct levels of physical damage when bacteria insert 
into host membranes. Upon damage, hosts may mount appropriate responses for distinguishing a 
virulent organism (BB120) from one that has lower disease-causing potential (JMH634). This 
might explain the different patterns of gene expression that were observed in most tested genes in 
the BB120L-exposed group versus the JMH634L-exposed group (Chapter 4, Table 4.4). Thus, 
host immune responses may be shaped not only in response to PAMPs but also in response to 
contextual cues for instance, pattern of pathogenesis such as adherence of pathogen to host cell, 
production of extracellular enzymes (such as proteases, phospholipases, elastase) provided by 
infected bacteria as part of their virulence strategy [197]. 
Based on this type of interpretation and conceptualization, it can be assumed that the switching 
from the L to NL variant, and differences in term of virulence factors production that were 
observed between the L and NL of the BB120 (Table 5.3) as a result from phase variation, may 
as well have an effect on host responses (Table 4.3 & 4.4).   
This differential level of virulence factor expression might lead to a distinct host response via 
gene expression for instance. However, at 12 h post infection, the gene expression levels of most 
tested genes in the Artemia challenged with the non-luminescent variant (BB120NL) did not 
significantly differ in comparison with its luminescent strain (BB120L) (Table 4.4). This result 
might be subject to 2 different interpretations. The first being, that host responses at the 
transcription level happen mostly with the first 6 h upon exposure. Or alternatively, there is a 
possibility that the non-luminescent strain might switch back to the luminescent phenotype, upon 
initial contact with the host (as they seem to swim faster) or upon initial infection. Consistent 
with the idea that in vivo switching is possible, a recent study on differences on uptake and killing 
of pathogenic (Vibrio) and non-pathogenic (E. coli) by hemocyte subpopulations of penaeid 
shrimp was conducted by Tuan et al. [272].  The authors observed that both pathogenic and non-
pathogenic bacteria were phagocytosed by penaeid shrimp hemocytes, however, only non-
pathogenic bacteria were destroyed upon phagocytosis. When these bacteria were mixed with 
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shrimp hemocyte subpopulations and incubated for 180 min, the percentage of viable intracellular 
V. campbellii recovered was significantly higher than the percentage recovered from V. harveyi 
group treated in the same manner. Interestingly, and related to the idea of phenotype switching, 
during the uptake experiment the morphology of the majority of V. campbellii cells changed to 
rod shaped immediately after ingestion but converted into a coccal form after 2 h of incubation. 
Results of this study also indicated that these pathogenic bacteria: V. campbellii and V. harveyi 
most probably inhibited phagosome maturation and phagosome-lysosome fusion.   
Host pathogenic bacteria could undergo physiological changes to adapt within the severe 
environment, and avoid host recognition, host cell damage as long as possible. Thus, host 
immune responses wil be evaded through PAMPs modification, resistance to antimicrobial 
peptides or escape from phagocyte responses [260, 272]. Alteration of these biological processes 
might be as a result of phenotypic variation or it is one of the mechanisms that are used by 
different phenotypic variants for surviving and cause disease. 
 
 
Figure 7.3 Pattern of pathogenesis – a pore-forming toxin as proposed for mammal (Source 
[197]) 
To survive and develop in a dynamic environment, invertebrates need to have an efficient defense 
mechanism to control the resident microflora and prevent invasive microbial disease. However, it 
appears that microbial organisms have coevolved with their host to overcome protective host 
barriers and innate host responses. Many bacterial pathogens avoid host recognition or suppress 
the subsequent immune activation through sophisticated interactions with the host responses, but 
some pathogens benefit from the stimulation of inflammatory reactions [273]. Pathogenic Vibrio 
spp.  evade host defensive mechanism by using different strategies, for example, Vibrio spp. 
avoid the host antimicrobial peptides (AMPs) by releasing their outer membrane vesicles to 
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create a protective membranous shield. In V. cholerae, the resistance-nodulation-cell-division 
superfamily (RND) efflux pumps are used to transport AMPs out of their cytoplasmid space 
[220] or through surface expression of capsule polysaccharides V. vulnificus can avoid host 
phagocytosis by macrophages [223]. Moreover, pathogenic microbes must acquire essential 
nutrients, including iron, from the host in order to proliferate and cause infections. In V. 
vulnificus as a result of phase variation, the bacteria shifted their yellow cells from producing 
antibiotic and pigment production to producing components involved in acquisition of iron, 
which may increase fitness during periods of iron limitation. Another strategy that was used by 
pathogenic bacteria to evade the host immunity is their involvement in host’s inhibitory immune 
pathways that are the ways of controlling over host immune responses, such as overamplification 
(of DAMPs) or inflammation. Some bacterial pathogens such as Moraxella catarrhalis, Neisseria 
meningitidis can take advantage of host inhibitory signaling by using the surface ligands to 
directly engage the immunoreceptor tyrosine-based inhibitory motif (ITIM)-bearing receptors, 
which they can co-ligate with activated PPRs (such as TLRs) to suppress cellular activation and 
increase bacterial survival [274]. 
Recently, many studies have shown that pathogenic bacteria evade host defense mechanisms 
during infection by limiting translation of host mRNAs that encode for proteins that mediate 
defense responses [193, 230]. Study of Fontana et al.  [230] showed that upon infection of 
macrophages with virulent Legionella pneumophila, secretion of five effector proteins caused a 
global decrease in host translation. The lgt1,2,3 genes encode related glucosyltransferases that 
modify eEF1A, sidl encodes a protein that binds to eEF1A and eEF1βγ, and sidL is toxic to 
mammalian cells and inhibits translation in vitro by an unknown mechanism. In case of 
Pseudomonas entomophila – a bacterial pathogen of Drosophila, to identify how the gut response 
to lethal and nonlethal bacterial pathogen differs, three Gram-negative bacterial strains: P. 
entomophia (lethal), E. carotovora (nonlethal, but pathogenic) and P. entomophila gacA mutant 
(avirulent) were investigated [193]. Results of this study showed that either injection with the 
virulent or avirulent bacterial strains induced an up-regulation of 142 genes involved in 
antimicrobial and oxidative stress in Drosophila. Although infection with both P. entomophila 
and Ecc15 caused a high induction of Dpt-lacZ transcription (a marker fusion gene), the 
corresponding increase in LacZ activity was low in infected P. entomophila compared to Ecc15-
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infected guts. In addition infection with P. entomophila also caused a protein inhibition of L-
azidohomoalanine (AHA), a methionine analog upon infection.  
Microbial infection impacts host translation in a variety of ways. Not only can infection modify 
the translational capacity of the host, but regulating mRNA translation can influence microbial 
pathogenesis by limiting or promoting translation of host mRNAs encoding the effector proteins 
that mediate innate responses. Damage to epithelia by bacteria can suppress host translation via 
cell signaling pathways, alerting the host to danger. By introducing the effector directly into the 
cytoplasm, bacteria can directly suppress host translation [275].  
In the present study (Chapter 5), we aimed to determine whether luminescent V. harveyi inflict 
damage and cause disease in Artemia by interfering with the mRNA translational machineries of 
the host defense system. To this end, we exposed the germ-free Artemia to luminescent and non-
luminescent wild type V. harveyi BB120 and its isogenic quorum sensing mutant JMH634 and 
then analyzed the transcription and translation profiles of heat shock protein 70 (Hsp70) and the 
high mobility group box 1 protein (Hmgb1) in Artemia.  
Hsp70 and Hmgb1 proteins are associated with both repair and immune mechanisms to fight 
against pathogenic stressors [219, 235]. More specifically, Hsp70 and Hmgb1 proteins upon 
induction play key roles in defining the resistance of organisms against stressors [235] by 
performing multifaceted functions, such as acting as molecular chaperone for protein and DNA, 
respectively, functioning as danger associated molecular pattern (DAMP) during inflammation 
and various cellular processes [236, 237], and/or participating in the activation of cell surface 
innate immune receptors, thereby modulating many aspects of the host’s immune responses [238, 
239]. Results of this study (Chapter 5) showed that the Hsp70 protein level in Artemia exposed to 
luminescent variant of the wild type BB120 did not differ significantly from those exposed to 
either the non-luminescent variant of the wild type BB120 or to the (non-) luminescent variants 
of the mutant JMH634. Our findings were in line with the previous study on P. entomophila 
showing that Hsp70 proteins were not detectable in the gut of Drosophila infected with P. 
entomophila, although the Hsp70 gene was induced transcriptionally [193]. From these results, it 
appeared less likely that this virulence factor (luminescent) contributed to the inhibition of the 
hsp70 synthesis in BB120. However, at this point we also can not exclude the possibility that V. 
harveyi BB120 modulates the Hsp70 production level independent of their virulence factors.  
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In addition, a Vibrio infection significantly changed the Hmgb1 level in Artemia (Chapter 5).  In 
response to exposure to BB120L, a significant decrease in the production of Hmgb1 protein was 
observed at 6 h and 12 h relative to the JMH634L while no significant difference in Hmgb1 gene 
expression in both treatment groups was observed (Table 5.3).  The latter is an indication for the 
fact that a virulent strain BB120L would be able to down-regulate protein production. Our results 
are in agreement with our earlier study that showed that in response to V. campbellii challenge, a 
significant reduction of hmgb1 was observed at the protein level but not at the mRNA level 
[219]. Probably, inhibition of host protein synthesis might be one of the virulence strategies of 
pathogenic bacteria to survive and cause disease after infection. This phenomenon has also been 
revealed in many recent studies [193, 231]. It could also be possible that upon the level of cellular 
damage inflicted by V. harveyi infection, the differences between nonlethal and lethal infections 
could be due to the severity of cellular damages determining different ranges of host responses 
[193].  
Chakrabarti et al [193] also supposed that the rate of protein synthesis could act as direct sensor 
of pathogen-induced processes, modulating the immune response. Such sensor would reflect the 
global level of cellular stress and therefore act in response to any type of infectious damage, 
rather than recognizing a specific pathogen effector. Presumably, bacterial pathogens that disrupt 
host translation drive benefit from this activity, perhaps by increasing availability of amino acid 
nutrients or by dampening production of the host response. Therefore there is a need to have 
meticulous data on the dynamics of transcription and translation in the host, together with 
evidence for the infection process to determine the effect of pathogenic factors on the 
machineries of the host defense system.  
In conclusion, pathogenic bacteria V. harveyi might alter the physiological processes, such as 
virulence factors production, and the bacteria–host interaction when they undergo the phenotypic 
variation by which bacteria might improve their persistence, or evade the host immune system, or 
affects host’s response, and eventually influence on the survival of host (Artemia) (Figure 7.4). 
Evidence in relation to the ecological significance of the described phenotypic switch remains to 
be gathered, especially because no environmental condition has been pinpointed that facilitates a 
switch from a non-luminescent strains back to a luminescent strain. 
 
Chapter 7 General discussion and conclusion  
124 
 
 
 
Figure 7.4 Detailed scheme of the thesis 
Ability to switch to another phenotype of V. harveyi and its association in changing virulence 
factors in vitro and in vivo may attract attention to design therapeutic approaches and/or to 
develop improved vaccine for this or related pathogens in aquaculture. 
 
7.3 Future perspectives 
Based on the results obtained in this PhD study, the question can be raised whether the non-
luminescent variant of the wild type V. harveyi can switch back to the luminescent variety once in 
the host. In the future, attempts could be made to reisolate the L variety from infected Artemia. 
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For that the difference in in vitro expression of virulence factors could be used. For instance one 
could verify for the reoccurrence of luminescent colonies or hemolytic colonies.  
Variation of surface proteins and/or LPSs in many bacteria is important, resulting in antigenic 
changes. Thus, further study on genes and proteins variation due to phenotypic variation in V. 
harveyi may be one of the subjects for study. 
Moreover, how the different mechanisms, environmental regulation, and the gene products each 
contribute to the success of the bacterial population largely remains to be determined. In addition, 
identification of environmental factors and regulatory networks that influence phenotypic 
variation in V. harveyi, will probably contribute to our understanding of the global changes that 
allow bacteria to adapt and survive in a changing environment.  
Research on inducing the VBNC status in luminescent and non-luminescent variants in V. 
harveyi can be a subject for further study. This might allow gaining insight into how the L and 
NL status relates to the capacity to acquire the VBNC status. 
A molecular method that can be used to verify the phenotypic status in V. harveyi and develop 
such method into a marker to test the status of newly isolated strains and/or verify the phenotypic 
status of strains in vibrio population present in aquaculture facilities could be of interest in the 
future. 
In addition, antiphagocytosis is being used by many bacterial pathogens to avoid host recognition 
ensuring their survival and causing disease in human [276, 277] . For example, Yersinia species, 
which cause gastrointestinal symptoms and are responsible for plague, are among the better-
studied antiphagocytic pathogens. After ingestion by the host, Yersinia translocates several 
effectors into the host cells that mediate antiphagocytosis. The first antiphagocytic effector 
described was the protein tyrosine phosphatase (PTP) YopH [276]. YopH is localized to focal 
complexes during phagocytosis where its carboxy-terminal tyrosine-phosphatase activity 
specifically targets and dephosphorylates host cell proteins [278]. YopE is another Yersinia 
effector implicated in the avoidance of phagocytosis by disrupting actin filaments that are 
essential for phagocytosis [279]. In V. harveyi, T3SS genes have been identified and their 
expression is regulated by quorum sensing system [214]. However, the functionality of T3SS 
genes, for instance in relation to effectors probably being translocated into the host by this system 
and their involvement in antiphagocytosis during infection has not studied yet in V. harveyi. 
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Further research on other immune-related genes at transcriptional level and translational level is 
recommended. With the Artemia genome now being available it will become possible to clone 
and express the cDNA of much more immune related genes. This will allow in turn to generate 
antibodies, which can be used to verify the production of immune-related proteins. 
Result of ArtHmgb1 gene isolation and ArtHmgb1 recombinant protein can be used to facilitate 
the study on the functionality of this hmgb1 gene in Artemia. For instance it can allow to verify if 
feeding hmgb1, through E. coli cells overproducing them, can contribute to the protection of 
Artemia against Vibrio, as has been established by feeding E. coli overproducing Hsp70. 
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SUMMARY/SAMENVATING 
Phenotypic (phase) variation or phenotypic switching is defined as a process of reversible, high 
frequency phenotypic variation that is mediated by DNA mutations, reorganization or 
modification [21]. Phenotypic variation is used by several bacterial species to generate population 
diversity that enhances bacterial fitness under certain conditions and is important in niche 
adaptation and host immune evasion. Phenotypic variation was intensively studied in 
Pseudomonas spp. or in E. coli. However, little is known about phenotypic variation in Vibrio 
especially in luminous vibriosis diseases for many aquaculture species. 
Vibrio harveyi, a luminescent Gram-negative motile marine bacterium, is an important pathogen 
responsible for causing severe diseases in shrimp, finfish and molluscs leading to severe 
economic losses. Non-luminescent V. harveyi obtained by culturing luminescent strains under 
static and dark conditions were reported to alter the levels of virulence factors and 
metalloprotease gene and luxR expression when compared to their luminescent variants. 
Presently, our results (Chapter 3) showed that switching from the luminescent to the non-
luminescent state changed the phenotypic physiology or behavior of V. harveyi, resulting in 
alterations in caseinase and hemolytic activities, swimming motility, and biofilm formation. The 
switching capacity was to a large extent independent from the quorum sensing status, because 
quorum sensing mutants were equally capable of preforming the phenotypic switch.   
In the next chapter (Chapter 4 & 5) the gnotobiotic Artemia model organism (GART) system was 
used to investigate the influence of virulent and non-virulent luminescent and non-luminescent of 
wild type V. harveyi (BB120) and its quorum sensing mutant (JMH634) on immune defense of 
Artemia franciscana. 
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The mRNA transcriptional level of eight immune-related genes including lipopolysaccharide and 
β-1,3-glucan binding protein (lgbp), down syndrome cell adhesion molecules (dscam), 
peroxinectin (pxn), prophenoloxidase (proPO), transglutaminase (tgase), ferritin (ftn), melanin 
inhibition protein (mip) and serpin (spn) was investigated by challenge with these bacterial 
strains to verify the hypothesis that changes in the production of virulence factors in V. harveyi 
by phenotypic variation might play a role in host’s recognition, consequently stimulating the host 
immune response in a different pattern of gene expression in gnotobiotic Artemia (Chapter 4). 
Results of this study provide evidence that alternation of in vitro virulence factors production 
such as luminescence and the enzyme activities caused by phenotypic variation might contribute 
to the pathogen-induced processes and host-pathogen interaction, by which bacteria can modulate 
host defense reaction commensurate with the attack being mounted. Virulent strains or strains 
producing more virulent factors induce proPO expression only early on upon pathogen exposure 
while spn/mip are up-regulated later on, probably to regulate phenoloxidase activity. The lbgp 
gene is overexpressed more constitutively within the experimental time frame. This is unexpected 
in view of the fact that most of the tested effector genes are down-regulated towards the end of 
the experiment. Assuming the non-luminescent (NL) strains could switch back to luminescent (L) 
strains, the difference in gene expression dynamics could be explained in the experiment with the 
BB120L and BB120NL strains, but that remains speculative.  
In response to a Vibrio infection, the host employs protective immune, and repair and stress 
mechanisms to maintain cellular homeostasis and integrity, and to limit pathogenicity. However, 
pathogenic Vibrio spp. evade host defensive mechanisms by using different strategies. Recently, 
a few studies have indicated that pathogenic bacteria evade host defense mechanisms during 
infection by limiting translation of host mRNAs which encode proteins that mediate defense 
responses. In this study (Chapter 5), we aimed to determine whether luminescent V. harveyi 
inflict damages and cause disease in Artemia by interfering with the mRNA translational 
machineries of the host defense system. Result of this study showed that there was a non-
corresponding response at transcriptional level and translational level of hsp70 and hmgb1 in 
Artemia at 12 h post infection, indicating that transcription of these 2 genes is still ongoing, but 
translation tends to be limited 
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The full-length sequence of Hmgb1 of Artemia franciscana was isolated for the first time in this 
thesis (Chapter 6). Results show that the deduced polypeptide of ArtHmgb1 consistent of 200 
amino acids, and it calculated molecular weight was 26.7 kDa, which was highly conserved to 
those from vertebrates and invertebrates. The conserved functional domains of ArtHmgb1 were 
high similar to previously characterized Hmgb1 genes, suggesting that ArtHmgb1 is a novel 
member of the invertebrate Hmgb1 family, and it could have similar function to those from 
vertebrates and other invertebrates. 
In conclusion, the work presented in this thesis indicates that in vitro virulence factors are 
changed as a result of phenotypic variation in V. harveyi. These alterations in the luminescent and 
non-luminescent variants of the wild type BB120 and its quorum sensing mutant JMH634 might 
modulate the innate immune response, and consequently influence the survival of Artemia. 
Evidence in relation to the ecological significance of the described phenotypic switch remains to 
be gathered, especially because no environmental condition has been pinpointed that facilitates a 
switch from a non-luminescent strains back to a luminescent strain. 
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SUMMARY/SAMENVATING 
Fenotypische variatie of alternatie bij bacteriën wordt gedefinieerd als een proces van reversibel 
hoge frequentie fenotypische alternatie dat wordt bewerkstelligd door DNA mutaties, 
reorganisaties of modificaties. Fenotypische variatie wordt gebruikt door verschillende bacteriën 
om diversiteit op populatie niveau te genereren, om op dit manier hun “fitness” onder bepaalde 
omstandigheden te verhogen. Het is een belangrijk proces in niche adaptatie en ontwijking van 
het gastheer immuun systeem. Fenotypische variatie is intens bestudeerd in bvb Pseudomonas 
spp. of in E. coli. Bij luminescente Vibrio is het fenomeen echter veel minder bestudeerd, 
alhoewel vibriosis een zeer belangrijke ziekte is in aquacultuur. 
Vibrio harveyi, een luminescente Gram negatieve mobiele marine bacterie, is een belangrijke 
pathogeen verantwoordelijk voor ziekten bij garnalen, mariene vissen en mollusken met zware 
economische consequenties. Niet-luminescente V. harveyi (NL) kunnen bekomen worden door 
luminescente (L) stammen te kweken onder statische en donkere omstandigheden. Deze switch 
gaat gepaard met veranderingen op het niveau van de productie van virulentie factoren zoals 
metalloprotease en luxR. Hier wordt aangetoond (Hfst 3) dat de switch van de L naar  de NL 
status gepaard gaat met een verandering in fysiologische karakteristieken, zoals productie van 
caseinase, hemolytische activiteit, mobiliteit zoals zwermen, en biofilm aanmaak. De capaciteit 
om van status te veranderen is voor een groot deel onafhankelijk van de quorum sensing (QS) 
status, aangezien QS mutanten ook in staat waren deze switch te maken. 
In de volgende hoofdstukken (4 en 5) werd het gnotobiotisch Artemia model systeem (GART) 
gebruikt om de invloed van virulente en niet-virulent luminescente en niet-luminescente stammen 
van de wild type stam V. harveyi (BB120) en zijn QS triple-mutant (JMH634) op het immuun 
systeem te bestuderen. 
Het transcriptie niveau van acht verschillende immuun-gerelateerde genen, met onder andere 
“lipopolysaccharide en β-1,3-glucan binding protein” (lgbp), “down syndrome cell adhesion” 
molecules (dscam), peroxinectine (pxn), prophenoloxidase (proPO), transglutaminase (tgase), 
ferritine (ftn), “melanin inhibition protein” (mip) and serpin (spn) werden onderzocht onder 
Summary/ samenvating  
152 
 
blootstelling met deze bacteriële stammen om de hypothese te verifiëren dat veranderingen in de 
productie van virulentie factoren bij V. harveyi door fenotypische switch een rol zou kunnen 
spelen in de herkenning door de gastheer, met een verschillend patroon van gen expressie als 
gevolg. (Hfst 4). De resultaten van deze studie tonen aan dat de verandering in fenotype door een 
switch kan bijdragen tot  andere patronen van gen expressie die waarschijnlijk verbonden zijn 
met een andere dynamiek van infectie. Virulente stammen of stammen die meer virulentie 
factoren produceren, induceren proPO expressie vroeg na blootstelling aan de pathogeen, terwijl 
spn/mip genen (genen betrokken in het moderatie van phenoloxidase activiteit) pas later 
opgereguleerd worden, waarschijnlijk om proPO activiteit te controleren. Het lbgp gene komt 
constitutief tot expressie na blootstelling aan virulente stammen binnen de experimentele periode. 
Dit is eerder onverwacht aangezien genen lager in de “cascade” betrokken in het uitschakelen van 
bacteriën eerder neerwaarts gereguleerd worden naar het einde van het experiment. In de 
veronderstelling dat NL stammen tijdens de infectie terug kunnen “switchen” naar een L stam, 
zou het verschil in dynamiek van gen expressie na blootstelling aan BB120L en BB120NL 
kunnen verklaard worden. Een NL naar L switch werd echter nooit vastgesteld en interpretatie 
van de data blijft dus speculatief. 
Als antwoord op Vibrio infectie, ontwikkelt de gastheer een immunologische response, en herstel 
om cellulaire homeostasis en integriteit te bewaren en pathogeniteit te limiteren. Nochtans kan 
verwacht worden dat Vibrio in staat is om het immuun systeem te ontwijken via verschillende 
mogelijke strategieën. Onlangs toonden verschillende studies aan dat pathogene bacteriën in staat 
zijn om het gastheer immuun systeem te ontwijken door de gastheer translatie van mRNA te 
beïnvloeden. In deze studie (Hfst5) werd een poging ondernomen om aan te tonen dat V. harveyi 
in staat is translatie in de gastheer te beïnvloeden. De resultaten van de studie tonen dat bij 
HSP70 en hmgb1 er een discrepantie is tussen gen expressie en eiwit productie, 12 uur na 
blootstelling aan de pathogeen, waarbij er in de aanwezigheid van gen expressie er een 
gelimiteerde translatie plaatsgrijpt. 
De cDNA sequentie van Hmgb1 van Artemia franciscana werd geïsoleerd voor de eerste maal 
(Hfst 6). De resultaten tonen aan het  afgeleide eiwit ArtHmgb1 200 aminozuren bevat met een 
voorspeld MW van 26, 7 kDa. Er is een hoge graad aan aminozuur conservatie in vergelijking 
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met Hmgb1 van andere vertebraten en invertebraten. De geconserveerde domeinen van het gen 
hebben een hoge gelijkenis met de andere Hmgb1 genen, wat er op wijst dat ArtHmgb1 een 
nieuw lid is van de Hmgb familie, met gelijke functie. 
In conclusie, de resultaten van dit werk tonen aan dat in vitro productie van virulentie factoren 
en/of virulentie beïnvloed wordt door een fenotypische switch bij V. harveyi. Deze veranderingen 
tussen luminescente en niet-luminescente stammen van het wild type BB120 en de triple mutant 
JMH634 moduleren de response van het aangeboren immuun systeem met effecten op het niveau 
van Artemia overleving. Er is op dit ogenblik geen bewijs voor de ecologische relevantie van de 
beschreven fenotypen aangezien een switch van NL naar L stammen nooit is kunnen aangetoond 
worden, door het gebrek aan omgevingsomstandigheden die een dergelijke switch kan induceren.  
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The Ct value of the house keeping gene (efα1) and target genes (hmgb1 and hsp70). 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Code 
 
EFα1 HMGB1 HSP70 
Sample 1 NHS 1a 0h 20.5 26.6 27.8 
Sample 2 NHS 1b 0h 19.7 26.2 26.5 
Sample 3 NHS 1c 0h 19.3 25.4 28.0 
Sample 4 NHS 2a 6h 20.7 26.9 29.7 
Sample 5 NHS 2b 6h 19.5 25.1 28.2 
Sample 6 NHS 2c 6h 20.4 27.0 29.0 
Sample 7 NHS+120L 3a 6h 21.6 27.2 29.2 
Sample 8 NHS+120L 3b 6h 20.4 27.4 28.4 
Sample 9 NHS+120L 3c 6h 21.7 27.5 28.6 
Sample 10 NHS+120NL 4a 6h 18.9 28.3 24.8 
Sample 11 NHS+120NL 4b 6h 18.3 27.9 24.7 
Sample 12 NHS+120NL 4c 6h 18.4 28.1 24.7 
Sample 13 NHS+634L 5a 6h 18.4 25.4 25.5 
Sample 14 NHS+634L 5b 6h 18.0 25.3 25.6 
Sample 15 NHS+634L 5c 6h 19.0 25.7 25.8 
Sample 16 NHS+634NL 6a 6h 18.6 24.7 25.7 
Sample 17 NHS+634NL 6b 6h 18.6 25.3 25.7 
Sample 18 NHS+634NL 6c 6h 18.9 25.0 25.7 
Sample 19 NHS 7a 12h 18.9 25.5 24.9 
Sample 20 NHS 7b 12h 18.5 25.4 24.8 
Sample 21 NHS 7c 12h 18.6 25.0 24.8 
Sample 22 NHS+120L 8a 12h 18.7 25.2 25.2 
Sample 23 NHS+120L 8b 12h 18.8 25.1 24.7 
Sample 24 NHS+120L 8c 12h 18.8 25.3 25.2 
Sample 25 NHS+120NL 9a 12h 18.5 26.0 24.8 
Sample 26 NHS+120NL 9b 12h 18.5 24.9 25.0 
Sample 27 NHS+120NL 9c 12h 18.6 25.2 25.2 
Sample 28 NHS+634L 10a 12h 18.4 25.2 26.0 
Sample 29 NHS+634L 10b 12h 18.8 25.8 26.5 
Sample 30 NHS+634L 10c 12h 18.2 26.2 25.6 
Sample 31 NHS+634NL 11a 12h 18.7 26.1 28.1 
Sample 32 NHS+634NL 11b 12h 18.3 25.9 27.2 
Sample 33 NHS+634NL 11c 12h 18.3 25.3 27.3 
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